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Abstract 
PEBPs (PhosphatidylEthanolamine Binding Proteins) form a protein family widely present in the 
living world since they are encountered in microorganisms, plants and animals. In all organisms 
PEBPs appear to regulate important mechanisms that govern cell cycle, proliferation, 
differentiation and motility. In humans, three PEBPs have been identified, namely PEBP1, 
PEBP2 and PEBP4. PEBP1 and PEBP4 are the most studied as they are implicated in the 
development of various cancers. PEBP2 is specific of testes in mammals and was essentially 
studied in rats and mice where it is very abundant. A lot of information has been gained on 
PEBP1 also named RKIP (Raf Kinase Inhibitory protein) due to its role as a metastasis 
suppressor in cancer. In contrast, PEBP4 is known to favor tumor growth in various cancers, but 
was less studied than PEBP1. The many studies carried out on PEBP1 has demonstrated its 
implication in cancer but also in Alzheimer’s disease, diabetes and nephropathies. PEBP1 was 
also described to be involved in many cellular processes, among them are signal transduction, 
inflammation, cell cycle, proliferation, adhesion, differentiation, apoptosis, autophagy, circadian 
rhythm and mitotic spindle checkpoint. On the molecular level, PEBP1 was demonstrated to 
regulate several signaling pathways such as Raf/MEK/ERK, NF-B, PI3K/Akt/mTOR, p38, 
Notch and Wnt. PEBP1 acts by inhibiting most of the kinases of these signaling cascades. 
Moreover, PEBP1 is able to bind to a variety of small ligands such as ATP, phospholipids, 
nucleotides, flavonoids or drugs. Considering PEBP1 is a small cytoplasmic protein (21kDa), its 
molecular features and its involvement in so many diseases and cellular mechanisms are 
amazing. The aim of this review is to highlight the molecular systems that are common to all 
these cellular mechanisms in order to decipher the specific role of PEBP1. Recent discoveries in 
the organization of cellular systems enable us to propose that PEBP1 is a modulator of molecular 
interactions that control signal transduction during membrane and cytoskeleton reorganization. 
 
1- Introduction 
 
PhosphatidylEthanolamine Binding Proteins (PEBPs) are a family of proteins implicated in 
numerous cellular processes in a large number of living organisms such as bacteria, yeasts, 
parasites, plants, insects and animals. Several PEBP isoforms were encountered in each specific 
species. In mammals, the main expressed isoform was firstly discovered and characterized in the 
brain from bovine (1, Bernier 1984; 2, Schoentgen), human (3, Seddiqi) and rat (4, Grandy), 
where it was associated with membranes and phospholipids. Studies measuring the affinity of this 
isoform toward different phospholipids showed a preference for phosphatidylethanolamine (PE) 
(5, Besnier 1986), then designated PEBP1. Later on, it was described to also bind other small 
ligands such as nucleotides (6, Bucquoy), flavonoids (7, Kim) or drugs (8, Dadvar). The PEBP1 
isoform was described to be present in almost all the tissues in mammals. Furthermore, it was 
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described to be downregulated in numerous types of cancer, the disappearance of PEBP1 in 
tumor cells being concomitant with metastases development (9, Lamiman, for a review), thus 
PEBP1 is considered a suppressor of metastases (10, Keller). In mammals, another PEBP 
isoform was identified, it appeared to be specific of testes with a role in mammal 
spermatogenesis and post-testicular sperm maturation (11, Hickox) and it was called PEBP2. 
Lastly, in humans, a third isoform was identified to be overexpressed in cells of several cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
tumors, it was called PEBP4 (12, Wang 2004). It should be noted that PEBP3 was never 
described to be expressed in any human tissue, probably corresponding to a pseudogene. 
Given the presence of PEBP1 in almost all human tissues and the observation that PEBP1 
downregulation leads to metastases, numerous studies were conducted to understand its 
mechanism of action. One major discovery was the inhibitory effect of PEBP1 toward Raf1, a 
kinase of the signaling pathway Raf/MEK/ERK (13, yeung 1999). This discovery prompted the 
authors to redefine PEBP1 as a Raf Kinase inhibitory protein (RKIP). Since then, PEBP1 was 
described to regulate many other protein kinases implicated in various signaling pathways such as 
NF-B, GPCRs, STAT3, GSK3 (14, Shin; 15, Raikumar) PI3K/Akt/mTOR (16, Lin), Wnt (14, 
shin), p38 (17, Lai) and Notch1 (18, Noh). Among the various properties of PEBP1, it was 
identified as a precursor of a hippocampal cholinergic neurostimulating peptide (HCNP) (19, 
Ojika 1992), so it is sometimes called HCNPpp (HCNP precursor protein) (20, Bassi). HCNP 
corresponds to the first 11 amino acids in N-terminal of PEBP1. This peptide was encountered in 
brain tissue where it enhances acetylcholine synthesis in the hippocampal medial septal nuclei 
(21, Ojika 1994). It was also observed to display a cardiotropic action by enhancing the 
cholinergic-mediated negative inotropy of rat heart through direct interaction with the G-protein-
coupled muscarinic receptor pathway (22, Angelone). The crystallographic structure of bovine 
(23, Serre) and human (24, Banfield) PEBP1 was solved, revealing one unique domain having a 
beta-fold and formed by two antiparallel β sheets in a Greek-key topology. A small cavity close 
to the protein surface has a high affinity for anions, such as phosphate, acetate, 
phosphorylethanolamine or cacodilate molecules and was identified as the binding site of PEBP1. 
Thus, presently, a lot of information is available about the molecular features of PEBP1, its 
binding properties toward small ligands, its implication in main cellular processes through its 
interaction with numerous protein partners, the regulation of its expression and its role in several 
diseases. However, there is no general explanation for the apparent diversity of PEBP1 biological 
functions. Clearly, it is not just a phosphatidylethanolamine binding protein, nor only a Raf 
kinase inhibitory protein, neither just an hippocampal cholinergic neurostimulating peptide 
precursor (25, Skinner). Then, one can wonder: how does PEBP1, a small 21kDa protein, 
perform such diverse functions? What is its mode of action? Are there common molecular 
mechanisms in the main cellular processes that could explain the implication of PEBP1 in several 
of them? 
In this review article, we attempt to highlight the facts and the convergences that could 
explain the general and original behavior of PEBP1 and its astonishing and unique role in cellular 
regulation and homeostasis. PEBP1 appears to be a fascinating protein controlling the intimate 
and subtle interactions between important molecular players in the cells. 
The first sections of this review are dedicated to an overview of the main properties and 
functions of PEBP1; then the following sections are devoted to the relationships and common 
features between the cellular processes implying PEBP1. These comparisons aim to decipher the 
special role of PEBP1 in cells. 
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2- Generalities on PEBP1 
 
2.1- Role of PEBP1 in physiological processes and diseases 
 
Surprisingly, PEBP1 was described to influence a considerable number of cell 
physiological behaviors, among them we can enumerate cell growth and differentiation (26, 
Hellmann; 27, Sagisaka 2010; 28, Toyoda), proliferation (29, Li 2014; 30, Zou; 31, Liu; 32, 
Zang), migration (33, Lei; 34, Xinzhou ; 35, Han), motility (36, Al-Mulla 2012; 33, Lei; 37, 
Dai), cell cycle (38, Al-Mulla 2011), genomic stability (39, Eves; 40, Al-Mulla 2008), apoptosis 
(31, Liu 2014; 41, Zuo; 42, Lin; 43, Wei), autophagy (44, Noh; 45 Wen), drug resistance (46, 
Li 2014; 47, Chen; 48, Bonavida), spermatogenesis (49, Moffit; 50, Klysik ), mechanical and 
oxidative stress (51, Głombik; 52, Li 2010; 53, Al-Mulla 2012), adhesion (54, Mc Henry; 55, 
Das), neuronal synapse (56, Kato; 57, Mizuno) and immunity (58, Gu; 59, Wright; 60, Wang 
2016). However, the growing interest of the researchers in investigating PEBP1 properties is due 
mainly to its implication in diseases. Some of the pathologies modulated by PEBP1, such as 
cancer, Alzheimer’s disease diabetes and ciliopathies, are major challenges in public health. 
2.1.1- PEBP1 in cancer 
A great number of papers have indicated that the downregulation of PEBP1 expression in 
tumor cells is crucial for development of metastases and patient survival. Loss of PEBP1 
expression has been clearly demonstrated in a large variety of cancers, affecting breast, prostate, 
brain, lung, liver, colorectal, endometrial, esophageal, gastric, renal, pancreatic, nasopharyngeal, 
melanoma (9, Lamiman for a review). For the most part, the effect of PEBP1 decrease in cancer 
appeared to be due to promotion of metastases and loss of PEBP1 pro-apoptotic activity. Finally, 
PEBP1 appeared to be a clinically relevant suppressor of metastases that may function by 
decreasing vascular invasion (61, Fu). 
2.1.2- PEBP1 in brain functioning  
In brain, apart its role in cancer, PEBP1 was also described to be involved in circadian 
rhythm, synaptic long term depression (LTD), neural development and differentiation, stress and 
depression, and Alzheimer’s disease (62, Ling). 
Circadian clock 
Activation of the MAPK/ERK signaling cascade in the suprachiasmatic nucleus (SCN), a 
region of the anterior hypothalamus, is a key event that couples light to circadian clock 
entrainment. An important role of PEBP1 in the regulation of MAPK/ERK signaling in the SCN 
and in photic entrainment of the SCN clock was demonstrated (63, Antoun). 
Long-term depression 
Long-term depression (LTD) is a mechanism that is used in different brain regions to 
influence synaptic plasticity which is the basis for many forms of learning and memory. It was 
suggested that a positive feedback loop, including protein kinase C (PKC), mitogen-activated 
protein kinase (MAPK) and PEBP1, is required for the gradual expression of cerebellar LTD (64, 
Yamamoto 2012). 
Neural development 
First studies showed that the peptide HCNP stimulated the development and differentiation 
of cholinergic neurons in cultures of rat medial septal nuclei, by enhancing the activity of choline 
acetyltransferase and thus promoting acetylcholine synthesis (19, Ojika 1992; 21, Ojika 1994). 
Similar findings were observed in rat hippocampal progenitor cells, where endogenous PEBP1 
expression closely correlated with differentiation into neurons and oligodendrocytes, but not 
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astrocytes (27, Sagisaka). Consistent with this, overexpression of PEBP1 promoted neuronal and 
oligodendrocyte differentiation, whereas PEBP1 silencing promoted differentiation into 
astrocytes (27, Sagisaka). 
Stress and depression 
Chronic restraint-induced stress downregulated the expression of PEBP1 in the rat brain; a 
parallel reduction in PEBP1 was observed in rat hippocampal cell lines stimulated with the 
synthetic glucocorticoid (stress hormone) dexamethasone (65, Kim 2007). PEBP1 transgenic 
mice exhibited enhanced depressive-like behavior that was apparent in aged subjects (30 weeks 
old) but not a younger cohort (12 weeks old) (66, Matsukawa). The cognitive impact of PEBP1 
overexpression was restricted to depression, as behaviors associated with anxiety and spatial 
learning and memory were not affected in these animals (66, Matsukawa). 
Alzheimer’s disease 
Several hypotheses have been proposed to provide a causative basis for Alzheimer’s 
disease (AD) (67, de la Torre). One of these, the cholinergic hypothesis, proposed that the 
cognitive impairments in AD patients are the result of a deficiency in acetylcholine synthesis, 
which, is promoted by HCNP, the peptide corresponding to the N-terminal part of PEBP1 (68, 
Bartus; 69, Maki). Additionally, HCNP/PEBP1 has been shown to accumulate in Hirano bodies, 
which are intracellular aggregates found in nerve cells of the elderly and patients with certain 
forms of neurodegenerative diseases (70, Mitake). 
2.1.3- PEBP1 in diabetic nephropathy and retinopathy 
In rats with diabetic nephropathy, the expression level of PEBP1 in glomerular tissue was 
downregulated and the expression level of NF-B was upregulated. With rituximab treatment, 
expression levels of PEBP1 and NF-κB were, respectively, upregulated and downregulated, and 
the concentrations of 24-h urine protein were also decreased. These results suggested that 
expression levels of PEBP1 might be regulated by rituximab via NF-κB (71, Li 2013). 
Otherwise, PEBP1 was upregulated in the insulin-targeting tissues (liver, muscle and fat) in type 
II diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats fed with fenofibrate, suggesting a 
role of PEBP1 in the improvement of insulin sensitivity and control of lipid metabolism (72, 
Hahm). It is worth noting that lower levels of PEBP1 were detected in the vitreous humor from 
type 2 patients with proliferative diabetic retinopathy, this result was related to the possible 
involvement of PEBP1 in neovascularization and cell cycle progression (72, Hahm).  
2.1.4- PEBP1 in olfaction deficit and ciliopathies 
The PEBP1−/− mice are viable and PEBP1 function appears to be largely dispensable 
during embryonic development. However, the PEBP1−/− mice display an olfaction deficit that is 
apparent by four months of age but increases in severity by 5–8 months. Moreover, the results 
also suggested that the mutation is associated with a general learning deficit (73, Theroux). This 
data are to be compared with the observation that in Drosophila, PEBP orthologues reside in 
antennae and olfactory hairs and play a role in odorant binding (74, Pikielny). 
In another study, mutations in CEP290 (a centrosomal protein of 290 kDa) resulted in 
relatively early onset severe retinal degeneration and dysfunction in mice and humans. PEBP1 
prevents cilia formation and is associated with Cep290-mediated photoreceptor degeneration in 
retina. Cep290-mediated photoreceptor degeneration is associated with aberrant accumulation of 
PEBP1 (75, Murga-Zamalloa). This data implicates CEP290-PEBP1 pathway in CEP290-retinal 
degeneration and suggests that targeting PEBP1 levels can delay photoreceptor degeneration (76, 
Subramanian). 
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2.2- PEBP1 is a modulator of signaling pathways 
PEBP1 was described to regulate the Raf/MEK/ERK by competitively disrupting the 
interaction between Raf-1 and MEK. By inhibiting the phosphorylation and activation of MEK 
by Raf-1, PEBP1 appeared as the only physiological endogenous inhibitor of the Raf/MEK/ERK 
cascade, a highly conserved signaling pathway that regulates cell growth, differentiation, 
migration, and apoptosis (13, Yeung 1999). Today, PEBP1 is admitted to interplay with many 
pivotal intracellular signaling cascades that control cellular growth, proliferation, division, 
differentiation, motility, apoptosis, genomic integrity, and therapeutic resistance (77, Al-Mulla 
2013). Here, we discuss briefly the main cascades and downstream effectors known to be 
regulated by PEBP1 and especially, we put emphasis on the crosstalk between most of these 
pathways (see Figure 1). 
 
2.2.1- Raf/MEK/ERK pathway 
The discovery that PEBP1 was an endogenous inhibitor of the Raf/MEK/ERK signaling 
pathway was the first study elucidating the role for PEBP1 in a main cellular signaling cascade. It 
was demonstrated that PEBP1 binds directly either to Raf1 and MEK. Furthermore, PEBP1 was 
also found to bind MEK and ERK, which subsequently caused Raf-1 to dissociate from MEK 
(78, Yeung 2000). In cancer, the downregulation of PEBP1 in metastases and invasive cells has 
been described for different types of cancer such as breast (79, Hagan), prostate (80, Fu 2006), 
colorectal (81, Koelzer), cervical cancers (82, Martinho) and melanoma (83, Schuierer). The 
effect of PEBP1 downregulation on ERK activation was reported in prostate cancer (61, Fu 
2003), hepatocellular cancer cells (84, Lee), and gastric cancer (85, Guo). However, whether 
cancer metastasis is linked to the ERK pathway is not always clear and the effect of PEBP1 loss 
on the Raf/MEK/ERK cascade seems to be cell-type dependent (86, Vandamme). In addition to 
Raf-1, PEBP1 could also bind to the B-Raf isoform and antagonized its kinase activity in 
melanoma cancer cells. (87, Park). 
 
2.2.2- G protein-coupled receptors (GPCRs) and G receptor kinase (GRK2)  
PEBP1 has been implicated in the control of G-protein coupled receptors (GPCR) signaling 
cascade (88, Lorenz). GPCRs belong to a large family of membrane receptors implicated in 
numerous cellular processes. G protein-coupled receptor kinase 2 (GRK2) phosphorylates 
activated receptors which causes them to dissociate from G proteins and leads to GPCR 
internalization. It was demonstrated that the PKC isoforms -, and atypical 
PKC phosphorylate PEBP1 at Ser153. The phosphorylated PEBP1 releases from Raf1 and then 
binds to GRK2. The inhibition of GRK2 by the phosphorylated form of PEBP1 then blocks the 
GPCRs internalization (89, Corbit). More recently, it was seen that, in non-inflamed tissue, Delta 
Opioid Receptors (DOR) are maintained in an analgesically incompetent state by association with 
GRK2. This interaction prevents G subunit association with the receptor DOR, reducing its 
activity. In inflamed tissue, PKC phosphorylates PEBP1 which, in turn, sequesters GRK2 in the 
cytosol, restoring DOR functionality in sensory neurons (90, Brackley). 
 
2.2.3- NF-B pathway  
In response to stimulation with necrosis factor alpha (TNF) or interleukin 1 beta, PEBP1 
was demonstrated to act upstream of the kinase complex that mediates the phosphorylation and 
inactivation of the inhibitor of NFB (IB). Similarly to its action upon the Raf/MEK/ERK 
pathway, PEBP1 physically interacted with four kinases of the NF-kappaB activation pathway: 
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NF-kappaB-inducing kinase (NIK), transforming growth factor beta-activated kinase 1 (TAK1), 
and the inhibitor of kappaB (IB) kinases IKKalpha, and IKKbeta, inhibiting them (91, Yeung 
2001). Since then, other studies gave evidence of the NFB pathway modulation by PEBP1. 
Indeed, it was demonstrated that PEBP1 plays a key role in neural cell apoptosis caused by 
oxygen-glucose deprivation (OGD) partly via regulating NFκB and ERK. PEBP1 overexpression 
significantly increased the cell viability of OGD cells, and attenuated apoptosis, cell cycle arrest, 
and reactive oxygen species generation. It was found that PEBP1 interacts with TAK1, NIK, 
IKK, and Raf-1 and negatively regulates the NFκB and ERK pathways (92, Su). In cultured 
cancer cells, the presence of PEBP1 favored the optimal ubiquitination of interleukine-1 receptor-
associated kinase (IRAK), TNF receptor-associated factor 6 (TRAF6), and TAK1 as well as the 
assembly of the IKK complex. PEBP1 seemed to function as a scaffold protein facilitating the 
phosphorylation of IB by upstream kinases IKKs. Interestingly, contrary to what one would 
expect of a scaffold protein, the results showed that PEBP1 has an overall inhibitory effect on the 
NFB transcriptional activities (93, Tang). In the intestine, the PEBP1 expression is positively 
correlated with the severity of inflammatory bowel disease. Mechanistically, PEBP1 enhances the 
induction of p53-upregulated modulator of apoptosis by interacting with TAK1 and promoting 
TAK1-mediated NFκB activation (42, Lin W). 
 
2.2.4- PI3K/Akt pathway  
In nasopharyngeal carcinoma (NPC), PEBP1 was frequently downregulated in the 
radioresistant tissues compared with radiosensitive tissues.  PEBP1 reduction promoted NPC cell 
radioresistance by increasing ERK and Akt activity, and Akt may be a downstream transducer of 
ERK signaling in clinical samples. These data highlighted a PEBP1-ERK-Akt signaling axis in 
NPC radiosensitization (94, Yuan). The expression of PEBP1 was markedly decreased in mouse 
retina following optic nerve crush (ONC). Furthermore, overexpression of PEBP1 inhibits retinal 
ganglion cells apoptosis and promotes axonal regeneration after ONC. It was shown that 
overexpression of PEBP1 increased the phosphorylation in ERK1/2 and Akt in the injured retina 
(95, Wei J). Finally, it was shown that the regulation of PEBP1 by didymin in hepatic fibrosis 
leads to inhibit ERK and PI3K/Akt pathways (16, Lin X). 
 
2.2.5- GSK3β, p38 MAPK and Wnt pathways 
PEBP1 levels in human colorectal cancer positively correlate with the expression of 
glycogen synthase kinase-3 (GSK3. GSK3 suppresses tumor progression by downregulating 
multiple oncogenic pathways including Wnt signaling and cyclin D1 activation. PEBP1 binds 
GSK3 proteins and maintains GSK3 protein levels. Depletion of PEBP1 augments oxidative 
stress–mediated activation of the p38 mitogen activated protein kinase, which, in turn, inactivates 
GSK3 (96, Al-Mulla 2011). On HEK293 cells, PEBP1 silencing induced an intense oxidative 
stress response that includes the activation of p38 MAPK. Activated p38 MAPK triggers the 
phosphorylation of numerous downstream proteins and kinases. Particularly, activated p38 
MAPK leads to phosphorylation and stabilization of the tumor suppressor protein p53, resulting 
in the induction of a p53-dependent G1/S and G2/M arrest, cellular growth inhibition, and 
apoptosis (86, Vandamme). Furthermore, the activation of p38 MAPK inhibits GSK3β by 
phosphorylating its inhibitory T390 residue (97, Thornton). PEBP1 prevents the inhibitory 
phosphorylation of GSK3 by p38 MAPK and also stabilizes GSK3β. It was found that PEBP1 
regulates GSK3β in two ways : first, by binding and maintaining GSK3β protein levels, and 
second, by preventing the p38 MAPK mediated inhibitory phosphorylation of GSK3β (96, Al-
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Mulla 2011). It should be mentioned that PEBP1 was also observed to stabilize Kelch-like ECH-
associated protein 1 (KEAP1) in colorectal cancer. KEAP1 is known to interact with nuclear 
factor 2 (NRF2) playing a central role in protecting cells against oxidative and xenobiotic stress. 
The Keap1–Nrf2 pathway counteracts ROS-mediated damage in cancers and neurodegenerative 
diseases. In colorectal cancer, PEBP1 loss causes a rapid reduction in the basal level of KEAP 1 
protein by accelerating its rate of degradation, inducing NRF2 nuclear accumulation and the 
transcriptional upregulation of NRF2-dependant drug resistant genes (53, Al-Mulla 2012). 
 
2.2.6- STAT3 
The signal transducer and activator of transcription 3 (STAT3) was described to play a role 
in correlation with PEBP1 in various types of cancer. In breast and prostate cancer cells, PEBP1 
overexpression inhibited c-Src auto-phosphorylation and activation, as well as IL-6-, JAK1 and 
2-, and Raf-mediated STAT3 activation. PEBP1 overexpression resulted in constitutive physical 
interaction with STAT3 and blocked c-Src and STAT3 association. Thus, PEBP1 was 
demonstrated to physically interact with STAT3. PEBP1 synergizes with microtubule inhibitors 
such as taxols to induce apoptosis and inhibit STAT3 activation of breast and prostate cancer 
cells (98, Yousuf). In gastric cancer, data suggested that PEBP1 inhibits gastric cancer metastasis 
via the downregulation of its downstream target genes STAT3 and cyclin D1 (99, Zhang).  
Consistently, in nasopharyngeal carcinoma (NPC) PEBP1 downregulation promoted NPC 
invasion, metastasis and epithelial–mesenchymal transition by activating STAT3 signaling. A 
direct interaction between PEBP1 and STAT3 was shown, leading to a reduced phosphorylation 
of STAT3 (100, He).  
 
2.2.7- LIN28 and Let-7 miRNA 
PEBP1 was described to suppress a metastasis signaling cascade involving LIN28 and let-7 
miRNA (101, Dangi-Garimella). The role of PEBP1 and let-7 was particularly supported in 
metastatic breast cancer. In this case, PEBP1 inhibits the let-7 targets HMGA2 and BACH1 that 
in turn upregulate bone metastasis genes encoding matrix metalloproteinase 1 (MMP1), 
osteopontin (OPN) and Chemokine (C-X-C motif) receptor 4 (CXCR4) (102, Yun). The 
implication of PEBP1 and let-7 was also highlight in neuroblastoma, where didymin overcomes 
drug-resistance in p53-mutant neuroblastoma through PEBP1-mediated inhibition of MYCN 
(103, Singhal). In esophageal cancer, other studies clearly demonstrated that PEBP1 inhibits cell 
invasion by downregulating the expression of GRK-2, LIN28 and MMP-14 (104, Zhao). It is 
known that the let-7 microRNAs and their antagonists, the Lin28 RNA-binding proteins, control 
the timing of embryonic development (105, Moss). This pathway was also shown to regulate 
glucose metabolism in adult mice and to reprogram metabolism during tissue injury and repair 
(106, Shyh-Chang).  In cancer, malignant cells exhibit major metabolic alterations. When 
expressed in multiple cancer cell lines, Lin28 actively promotes aerobic glycolysis while 
inhibiting mitochondrial OxPhos to facilitate cancer proliferation. Moreover, conditionally 
overexpressing human LIN28B in the liver resulted in the development of liver cancer, with 
histological features of both hepatoblastoma and hepatocellular carcinoma (107, Nguyen). 
 
2.2.8- Crosstalk between pathways 
It is to note here that PEBP1 interacts with various kinases implicated in several cellular 
signaling cascades. Another important note is that crosstalk was described between most of these 
pathways, either in normal or in pathological conditions (Figure 1). In particular, crosstalk 
between two main pathways regulated by PEBP1, namely Raf/MEK/ERK and PI3K/Akt/mTOR 
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was found during brain ischemia/reperfusion. The findings suggested that Raf/MAPK/ERK1/2 
signal pathway was inhibited by Akt via direct phosphorylation and inhibition at Raf-1 node 
during ischemia. During reperfusion, the ROS-dependent increase in phosphatase and tensin 
homolog activity in relieved ERK1/2 from inhibition of Akt (108, Zhou 2015). Crosstalk 
between PI3 Kinase/PDK1/Akt/ Rac1 and Ras/Raf/MEK/ERK pathways was described 
downstream of platelet-derived growth factor (PDGF) receptor in human lung cells. It was 
proved that PI3K, PDK1, Akt, and Rac1 could activate ERK in MSTO-211H cells and that MEK 
and ERK could otherwise activate Akt and Rac1 (109, Niba). A functional and complex interplay 
between Akt/mTOR and Ras/MAKP pathways was described to promote rapid 
hepatocarcinogenesis in a well-defined mouse model, in vivo (110, Wang 2013). It appeared that 
a relationship may exist between Raf/MEK/ERK and Wnt pathways. Thus, crosstalk was 
described between Raf/MEK/ERK and Wnt during cartilage regeneration (111, Zhang 2014). In 
a theoretical study, a mathematical model suggested that multiple feedback loops implying 
PEBP1, Snail and GSK3beta are involved in crosstalk between Raf/MEK/ERK and Wnt 
pathways to regulate Epithelial-Mesenchymal Transition in the generation of invasive tumor cells 
(14, Shin 2010). In a series of various cancer types, a crosstalk between MAPK and Hedgehog-
GLI signaling pathways was also described (112, Rovida). Finally, there is compelling evidence 
that GSK3-Wnt-Lin28-let-7miRNA constitutes a central signaling axis in regulating proliferation 
and neurogenic potential of Müller glial cells in adult mammalian retina (113, Yao).  
 
2.3- Regulation of PEBP1 expression 
The downregulation of PEBP1 expression in cancer cells was correlated with development 
of metastases and resistance against chemical and immunological treatment. Thus, delineating the 
molecular mechanisms controlling the expression level of PEBP1was the focus a several studies. 
First, Snail was determined to be the repressor of PEBP1 transcription in metastatic prostate 
cancer cells (114, Beach, 2008). Then, a NFB-snail-RKIP circuitry was described to regulate 
both the metastatic cascade and resistance to apoptosis by cytotoxic drugs (115, Wu, 2009) and 
finally, a NFB/Snail/YY1/RKIP loop was proposed to regulate the resistance of cancer cells to 
chemo-immunological treatment (48, Bonavida 2014). More recently, the inverse correlation of 
expression between the metastasis suppressor PEBP1 and the metastasis inducer Yin Yang 1 
(YY1) was studied (116, Wottrich 2017). Analyses of the molecular regulation of the expression 
patterns of PEBP1 and YY1 as well as epigenetic, post-transcriptional, and post-translational 
regulation revealed the existence of several effector mechanisms and crosstalk pathways, of 
which five pathways of relevance have been identified and analyzed. The five examined crosstalk 
pathways include the following loops: PEBP1/NF-κB/Snail/YY1, 
p38/MAPK/PEBP1/GSK3β/Snail/YY1, PEBP1/Smurf2/YY1/Snail, PEBP1/MAPK/Myc/Let-
7/HMGA2/Snail/YY1, as well as PEBP1/GPCR/STAT3/miR-34/YY1. Each loop is comprised of 
multiple interactions and cascades that provide evidence for the negative regulation of PEBP1 
expression by YY1 and vice versa (116, Wottrich 2017).  
Contrary to the five loops that regulate PEBP1 expression in an inverse correlation of YY1, 
TWEAK (necrosis factor-like weak inducer of apoptosis) was described to regulate positively 
PEBP1 in colorectal cancer (117, Lin 2012). Tumor TWEAK is a member of the TNF (tumor 
necrosis factor) superfamily of cytokines that together are involved in many critical biological 
processes, including embryo development, organogenesis, tissue repair, and innate and adaptive 
immune responses. TWEAK has been also implicated in tumor development and progression. A 
cDNA microarray analysis identified a signature of 46 genes that were upregulated and 
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downregulated after recombinant TWEAK treatment for 3 and 6 h. One of the most strongly 
upregulated genes was PEBP1. Additionally, functional assays indicated that TWEAK protein 
reduced the invasive ability of colon cancer cells (117, Lin 2012).  
In human gastric cell line SGC-7901, the downregulation of PEBP1 expression was 
attributed to miR-224. It was concluded that miR-224 could negatively regulate the expression 
and biological characteristics of PEBP1, contributing to suppress the proliferation and invasion of 
gastric cells (31, Liu 2014). 
Aberrant DNA methylation in the promoter regions of genes, which leads to inactivation of 
tumor suppressor and other cancer-related genes, is the most well-defined epigenetic hallmark in 
gastric cancer (118, Qu). The frequency of methylation in the promotor region of PEBP1 
encoding gene in gastric cardia adenocarcinoma (GCA) tumor tissues was 62.1 %, i.e. 
significantly higher than that in corresponding normal tissues (4.1 %). The high promotor 
methylation level was associated with tumor stage, histological differentiation, depth of invasion, 
lymph node metastasis, distant metastasis and upper gastrointestinal cancers (UGIC) family 
history. These results suggested that epigenetic silencing of the PEBP1 promoter via 
hypermethylation may be one of the mechanisms for inactivation of PEBP1 in GCA, especially in 
patients with UGIC family history of North China (85, Guo 2013). The promoter 
hypermethylation of the gene encoding PEBP1 was also found to occur in Esophageal Squamous 
Cell Carcinoma (ESCC) and a close correlation was noted between PEBP1 gene methylation and 
the loss of mRNA and protein expression in ESCC specimens (119, Guo 2012). 
Independently of the regulation of the gene encoding PEBP1, the degradation of the 
expressed PEBP1 itself was also reported. In neurons, it was demonstrated that PEBP1 is a 
substrate of cyclin-dependent kinase 5 (CDK5) and that the phosphorylation of PEBP1 at T42 
causes the release of Raf-1. Moreover, T42 phosphorylation promoted the exposure and 
recognition of the target motif "KLYEQ" in the C-terminus of PEBP1 by chaperone Hsc70 and 
the subsequent degradation of PEBP1 via chaperone-mediated autophagy. Furthermore, in the 
brain sample of Parkinson's disease patients, CDK5-mediated phosphorylation and autophagy of 
PEBP1 were involved in the overactivation of the ERK/MAPK cascade, leading to S-phase 
reentry and neuronal loss (45, Wen). 
 
2.4- PEBP1 is a target for treatment and prevention in diseases 
The fight against cancer have resulted in two main research axes concerning PEBP1, 
namely 1) countering the resistance of cancer cells to drugs and 2) increasing the levels of PEBP1 
expression in order to prevent metastases development. 
2.4.1- The resistance of cancer cells to drugs 
As early as 2004, studies suggested that PEBP1 may represent a novel effector of signal 
transduction pathways leading to apoptosis, and a prognostic marker of the pathogenesis of 
human cancer cells and tumors after treatment with clinically relevant chemotherapeutic drugs 
(120, Chatterjee 2004). Several papers indicated an effect of some anti-cancer drugs on PEBP1 
expression level. Indeed, during treatment with rituximab, a chemosensitization of non-hodgkin 
lymphoma B cells was observed (121, Jazirehi). Rituximab was shown to sensitize non-
Hodgkin's lymphoma (NHL) cell lines to chemotherapeutic drug-induced apoptosis. Rituximab 
treatment of NHL B cells significantly up-regulated PEBP1 expression, thus interrupting the 
ERK1/2 signaling pathway through the physical association between Raf-1 and PEBP1, which 
was concomitant with Bcl-xL downregulation (121, Jazirehi). Nitrite oxide was also found to 
sensitize prostate carcinoma cell lines to TRAIL-mediated apoptosis (122, Huerta-Yepez). 
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Later on, studies have implicated the role of Nitric Oxide (NO) in the regulation of tumor 
cell behavior and have shown that NO either promotes or inhibits tumorigenesis. Treatment of 
metastatic cancer cell lines with DETANONOate inhibited the epithelial mesenchymal transition 
(EMT) phenotype, and thus tumor metastasis, through the NF-κB/Snail/YY1/PEBP1 loop (123, 
Bonavida 2011). Nitric oxide have the dual function of both inhibiting metastasis and sensitizing 
tumor cells to chemotherapy and immunotherapy (124, Bonavida 2008). A gene regulatory 
mechanism that inhibits, in large part, the cell death apoptotic pathways is the result of several 
inter-related gene products that form a loop and consist of the NF-κB/Snail/YY1/PEBP1/PTEN. 
The expressions and activities of NFκB, Snail and YY1 are upregulated whereas the expressions 
and the activities of PEBP1 and PTEN are downregulated. The upregulated gene products are 
involved in the cell survival and growth and the expression of anti-apoptotic gene products. The 
downregulated gene products are involved in the inhibition of cell survival and anti-apoptotic 
gene products. Treatment of tumor cells with high levels of NO donors resulted in the 
downregulation of the expression of NFκB, Snail and YY1 while upregulation of PEBP1 and 
PTEN. Hence, treatment of resistant tumor cells with NO resulted in both the chemo and 
immunosensitization of tumor cells to apoptosis, in vitro and in vivo (125, Bonavida 2015).  
More specifically, PhotoDynamic Therapy (PDT) against cancer has gained attention due to 
the successful outcome in some cancers, particularly those on the skin. NO revealed to be a 
modulator of PDT. By acting on the NFB/Snail/PEBP1 survival/anti-apoptotic loop, NO can 
either stimulate or inhibit apoptosis. Low-dose PDT induces low NO levels by stimulating the 
anti-apoptotic nature of the above loop, whereas high-dose PDT stimulates high NO levels 
inhibiting the loop and activating apoptosis (126, Rapozzi 2013). The anti-cytoprotective effect 
of PDT-induced NO was observed at high NO levels, which inhibit the anti-apoptotic 
(prosurvival) NFB and YY1 while inducing the pro-apoptotic (antisurvival) and metastasis 
suppressor PEBP1, resulting in significant anti-tumor activity. Thus, a successful application of 
NO in anticancer therapy requires control of its concentration in the target tissue. To address this 
issue Rapozzi et al. (127, Rapozzi 2017) proposed a bimolecular conjugate composed of a 
photosensitizer (Pheophorbide a) and a non-steroidal anti-androgen molecule capable of releasing 
NO under the exclusive control of light.  
 
2.4.2- Physical and chemical factors influencing levels of PEBP1 expression  
Independently of the role of NO on PEBP1 expression level, other physical and chemical 
factors were described to influence the levels of PEBP1 expression. Indeed, the expression level 
of PEBP1 is variable according to the tissue and to the cells investigated. Particularly, PEBP1 
expression differs between healthy and cancer tumor cells, a low level of PEBP1 promoting 
metastasis formation and being considered as a factor of bad prognostic in cancer. Apart from 
these observations other variations in PEBP1 expression were described depending on physical or 
chemical treatment of various cell types. 
The mechanical effect of flow was demonstrated on renal epithelial cells. In these cells, 
primary cilia act as mechanosensors in response to changes in luminal fluid flow. Primary cilia 
are nonmotile projections from polarized, highly differentiated epithelial cells (128, Praetorius). 
In the kidney, primary cilia are present on nearly all epithelial cells and extend from the apical 
surface into the tubular lumen, where they respond to luminal fluid flow. Recent studies suggest 
that primary cilia also serve an important role in the maintenance of cell differentiation. To 
determine the role of cilia bending in the mechanosensory function of cilia, a proteomic analysis 
of collecting duct cell lines with or without cilia was performed (129, Sas). A comparison 
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between cells kept stationary or rotated to stimulate cilia bending revealed that expression of 
PEBP1 was significantly elevated in rotated cilia (+) cells. Downstream of PEBP1, expression of 
phosphorylated ERK was decreased only in cells that had cilia and were subjected to constant 
cilia bending. A PKC inhibitor significantly reduced the levels of PEBP1 in rotated cilia cells 
suggesting that PKC has a role in PEBP1 regulation in response to cilia bending (129, Sas) These 
findings indicated that it may not be just the presence of cilia but rather ciliary movement that is 
essential for the maintenance of cell differentiation and suppression of cell proliferation and that 
this occurs, at least in part, through regulation of PEBP1. In terms of polycystic kidney disease, 
loss of cilia and therefore sensitivity to flow may lead to reduced PEBP1 levels, activation of the 
MAPK pathway, and contribute to the formation of cysts (129, Sas).  
Several drugs and natural products were demonstrated to act on the level of PEBP1 
expression. In prostate cancer cells, a significant increase in PEBP1 expression was observed in 
androgen-independent PC3 cells after treatment with the anti-cancer drug 9-nitrocamptothecin. 
Similarly, exposure to other genotoxic stimuli such as etoposide or cisplatin resulted in the 
induction of PEBP1 expression in the prostate carcinoma cell line DU145. In addition, similar 
results were also found in drug-sensitive and drug-resistant breast carcinoma cell lines (130, 
Odabaei). 
Proteomic analysis of rat hippocampus after chronic treatment with antidepressants, such as 
fluoxetine and venlafaxine, revealed up-regulation of PEBP1 (131, Khawaja). This was in 
accordance with the observation that PEBP1 decreased by stress exposure in rat brain could be 
restored by antidepressant treatment (65, Kim 2007). Chronic methamphetamine (a strong central 
nervous system stimulant) intake has been shown to induce a neuroinflammatory state leading to 
significant changes in brain functioning including behavioral changes. These changes can persist 
for years after drug use is discontinued and likely contribute to the risk of relapse. While 
methamphetamine intake was associated with reduced PEBP1 protein levels, treatment with 
ibudilast (an anti-inflammatory phosphodiesterase inhibitor) reversed this effect. Furthermore, 
Raf-1, MEK, and ERK expression levels were also attenuated by ibudilast treatment. It was 
suggested that PEBP1, given its synaptic localization and its role as a modulator of the 
ERK/MAPK pathway, could be a potential therapeutic target mediating drug-seeking behaviors 
associated with neuroinflammation (132, Charntikov).  
Very interestingly, several natural products were reported to upregulate PEBP1. Naturally 
occurring polyphenols found in food sources provide health benefits. Chemically, all polyphenols 
have one or more hydroxylated aromatic rings that account for both structural and 
physicochemical properties, and allow their classification into several chemical classes including 
lignans, flavonoids, stilbenes, isoflavones and phenolic acid derivatives. All polyphenols have 
reducing properties; they can donate hydrogen to oxidized cellular constituent, and play a 
significant role against oxidative stress-related pathologies, like cardiovascular diseases, cancer 
and variety of neurodegenerative disorders. Flavonoids are the most abundant polyphenols 
consumed by peoples worldwide; therefore, many researchers focused on the effects of many 
flavonoids like resveratrol, quercetin, epigallocathechin-3-gallate (EGCG), rutin and curcumin, as 
a health promoting compounds in treatments of several diseases (133, Hussain). As PEBP1 
appears to be a target for cancer therapy, modulation of PEBP1 expression using different natural 
agents was studied in cancer cells (134, Farooqi). American ginseng extracts tested on MCF-7 
human breast cancer cells produced a decrease in phospho-MEK1/2 and -ERK1/2 and an increase 
in phospho-Raf-1. Furthermore, in these tests, American ginseng appeared to inhibit breast cancer 
cell proliferation by increasing the expression of PEBP1, resulting in inhibition of the MAPK 
pathway (135, King).  
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PEBP1 expression was considerably enhanced in pancreatic adenocarcinoma cells treated 
with epigallocatechin gallate (EGCG). EGCG induced PEBP1 upregulation via the inhibition of 
histone deacetylase (HDAC) activity which increased histone H3 expression and inhibited Snail 
expression, NFκB nuclear translocation, MMP-2 and -9 activity and Matrigel invasion in AsPC-1 
cells. These results strongly suggest that EGCG regulates RKIP/ERK/NFκB and/or 
RKIP/NFκB/Snail and inhibits invasive metastasis (7, Kim 2013).  
Dihydroartemisinin (DHA) inhibited the proliferation of Hela and Caski cervical cancer 
cells in a dose-dependent and time-dependent manner. Apoptosis was significantly upregulated in 
DHA-treated cells and this upregulation of apoptosis was associated with an increase in the levels 
of PEBP1 and a decrease in the levels of bcl-2. In addition, DHA inhibited tumor growth in nude 
mice bearing Hela or Caski tumors (136, Hu).  
In human hepatocellular carcinoma cell line HepG-2, silibinin inhibited cell proliferation, 
matrix metalloproteinase 2 enzymatic activity, NO production and ERK 1/2 phosphorylation in a 
dose-dependent manner without exerting any cytotoxicity effect. An expressive increase in 
mRNA levels of PEBP1, Spred-1 and Spred-2 was coupled with a significant reduction in 
transcriptional levels of Hec1 and MMP-2. These data suggested that silibinin treatment could 
inhibit cell proliferation and invasive potential of HepG2 cells through inhibition of ERK 1/2 
cascade both directly (through suppression of ERK 1/2 phosphorylation) and indirectly (through 
up-regulation of PEBP1, Spred-1 and Spred-2) (137, Momeny).  
Today, didymin is a flavonoid that is studied for its action in cancer. The orally 
administered didymin, an active citrus flavonoid, causes regression of neuroblastoma xenografts 
in mouse models, without toxicity to non-malignant cells, neural tissues, or neural stem cells. In 
these models, PEBP1 that regulates the activation of the transcription factor MYCN, is 
transcriptionally upregulated by didymin, and appears to play a key role in the anti-
neuroblastoma actions of didymin (103, Singhal). Didymin from Origanum vulgare (OVD) was 
assessed on human HepG2 liver carcinoma cells. The results showed that OVD induces apoptosis 
against of HepG2 cells through mitochondrial dysfunction and inactivation of the ERK/MAPK 
and PI3K/Akt pathways by up-regulating PEBP1. OVD significantly induced apoptosis and 
induced cell cycle arrest at G2/M phase by regulating cyclin B1, cyclin D1 and CDK4. The anti-
proliferative and pro-apoptotic effects were associated with changes in the Bcl-2/Bax ratio and 
induction of caspase-mediated apoptosis. Moreover, OVD attenuated the mitochondrial 
membrane potential, accompanied by the release of cytochrome C (43, Wei 2017).  
Other studies showed that OVD treatment significantly reduced CYP2E1 activity, lipid 
peroxidation level, ROS generation, NO production and pro-inflammatory cytokines (such as 
TNF-α, IL-6 and IL-1β) in liver tissues and RAW 264.7 cells, but enhanced the hepatic 
antioxidative enzymes activities. OVD significantly inhibited the NFκB and MAPK pathways by 
up-regulating PEBP1 expression (138, Huang).  
 
3- Molecular partners of PEBP1 
 
3.1- Proteins interacting with PEBP1 
Above, we have described the physical interaction between PEBP1 and kinases belonging 
to several signaling pathways. However, PEBP1 was suggested to interact with many other 
proteins including kinases, small GTPases, centrosomal proteins, cytoskeletal proteins, glycolytic 
enzymes, molecular chaperones, mitochondrial proteins as well as proteins implicated in protein 
biosynthesis and transport of proteins and vesicles. By describing these partners of PEBP1, we 
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take the opportunity to underline the properties of these proteins as much as their functions 
correlate with those of PEBP1.  
3.1.1- Phosphorylation of PEBP1 by several kinases 
Apart from the phosphorylation of PEBP1 at S153 by PKC, several other phosphorylated 
sites were described on PEBP1, particularly residues S6, T42, S52, S54, S98, S99 and S109. As 
described below, different kinases are responsible for these phosphorylations, particularly CDK5, 
TBK1 and ERK. The phosphorylated sites have the effect of modifying and specifying the 
interactions between PEBP1 and its partners. The phosphorylation of residues S6 and S98 was 
observed in liver phosphoproteome (139, Bian). A quantitative atlas of mitotic phosphorylation 
indicated that the PEBP1 T42 was unphosphorylated in the G1-phase but was phosphorylated in 
M-phase while S52 and S54 were phosphorylated in G1 and M (140, Dephoure). In neurons, it 
was demonstrated that PEBP1 is a substrate of CDK5 leading to the phosphorylation of PEBP1 at 
T42 that promotes the recognition of PEBP1 by Hsc70 and the subsequent degradation of PEBP1 
via chaperone-mediated autophagy (45, Wen). S99 was mentioned as a residue subjected to 
phosphorylation by ERK activation (77, Al-Mulla 2013). Finally, upon viral infection, PEBP1 
was observed to be phosphorylated at S109 by TANK-binding kinase 1 (TBK1) in bone marrow-
derived macrophages. Phosphorylation at S109 was observed only in PEBP1 purified from 
vesicular stomatitis virus-treated cells while that at S52 was observed in PEBP1 from both 
vesicular stomatitis-treated or untreated cells (58, Gu 2016). 
 
3.1.2- Interaction of PEBP1 with LC3, syntenin, CEP290, Rab8A and relationships with 
Aurora B 
Recently, PEBP1 was described to be implicated in important cellular mechanisms such as 
autophagy, primary cilium formation, mitotic spindle checkpoint, chromosome segregation and 
vesicular traffic by directly interacting with key proteins known to control these mechanisms. 
3.1.2.1- LC3 
Autophagy plays a critical role in maintaining cell homeostasis in response to various 
stressors, especially starvation or hypoxia. During autophagy, autophagosomes engulf 
cytoplasmic components, including cytosolic proteins and organelles. Concomitantly, a cytosolic 
form of microtubule-associated protein 1A/1B-light chain 3 (LC3) is conjugated to 
phosphatidylethanolamine to form LC3-phosphatidylethanolamine conjugate (LC3-II), which is 
recruited to autophagosomal membranes. Then, autophagosomes fuse with lysosomes to form 
autolysosomes, in such a way that intra-autophagosomal components are degraded by lysosomal 
hydrolases (141, Tanida). LC3 is conjugated with phosphatidylethanolamine in the membranes 
and regulates initiation of autophagy through interaction with many autophagy-related proteins 
possessing an LC3-interacting region (LIR) motif constituted by the amino acids WXXL (where 
X represents any of the 20 amino acids). PEBP1 was demonstrated to bind with LC3 by direct 
interaction through the LIR motif 55WDGL58 that is situated in an exposed external loop of 
PEBP1. PEBP1 was observed specifically bound to PE-unconjugated LC3 in cells, and mutation 
of the LIR motif disrupted its interaction with LC3 (44, Noh 2016). Interestingly, under 
starvation conditions, ablation of PEBP1 expression dramatically promoted the autophagic 
process. In contrast, overexpression of PEBP1 significantly inhibited starvation-induced 
autophagy by activating the Akt/mTORC1 signaling pathway. Thus, PEBP1-dependent 
suppression of autophagy was not associated with the MAPK pathway but through stimulation of 
the Akt-mTORC1 pathway and direct interaction with LC3. Furthermore, PEBP1 
phosphorylation at S153 caused dissociation of LC3 from the PEBP1-LC3 complex for 
autophagy induction (44, Noh). 
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LC3 is considered to be involved in microtubule assembly/disassembly. To elucidate the 
mechanism by which LC3 facilitates epithelial ovarian cancer (EOC) cell migration and invasion 
under conditions of hypoxia, the effects of LC3B inhibition under hypoxic conditions on 
migration, invasion, and adhesion in HO8910PM and HO8910 EOC cell lines were investigated. 
The conclusion was that LC3B may promote the migration and invasion of EOC cells by 
affecting the cytoskeleton via the RhoA pathway (142, Tang).  
3.1.2.2- Syntenin 
Also called MDA-9, syntenin functions as a positive regulator of melanoma progression 
and metastasis. Tissue microarray and cell lines analyses showed that syntenin transcriptionally 
downregulated PEBP1. Furthermore, syntenin and PEBP1 physically interacted in a manner that 
correlated with a suppression of focal adhesion kinase (FAK) and c-Src phosphorylation, crucial 
steps necessary for syntenin to promote FAK/c-Src complex formation and initiate signaling 
cascades that drive the metastatic phenotype. Ectopic PEBP1 expression in melanoma cells 
overrode syntenin-mediated signaling, inhibiting cell invasion, anchorage-independent growth, 
and in vivo dissemination of tumor cells (55, Das). It should be pointed out here some functional 
properties of syntenin. Syntenin was initially identified as a molecule linking syndecan-mediated 
signaling to the cytoskeleton. Syntenin contains tandemly repeated PDZ domains that bind the 
cytoplasmic C-terminal domains of a variety of transmembrane proteins. Syntenin may also 
affect cytoskeletal-membrane organization (143, Grootjans), cell adhesion, cell migration, 
protein trafficking, and cell cycle progression in cancer cells (144, Kashyap). The protein was 
primarily localized to membrane-associated adherens junctions and focal adhesions but was also 
found at the endoplasmic reticulum and nucleus. Syntenin is also known to be implicated in the 
biogenesis of exosomes (145, Friand; 146, Fares).  
3.1.2.3- CEP290 
It was shown that PEBP1 interacts with the centrosomal protein of 290 kDa (CEP290) at 
the Connecting Cilium (Transition Zone) of Photoreceptors. PEBP1 prevented cilia formation 
and was associated with CEP290-mediated photoreceptor degeneration. In-frame deletion of 299 
amino acids in CEP290 is associated with retinal degeneration in the rd16 mouse, this domain 
more specifically interacted with PEBP1. The CEP290 mutant mouse rd16, revealed that 
CEP290-mediated photoreceptor degeneration is associated with aberrant accumulation of 
PEBP1. In rd16 retina cells, there was 2.5-fold increase in the levels of endogenous PEBP1, as 
compared with the wild type (75, Murga-Zamalloa). 
CEP290 is essential for the formation of the primary cilium, a small antenna-like 
projections of the cell membrane that plays a main role in the photoreceptors at the back of the 
retina, in brain, kidney, and many other organs. CEP290 is a microtubule and membrane binding 
protein that might serve as a structural link between the microtubule core of the cilium and the 
overlying ciliary membrane. Knocking down the level of CEP290 resulted in dramatic 
suppression of ciliogenesis in retinal pigment epithelial cells in culture (147, Drivas).  
CEP290 is also one of the centrosomal protein. The centrosome is an important cellular organelle 
which nucleates microtubules to form the cytoskeleton during interphase and the mitotic spindle 
during mitosis. Depletion of CEP290 caused a reduction of the astral spindle, leading to 
misorientation of the mitotic spindle. Microtubules polymerization also decreased in CEP290-
depleted cells, indicating that CEP290 is involved in spindle nucleation (148, Song).  
3.1.2.4- Rab8A 
In ciliopathies, the study of photoreceptor degeneration mediated by Cep290 revealed the 
direct interaction of PEBP1 with Cep290 and an aberrant accumulation of PEBP1. Moreover, in 
zebrafish and cultured cells, ectopic accumulation of PEBP1 led to defective cilia formation, an 
 15 
 
effect mediated by its interaction with the ciliary GTPase Rab8A. Overexpression of PEBP1 
revealed mislocalization of Rab8A in about 40% of the cells and it was shown that PEBP1 
directly interacted preferentially with the GDP-locked mutant of Rab8A while little interaction 
was detected with the GTP-locked mutant of Rab8A (75, Murga-Zamalloa). Moreover, the 
GTPase Rab8A is a critical component of the protein trafficking machinery of photoreceptors and 
studies showed that overexpression of the GDP-locked variant of Rab8A resulted in 
mistrafficking of rhodopsin and photoreceptor degeneration (149, Deretic). Whereas the GDP-
locked variant Rab8A disrupted cilia formation, expression of the GTP-locked variant Rab8A 
promoted ciliogenesis. As PEBP1 interacts preferably with the GDP-bound form of Rab8A in the 
retina and accumulation of PEBP1 due to Cep290 mutation is associated with retinopathy, it was 
proposed that the PEBP1-Rab8A (GDP) complex may need to dissociate for the release of 
Rab8A-GDP and subsequent conversion to Rab8A-GTP for appropriate ciliary transport (75, 
Murga-Zamalloa). Finally, Rab8 was recognized as a shared regulator of ciliogenesis and 
immune synapse assembly (150, Patrussi).  
Rab8 was also described to be implicated in autophagy. Numerous Rab proteins have been 
shown to be involved in various stages of autophagy. Rab1, Rab5, Rab7, Rab9A, Rab11, Rab23, 
Rab32, and Rab33B participate in autophagosome formation, whereas Rab9 is required in non-
canonical autophagy. Rab7, Rab8B, and Rab24 have a key role in autophagosome maturation. 
Rab8A and Rab25 are also known to be involved in autophagy (151, Ao).  
Rab8 activation increased Rac1 activity, whereas its depletion activated RhoA, which led to 
reorganization of the actin cytoskeleton. Rab8 was also associated with focal adhesions, 
promoting their disassembly in a microtubule-dependent manner. This Rab8 effect involved 
calpain, MMP14 and Rho GTPases. Moreover, data revealed that Rab8 drives cell motility by 
mechanisms both dependent and independent of Rho GTPases, thereby regulating the 
establishment of cell polarity, turnover of focal adhesions and actin cytoskeleton rearrangements, 
thus determining the directionality of cell migration (152, Bravo-Cordero).  
3.1.2.5- Aurora B 
Chromosome segregation in mitosis is orchestrated by the dynamic interactions between 
the kinetochore and spindle microtubules. The microtubule depolymerase mitotic centromere-
associated kinesin (MCAK) is a key regulator for an accurate kinetochore-microtubule 
attachment. It was reported that the phosphorylation of shugoshin (hSgo2) by Aurora B, promotes 
its association with MCAK, the recruitment of MCAK to inner-centromeres, and chromosome 
alignment (153, Tanno). Therefore, although Aurora B blocks MCAK activity at early mitosis 
for initial spindle assembly, it also recruits MCAK to the centromeres and activates polo-like 
kinase 1 (PLK1) to ensure subsequent activation of MCAK to timely correct the improper 
attachments of kinetochores to microtubules (154, Shao 2015). 
Interestingly enough, PEBP1 was shown to associate with centrosomes and kinetochores, 
and to regulate Aurora B and the spindle checkpoint in mammalian cells. Kinetochores form the 
interface between microtubules of the mitotic spindle and chromosomes and regulate 
chromosome movements during mitosis. PEBP1 depletion altered localization and kinase activity 
of Aurora B at kinetochores. In addition, PEBP1 depletion led to a decrease in mitotic index, an 
acceleration in timing of the metaphase/anaphase transition and a defect in the spindle checkpoint 
in HeLa and H19-7 cells. However, a direct interaction between PEBP1 and Aurora B was not 
proved and it was suggested that Aurora B kinase activity could be inhibited directly by ERK1/2 
phosphorylation of Aurora B or indirectly by mechanisms such as phosphorylation of other 
proteins required for recruitment of the kinase to the kinetochores (155, Eves 2006). In another 
note, by monitoring mitotic index and transit time from nuclear envelope breakdown to anaphase, 
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it was demonstrated that PEBP1 depletion led to a defective spindle checkpoint and genomic 
instability, particularly in response to drugs that disrupt microtubule function (39, Eves 2010). In 
contrast to elevated MAP kinase signaling during the G1, S or G2 phases of the cell cycle that 
activates checkpoints and induces arrest or senescence, loss of PEBP1 during M phase leads to 
bypass of the spindle assembly checkpoint and the generation of chromosomal abnormalities. 
These results revealed a role for PEBP1 in ensuring the fidelity of chromosome segregation prior 
to cell division and raised the possibility that PEBP1 status in tumors could influence the efficacy 
of treatments, such as Taxol, that stimulate the Aurora B-dependent spindle assembly checkpoint 
(156, Rosner). 
 
3.1.3- Interactome of PEBP1 in gastric cancer cell line SGC7901 
Mapping the interactome of overexpressed PEBP1 in a gastric cancer cell line (SGC7901 
cells) was of particular interest as a total of 72 PEBP1-interacting proteins were identified by 
MS/MS (157, Gu 2013). These proteins play roles in enzyme metabolism, molecular 
chaperoning, biological oxidation, cytoskeleton organization, signal transduction, and 
enzymolysis (Table 1). For the first time, interactions of PEBP1 with HSP90, 14-3-3epsilon and 
keratin 8 were found and were confirmed by Western blot analysis and co-immunoprecipitation. 
For data analysis, three databases, including Michigan Molecular Interactions (MiMI), Functional 
Linkage Network, and Predictome, were chosen to acquire the interaction network diagrams. 
Among the 72 proteins, 7 were identified as first level neighbors of PEBP1 with the three protein 
network diagrams and only 35 proteins were found through the MiMI analysis to have existing 
interactions with PEBP1 (first and second level neighbors). These 35 proteins were also 
consistently found to be closely related to PEBP1 with Functional Linkage Network and 
Predictome analysis. Table 1 presents the 35 proteins classified according to their main cellular 
function, i.e. proteins related to cytoskeleton, protein biosynthesis, glycolytic enzymes, molecular 
chaperones, mitochondrial proteins and proteins/vesicles transport. We discuss here the main 
properties of these 35 close partners of PEBP1, starting with the 7 proteins considered as the 
closer partners of PEBP1 by the three diagram analysis. These 7 proteins are Ras GTPase-
activating-like protein IQGAP, pyruvate kinase isozymes M1/M2, elongation factor 1-alpha 1, 
ATP synthase subunit alpha mitochondrial, isoleucyl-tRNA synthase cytoplasmic, voltage-
dependent anion-selective channel protein1 (VDAC) and Clathrin heavy chain. 
 
3.1.3.1- The seven proteins identified as first level neighbors of PEBP1 
The Ras GTPase-activating-like protein IQGAP1 is a scaffold protein involved in the 
regulation of various cellular processes ranging from organization of the actin cytoskeleton, 
transcription and cellular adhesion to cell cycle control. Over-expression of IQGAP1 was 
associated with increased migration and invasion in the human breast epithelial cancer cell line 
MCF-7 (158, White; 159, Jadeski). IQGAP1 may also be involved in the deregulation of 
proliferation and differentiation through its modulation of the MEK/ERK pathway (160, Brown).  
Elongation factor 1-alpha 1 (eEF1A1) is an isoform of the alpha subunit of the elongation 
factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the 
ribosome. eEF1A1 is expressed in most cells and induces HSP70 during heat shock. The eEF1A1 
is a GTPase that couples the hydrolysis of GTP to GDP with the delivery of aminoacyl tRNAs to 
the ribosome during protein translation. eEF1A also has translation-independent roles in 
embryogenesis, senescence, oncogenic transformation, cell proliferation, apoptosis, cytoskeletal 
organization and protein degradation (161, Blanch). Furthermore, it participates in several 
processes including mitotic apparatus formation and signal transduction (162, Sasikumar). 
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eEF1a1 colocalizes with filamentous actin and putatively binds actin and microtubules at 
synapses to modulate the cytoskeleton. In breast and prostate cancer samples, the upregulation of 
eEF1A was reported (163, Pecorari; 164, Liu 2010). 
Isoleucyl-tRNA synthase cytoplasmic catalyzes the aminoacylation of the tRNA by isoleucine. 
The three branched amino acids (BCAAs) Leucine, Isoleucine and Valine, are among the nine 
essential amino acids for humans and provide several metabolic and physiologic roles. 
Metabolically, BCAAs promote protein synthesis and turnover, signaling pathways and 
metabolism of glucose. BCAAs are a marker of insulin resistance (165, Lynch), as insulin 
resistance increases the rate of appearance of BCAAs and is linked to reduced expression of 
mitochondrial BCAA catabolic enzymes. Circulating levels of BCAAs tend to be increased in 
individuals with obesity and are associated with worse metabolic health and future insulin 
resistance or type 2 diabetes mellitus (166, Newgard). 
Pyruvate kinase isozymes M1/M2 are glycolytic enzymes. They catalyze the last step within 
glycolysis, the dephosphorylation of phosphoenolpyruvate to pyruvate, and are responsible for 
net ATP production within the glycolytic sequence. The final step of glycolysis is highly 
regulated and irreversible because pyruvate is a crucial intermediate building block for further 
metabolic pathways. Once pyruvate kinase synthesizes pyruvate, pyruvate either enters 
the tricarboxylic acid (TCA) cycle for further production of ATP under aerobic conditions, or is 
reduced to lactate under anaerobic conditions (167, Gupta). In contrast to mitochondrial 
respiration, energy regeneration by pyruvate kinase is independent from oxygen supply and 
allows survival of the organs under hypoxic conditions often found in solid tumors (168, 
Vaupel). PKM2 is a cytosolic enzyme that is associated with other glycolytic enzymes within a 
so-called glycolytic enzyme complex. Particularly, in vitro studies on breast cancer cell line have 
revealed that glycolytic enzymes may form a multienzymatic complex consisting of 
glyceraldehyde 3-phosphate dehydrogenase, phosphoglycerate kinase, enolase, pyruvate kinase, 
adenylate kinase, nucleoside diphosphate kinase type A (NDPK A), hexokinase, 
phosphoglycerate mutase (PGAM), lactate dehydrogenase, and A-Raf kinase (169, Kowalski). 
Pyruvate kinase inhibits taxol-induced tubulin polymerization into microtubules and partially 
disassembles taxol-stabilized microtubules into less sedimentable oligomers leading to the 
appearance of tubulin in the supernatant fractions. Thus, these data suggest that pyruvate kinase 
may display multiple regulatory functions as a glycolytic control enzyme and as a modulator of 
microtubule dynamics (170, Vertessy).  
ATP synthase subunit alpha mitochondrial is a subunit of mitochondrial F1Fo ATP synthase 
which catalyzes ATP synthesis from ADP and inorganic phosphate. The formation of ATP from 
ADP and Pi is energetically unfavorable and would normally proceed in the reverse direction. In 
order to drive this reaction forward, ATPase couples ATP synthesis during cellular respiration to 
an electrochemical gradient created by the difference in proton (H+) concentration across 
the mitochondrial inner membrane (171, Bernardi; 172, Bernardi). Subunit alpha does not bear 
the catalytic high-affinity ATP-binding sites, however, mutations affecting the ATP synthase 
subunit alpha gene cause combined oxidative phosphorylation deficiency, a mitochondrial 
disorder characterized by intrauterine growth retardation, microcephaly, hypotonia, pulmonary 
hypertension, encephalopathy, and heart failure (173, Janer).  
Microtubule cytoskeleton is reformed during apoptosis, forming a cortical structure beneath 
plasma membrane, which plays an important role in preserving cell morphology and plasma 
membrane integrity. Apoptotic microtubule network (AMN) was organized in apoptotic cells 
with high ATP levels and hyperpolarized mitochondria and, on the contrary, was dismantled in 
apoptotic cells with low ATP levels and mitochondrial depolarization. Furthermore, high ATP 
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levels and mitochondria polarization collapse after oligomycin treatment in apoptotic cells 
suggested that ATP synthase works in "reverse" mode during apoptosis (174, Oropesa).  
The voltage-dependent anion-selective channel protein 1 (VDAC1) forms an ion channel in 
the outer mitochondrial membrane (OMM) and allows ATP and other small metabolites to 
diffuse out of the mitochondria into the cytoplasm. VDAC1 is involved in cell metabolism, 
allowing regulation of the tricarboxylic acid (TCA) cycle and, by extension, reactive oxygen 
species (ROS) production (175, Huang 2014). Besides metabolic permeation, VDAC1 also acts 
as a scaffold for proteins such as hexokinase that can in turn regulate metabolism (176, Reina). 
There are three VDAC isoforms (VDAC1, 2 and 3), of the three isoforms, VDAC1 is the main 
calcium ion transport channel and the most abundantly transcribed, its dysfunction is implicated 
in cancer (177, Gao), Parkinson's disease (178, Chu) and Alzheimer disease (179, Smilansky). 
In Parkinson disease, VDAC1 increases calcium ion levels within the mitochondria, resulting in 
increased mitochondrial permeability, disrupted mitochondrial membrane potential, elevated 
ROS production, cell death, and neuronal degeneration. (178, Chu). VDAC1 has been implicated 
in cancer through its interactions with the anti-apoptotic family of proteins, Bcl-2 proteins, 
particularly Bcl-xl, and Mcl-1, which are overexpressed during cancer. These two Bcl-2 proteins 
interact with VDAC1 to regulate calcium ion transport across the OMM and, ultimately, ROS 
production (182, Shoshan-Barmatz). VDAC1 has also been described in association with 
apoptotic processes and as interacting with cytoskeletal proteins (176, Reina).  
Clathrin heavy chain is a subunit of the clathrin coat that is composed of three heavy chains and 
three light chains forming a triskelion (181, Halebian). Clathrin is a major protein component of 
the cytoplasmic face of intracellular organelles, called coated vesicles and coated pits. These 
specialized organelles are involved in the intracellular trafficking of receptors and endocytosis of 
a variety of macromolecules (182, McMahon). In a cell, clathrin triskelion binds to an adaptor 
protein that has bound membrane, linking one of its three feet to the membrane at a time; many 
proteins involved in clathrin-mediated endocytosis have been described (183, Pucadyil). 
Formation of clathrin-coated vesicles is shut down in cells undergoing mitosis. During mitosis, 
clathrin binds to the spindle apparatus, in complex with TACC3 and CKAP5. Clathrin aids in the 
congression of chromosomes by stabilizing kinetochore fibers of the mitotic spindle (184, 
Royle). Otherwise, clathrin-mediated endocytosis (CME) involves the recruitment of numerous 
proteins to sites on the plasma membrane with prescribed timing to mediate specific stages of the 
process. Actin assembly generally preceded and then promoted dynamin-2 recruitment during the 
late phases of CME. Thus, precise temporal and quantitative regulation of the dynamin-2 
recruitment is influenced by actin polymerization (185, Grassart).  
 
3.1.3.2- The 28 other proteins neighbors of PEBP1 
Among the 28 remaining proteins presented in Table1, nine are components of cytoskeleton 
or are associated to filaments and microtubules formation. Eukaryotic cells contain three main 
kinds of cytoskeletal filaments: microtubules, actin microfilaments and intermediate filaments. 
(186, Fletcher). The cytoskeleton is involved in a multitude of functions. It gives the cell its 
shape and mechanical resistance to deformation and allows cells to migrate (186, Fletcher). It is 
implicated in many cell signaling pathways, in endocytosis, in chromosomes segregation 
during cellular division, and intracellular transport. Furthermore, it forms specialized structures, 
such as cilia (187, Pedersen), lamillepodia (188, Guo) and podosomes (189, Veillat). 
3.1.3.2.1- Components of cytoskeleton  
Tubulin-beta is a major constituent of microtubules that are made up of polymerised α- and β-
tubulin dimers (190, Nogales). Microtubules are typically nucleated and organized by dedicated 
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organelles called microtubule-organizing centers (MTOCs). However, microtubules can be 
nucleated at cilia at their base termed basal bodies and the microtubule can dynamically switch 
between growing and shrinking phases in this region (191, Pearson). Tubulin dimers can bind 
two molecules of GTP, one of which can be hydrolyzed subsequent to assembly. During 
polymerization, the tubulin dimers are in the GTP-bound state. The GTP bound to α-tubulin is 
stable and it plays a structural function in this bound state. However, the GTP bound to β-tubulin 
may be hydrolyzed to GDP shortly after assembly and GDP-tubulin is more prone to 
depolymerization (192, Piedra). 
Actin cytoplasmic 1, is also known as beta-actin, it is one of six different actin isoforms which 
have been identified in humans and one of the two nonmuscle cytoskeletal actins. The most 
abundant isoactin in many nonmuscle cells including myeloid and neuronal cells is -actin (193, 
Cheever). Cytoplasmic - actin is essential for cell migration, cell shape maintenance, mitosis 
and intracellular transport processes. Cellular studies showed that the -isoform is preferentially 
recruited into cellular protrusions (194, Svitkina), stress fibers, circular bundles and at cell–cell 
contacts (195, Collinet). The rapid cytoskeletal rearrangements observed for these structures 
appear to be linked to the highly dynamic turnover of actin filaments made from -actin (196, 
Hundt). It is noted that actin is an ATPase. Each molecule of actin is bound to a molecule of 
ATP or ADP that is associated with an Mg2+ cation. The most commonly found forms of actin, 
compared to all the possible combinations, are ATP-G-Actin (globular actin, free monomer) and 
ADP-F-actin (filamentous, part of a linear polymer microfilament) (197, Graceffa).  
Plectin, F-actin-capping protein and vinculin are actin-binding proteins. Plectin acts as a link 
between the three main components of the cytoskeleton: actin microfilaments, microtubules and 
intermediate filaments (198, Svitkina). Plectin links the cytoskeleton to junctions found in the 
plasma membrane that structurally connect different cells. By holding these different networks 
together, plectin plays an important role in maintaining the mechanical integrity and viscoelastic 
properties of tissues (199, Wiche).  
The F-actin capping protein binds in a calcium-independent manner to the fast-growing 
ends of actin filaments (barbed end), thereby blocking the exchange of subunits at these ends. In 
its absence, cells progressively accumulate actin filaments and eventually die (200, Delalle). 
Vinculin is a membrane-cytoskeletal protein in focal adhesion plaques that is involved in 
linkage of integrin adhesion molecules to the actin cytoskeleton. Vinculin is a cytoskeletal 
protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one 
of several interacting proteins involved in anchoring F-actin to the membrane. Thus it plays a role 
in cellular adhesion and migration (201, Dumbauld).  
Finally, Myosin-9 (Myosin, heavy chain 9, non-muscle) is also a multifunctional protein, it 
binds PKC epsilon, affects actin cytoskeleton (202, Yuan) and plays a role in cytokinesis and 
secretion (203, Atanasova). 
Three proteins are involved in intermediate filaments: keratin type1 cytoskeletal 18, 
keratin type 2 cytoskeletal 8 and vimentin. Intermediate filaments are an important component of 
the cellular cytoskeleton, they play a role in the organization of microtubules and microfilaments, 
the regulation of nuclear structure and activity, the control of cell cycle and the regulation of 
signal transduction pathways. It was shown that intermediate filaments associate with key 
proteins of the vesicular membrane transport machinery. In particular, the contribution of 
intermediate filaments to the endocytic pathway was strongly suggested (204, Margiotta). It is to 
note that unlike the other cytoskeleton components, intermediate filament (IF) monomers do not 
have any enzymatic activity. Their assembly in mature insoluble filaments and their disassembly 
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in soluble components (from tetramers to monomers) are regulated by 
phosphorylation/dephosphorylation cycles (204, Margiotta).  
More particularly, when phosphorylated, keratin type 1 cytoskeletal 18 plays a role in 
filament reorganization during apoptosis (205, Weerasinghe). Keratin type 2 cytoskeletal 8 is 
present in certain forms of cancer and can be used to differentiate lobular carcinoma of the breast 
from ductal carcinoma of the breast (206, Kongara). It hampers the biogenesis of mutated CFTR 
(Cystic fibrosis transmembrane conductance regulator) and its insertion at the plasma membrane 
(207, Premchandar) and at the interleukin-6 (IL-6)-mediated barrier protection (208, Wang 
2007). Vimentin is the major cytoskeletal component of mesenchymal cells, it is often used as a 
marker of mesenchymally-derived cells or cells undergoing an epithelial-to-mesenchymal 
transition (EMT) during both normal development and metastatic progression. Vimentin plays a 
significant role in supporting and anchoring the position of the organelles in the cytosol. 
Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or 
terminally (209, Katsumoto). Moreover, it is accepted that vimentin is the cytoskeletal 
component responsible for maintaining cell integrity (210, Goldman). 
 
3.1.3.2.2- protein biosynthesis 
Apart from Elongation factor-1-alpha1 and Isoleucyl-tRNA synthase described above as 
being among the seven first level partners of PEBP1, the interactome of overexpressed PEBP1 in 
gastric cancer cells, revealed 6 proteins associated with ribosomes and implicated in protein 
biosynthesis. These are valyl-tRNA synthase, elongation factor 1-gamma, elongation factor 2, 
initiation factor 4A, guanine nucleotide-binding protein subunit beta-2-like 1 and 40S ribosomal 
protein S3. 
Among them valyl-tRNA synthase catalyzes the aminoacylation of the tRNA by valine. 
Like Isoleucine and Leucine, valine is a branched chain amino-acid (BCAA). As Isoleucyl-tRNA 
synthase, valyl-tRNA synthase promotes protein synthesis and turnover, but is also implicated in 
metabolism of glucose (211, Higuchi), insulin resistance (212, Mahendran) and signaling 
pathways (213, Mattick).  
Elongation factor 1-gamma is a subunit of the elongation factor-1 complex, which is 
responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This subunit 
contains an N-terminal glutathione transferase domain, which may be involved in regulating the 
assembly of multisubunit complexes containing this elongation factor and aminoacyl-tRNA 
synthetases (214, Achilonu).  
The eukaryotic Elongation factor 2 (eEF2) is a member of the GTP-binding translation 
elongation factor family. This protein is an essential factor for protein synthesis. It promotes the 
GTP-dependent translocation of the ribosome. eEF2 is completely inactivated by EF-2 kinase 
phosphorylation which is regulated by p90RSK1 and p70 S6 kinase (215, Hizli).  Findings suggest 
that eEF2K likely contributes to neuronal function by regulating the synthesis of microtubule-
related proteins. Modulation of the elongation phase of protein synthesis is important for 
numerous physiological processes in neurons. The synthesis of microtubule-related proteins is 
up-regulated by inhibition of elongation suggesting that translation elongation is a key regulator 
of cytoskeletal dynamics in neurons (216, Kenney). 
The eukaryotic initiation factor-4A (eIF4A) family consists of 3 closely related proteins 
EIF4A1, EIF4A2, and EIF4A3. These factors are required for the binding of mRNA to 40S 
ribosomal subunits. In addition these proteins are helicases that function to unwind double-
stranded RNA (217, Marintchev). These proteins stabilize the formation of the functional 
ribosome around the start codon and also provide regulatory mechanisms in translation initiation.  
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Guanine nucleotide-binding protein subunit beta-2-like 1 was alternatively named 
Receptor of activated protein kinase C 1 (RACK1). RACK1 is a major component of translating 
ribosomes, which harbor significant amounts of PKC and which recruits and binds a variety of 
signaling molecules such as integrins, proto-oncogene tyrosine-protein kinase Src (pp60c-src) 
and focal adhesion kinase (218, Nielsen).  
40S ribosomal protein S3 is a ribosomal protein that is a component of the 40S subunit, in 
which it forms part of the domain where translation is initiated. Studies of the mouse and rat 
proteins have demonstrated that 40S ribosomal protein S3 has an extraribosomal role as an 
endonuclease involved in the repair of mitochondrial DNA damage (219, Kim 2013). Successive 
structural re-arrangements in ribosomal protein S3 promote maturation of the 40S ribosomal 
subunit. 
 
3.1.3.2.3- Glycolytic enzymes 
In addition to pyruvate kinase described above, five glycolytic enzymes were suggested to 
interact with PEBP1 according to the interactome analysis. These are glyceraldehyde-3-
phosphate dehydrogenase, L-lactate dehydrogenase chain A and chain B, alpha enolase and 
fructose-bisphosphate aldolase A.  
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalyzes the sixth step 
of glycolysis corresponding to the conversion of glyceraldehyde-3- phosphate in D-glycerate 1,3 
bisphosphate. In addition to this long established metabolic function, it was implicated in several 
non-metabolic processes, including transcription activation, initiation of apoptosis (220, Tarze), 
endoplasmic reticulum to Golgi vesicle shuttling, and fast axonal or axoplasmic transport (221, 
Zala). In sperm, a testis-specific isoenzyme named GAPDHS is expressed (222, Margaryan). 
Lactate dehydrogenase (LDH) chain A and chain B catalyze the interconversion 
of pyruvate and lactate with concomitant interconversion of NADH and NAD+. Pyruvate, the 
final product of glycolysis is converted to lactate when oxygen is absent or in short supply, and 
the reverse reaction is performed during the Cori cycle in the liver. It has also been shown that 
LDHA plays an important role in the development, invasion and metastasis of malignancies (223, 
Miao). Using the cancer cell line MDA-MB-435, it was shown that knockdown of LDHA results 
in elevated mitochondrial ROS production and a concomitant decrease in cell proliferation and 
motility. Thus, in cancer, aerobic glycolysis and reduced mitochondrial ROS production create an 
environment conducive to cytoskeletal remodeling and high cell motility (224, Arseneault). 
Alpha enolase (ENO1) is expressed in most tissues, it catalyzes the conversion of 2-
phosphoglycerate to phosphoenolpyruvate. In addition, it functions as a structural lens protein 
(tau-crystallin) in the monomeric form. Alternative splicing of the gene encoding alpha enolase 
results in a shorter isoform that was shown to bind to the c-myc promoter and functions as 
a tumor suppressor. ENO1 also plays a role in other functions, including a cell surface receptor 
for plasminogen on pathogens, an oxidative stress protein, a heat shock protein (HSP48), and a 
binding partner of cytoskeletal (225, Díaz-Ramos). It was demonstrated that enolase isoforms 
interact with microtubules during muscle satellite cell differentiation suggesting that binding of 
enolase to microtubules could contribute to the regulation of the dynamism of the cytoskeletal 
filaments known to occur during the transition from myoblasts to myotubes (226, Keller). ENO1 
overexpression was associated with multiple tumors (227, Capello). In many of these tumors, 
ENO1 promoted cell proliferation by regulating the PI3K/Akt signaling pathway and 
induced tumorigenesis by activating plasminogen (228, Fu). Moreover, ENO1 is expressed on 
the tumor cell surface during pathological conditions such as inflammation, autoimmunity, 
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and malignancy. Its role as a plasminogen receptor leads to extracellular matrix degradation and 
cancer invasion (229, Hsiao). 
Fructose-bisphosphate aldolase A is an enzyme catalyzing a reversible reaction that 
splits fructose 1,6-bisphosphate, into the triose phosphates dihydroxyacetone phosphate (DHAP) 
and glyceraldehyde 3-phosphate (G3P). Aldolase A is found in the developing embryo and is 
produced in even greater amounts in adult muscle. Signal transduction via PI3K allows for the 
physical dissociation of aldolase from F-actin into the cytoplasm where it is active. This simple, 
biophysical mechanism of activating aldolase through recruitment from the cytoskeleton is a 
rapid and efficient way for cells to increase metabolic flux. Redistribution of aldolase in response 
to PI3K signaling achieves coordination of cytoskeletal dynamics and glycolysis, while avoiding 
the time- and energy-consuming path of transcriptional activation and biosynthesis of new 
enzyme molecules (230, Hu). 
In the end, cancer cells enhance their glycolysis, producing lactate, even in the presence of 
oxygen. Glycolysis is a series of ten metabolic reactions catalyzed by enzymes whose expression 
is most often increased in tumor cells. HKII and phosphoglucose isomerase (PGI) have mainly an 
anti-apoptotic effect; PGI and glyceraldehyde-3-phosphate dehydrogenase activate survival 
pathways; phosphofructokinase 1 and triose phosphate isomerase participate in cell cycle 
activation; aldolase promotes epithelial mesenchymal transition; PKM2 enhances various nuclear 
effects such as transcription and stabilization. Thus, the multiple non-glycolytic roles of 
glycolytic enzymes appeared essential for promoting survival, proliferation, chemoresistance and 
dissemination of cancer cells (231, Lincet). Interestingly, the phosphoinositide 3-kinase (PI3K) 
pathway regulates multiple steps in glucose metabolism and also cytoskeletal functions, such as 
cell movement and attachment. PI3K directly coordinates glycolysis with cytoskeletal dynamics 
in an Akt-independent manner. Growth factors or insulin stimulate the PI3K-dependent activation 
of Rac, leading to disruption of the actin cytoskeleton, release of filamentous actin-bound 
aldolase A, and an increase in aldolase activity. These results point toward a master regulatory 
function of PI3K that integrates an epithelial cell metabolism and its shape and function, 
coordinating glycolysis with the energy-intensive dynamics of actin remodeling (230, Hu 2016). 
3.1.3.2.3- Molecular chaperones 
Five molecular chaperones were identified by the interactome analysis of gastric cancer cells 
overexpressing PEBP1: HSP-90 beta, HScognate 71 kDa, HSP-90 alpha, Stress-70 protein 
mitochondrial, 60kDa HSP mitochondrial. 
Hsp90 (heat shock protein 90) alpha and beta are cytoplasmic homologues, human 
HSP90 alpha sharing 85% sequence identity with HSP90 beta. A proteomic differential display 
analysis between the regressive cancer cell line QR-32 and the inflammatory cell-promoting 
progressive cancer cell line QRsP-11 of murine fibrosarcoma, indicated that calreticulin 
precursor, tropomyosin 1 alpha chain, annexin A5, Prx II, heat shock protein (HSP)90-alpha, 
HSP90-beta and PEBP1, were overexpressed (232, Hayashi). The two HSP90 isoforms are 
chaperone proteins that assist other proteins to fold properly, stabilize proteins against heat stress, 
and aid in protein degradation. Hsp90 alpha and beta contain three functional domains, the ATP-
binding, protein-binding, and dimerizing domain, each of which playing a crucial role in the 
function of the protein. The region of the protein near the N-terminus has a high-affinity ATP-
binding site formed by a sizable cleft. When given a suitable protein substrate, Hsp90 cleaves the 
ATP into ADP and Pi (233, Didenko). The protein-binding region of Hsp90 is located toward 
the C-terminus of the amino sequence. The Hsp90 conformation is an open ATP-bound state or a 
closed ADP-bound state. Thus, when a bound substrate is in place, the energy-releasing ATP 
hydrolysis by the ATPase near the N-terminal domain forces conformational changes that clamp 
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the Hsp90 down onto the substrate (234, Pearl). The ability of Hsp90 to clamp onto proteins 
allows it to perform several functions including assisting folding, preventing aggregation, and 
facilitating transport. In particular, HSP90 stabilizes the 26S proteasome which enables the cell to 
degrade unwanted proteins and modulates tumor cell apoptosis through effects on Akt, TNFR 
and NFκB (235, Graner). 
HScognate 71 kDa also known as Hsc70 is a member of the heat shock protein 70 family. 
It is a chaperone protein which facilitates the proper folding of newly translated and misfolded 
proteins, as well as stabilizes or degrades mutant proteins (236, Mayer). HScognate 71 kDa 
contributes to biological processes including signal transduction, apoptosis, protein homeostasis, 
cell growth and differentiation and it was associated with an extensive number 
of cancers, neurodegenerative diseases, cell senescence and aging (237, Liu 2012). As HSP90, it 
has a C-terminal protein substrate-binding domain and an N-terminal ATP-binding 
domain. HScognate 71 kDa is known to localize to the cytoplasm and lysosome, where it 
participates in chaperone-mediated autophagy by aiding the unfolding and translocation of 
substrate proteins across the membrane into the lysosomal lumen (238, Xie). HScognate 71 kDa 
additionally serves as a positive regulator of cell cycle transition and carcinogenesis. For 
example, HScognate 71 kDa regulates the nuclear accumulation of cyclin D1, which is a key 
player in G1 to S phase cell cycle transition (239, Hatakeyama). Interestingly, another function 
of HScognate 71 kDa is as an ATPase in the disassembly of clathrin-coated vesicles during 
transport of membrane components through the cell (240, Cho). HScognate 71 kDa plays a 
protective role in neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s 
disease, Huntington’s disease, spinocerebellar ataxias, aging and cell senescence, as observed in 
centenarians subjected to heat shock challenge (241, Jinwal). In neurons, cyclin-dependent 
kinase 5 (CDK5) phosphorylates PEBP1 at T42 promoting the exposure and recognition of the 
target motif "KLYEQ" in the C-terminus of PEBP1 by HScognate 71 kDa and the subsequent 
degradation of PEBP1 via chaperone-mediated autophagy. In the brain sample of Parkinson's 
disease patients, CDK5-mediated autophagy of PEBP1 is involved in the over-activation of the 
ERK cascade, leading to S-phase reentry and neuronal loss (45, Wen). 
Stress-70 protein mitochondrial also named mitochondrial 70kDa HSP and HSPA9, is 
also known as mortalin. 70kDa HSP is a heat-shock cognate protein; it plays a role in the control 
of cell proliferation and may also act as a chaperone. 70kDa HSP is primarily localized to the 
mitochondria but is also found in the endoplasmic reticulum, plasma membrane and cytoplasmic 
vesicles. 70kDa HSP has been attributed many cellular functions, including energy generation, 
proliferation, stress response and carcinogenesis (242, Wu). 70kDa HSP regulates the functions 
of the tumor suppressor protein p53 and plays important roles in stress response and maintenance 
of the mitochondria and endoplasmic reticulum. Furthermore, 70kDa HSP appears to have roles 
in membrane trafficking and viral release regulation. More recently, mutations in 70kDa HSP 
gene have been found in Parkinson΄s disease patients. It was shown that 70kDa HSP expression 
differs in hippocampus of patients with Alzheimer΄s disease and could regulate the β-amyloid 
toxicity pathway (243, Flachbartova). 
60kDa HSP mitochondrial (HSP60) is a mitochondrial chaperonin that is typically held 
responsible for the transportation and refolding of proteins from the cytoplasm into 
the mitochondrial matrix. HSP60 functions as a chaperonin to assist in folding linear amino 
acid chains into their respective three-dimensional structure. Further studies have linked HSP60 
to diabetes, stress response, cancer and certain types of immunological disorders (244, Capello).  
Under normal physiological conditions, HSP60 is a 60 kilodalton oligomer composed of 
monomers that form a complex arranged as two stacked heptameric rings (245, Cheng). This 
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double ring structure forms a large central cavity in which the unfolded protein binds via 
hydrophobic interactions. Each subunit of HSP60 has three domains: the apical domain, the 
equatorial domain, and the intermediate domain. The equatorial domain contains the binding site 
for ATP. The intermediate domain induces a conformational change when ATP is bound 
allowing for an alternation between the hydrophilic and hydrophobic substrate binding sites (246, 
Okamoto). HSP60 possesses two main responsibilities with respect to mitochondrial protein 
transport. It functions to catalyze the folding of proteins destined for the mitochondrial matrix 
and maintains protein in an unfolded state for transport across the inner membrane of the 
mitochondria. Subsequent changes in ATP concentrations hydrolyze the bonds between the 
protein and HSP60 which signals the protein to exit the mitochondria (247, Koll). 
In sum, PEBP1 interacts with cytoplasmic and mitochondrial HSPs implicated in proteins 
and vesicular transport. All these HSPs are implicated in numerous processes and several 
diseases such as cancer and neurodegenerescence. They all display an ATP binding site and an 
important ATPase activity. 
3.1.3.2.4- Transport of proteins  
In addition to Clathrin heavy chain, importin subunit beta 1 is a partner of PEBP1 that is 
implicated in transport of proteins and vesicles. 
Importin subunit beta 1 is a type of karyopherin that transports proteins into 
the nucleus by binding to specific recognition sequences, called nuclear localization sequences 
(NLS) (248, Lott). Importin has two subunits, importin α and importin β. Members of the 
importin-β family can bind and transport cargo by themselves, or can form heterodimers with 
importin-α. As part of a heterodimer, importin-β mediates interactions with the pore complex. 
The NLS-Importin α-Importin β trimer dissociates after binding to Ran GTP inside the nucleus, 
with the two importin proteins being recycled to the cytoplasm for further use (249, Lowe). 
Importins are vital regulatory proteins during the processes of gametogenesis and embryogenesis. 
(250, Miyamoto). 
3.1.3.2.5- Others 
Finally, Table I indicates two proteins that are considered as implicated in signal 
transduction: Annexin A1 and 14-3-3 protein epsilon. 
Annexin A1 belongs to the annexin family of Ca2+-dependent phospholipid-binding 
proteins that are preferentially located on the cytosolic face of the plasma membrane. Annexin 1 
has been involved in a broad range of molecular and cellular processes, including anti-
inflammatory signalling, kinase activities in signal transduction, maintenance of cytoskeleton and 
extracellular matrix integrity, tissue growth, apoptosis, and differentiation (251, Bizzarro 2012). 
Annexin A1 protein has an phospholipase A2 inhibitory activity. Increasing the synthesis and 
function of annexin A1 by Glucocorticoids treats diseases caused by an overactive immune 
system, including allergies, asthma, autoimmune diseases, and sepsis (252, Perretti). Upon 
induction by anti-inflammatory drugs, annexin A1 inhibits the NFκB signal transduction 
pathway, which is exploited by cancerous cells to proliferate and avoid apoptosis (253, Bist). 
Exposure of MCF-7 breast cancer cells to high physiological levels of estrogen lead to an up-
regulation of annexin A1 expression, suggesting that Annexin A1 may act as a tumor suppressor 
and modulates the proliferative functions of estrogens (254, Ang). In PCa cells, annexin A1 
knockdown is able to inhibit epithelial to mesenchymal transition (EMT) and to reduce FAK and 
metalloproteases (MMP)-2/9 expression (255, Bizzarro 2015). In nasopharyngeal carcinoma 
(NPC), the biological functions of Annexin A1 can inhibit the in vitro invasive ability of NPC 
cells through S100A9 and Vimentin interaction (256, Xiao 2017). 
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14-3-3 protein epsilon is an adapter protein implicated in the regulation of a large 
spectrum of both general and specialized signaling pathways. It binds to a multitude of 
functionally diverse signaling proteins, including kinases, phosphatases and transmembrane 
receptors, usually by recognition of a phosphoserine or phosphothreonine motif. Binding 
generally results in the modulation of the activity of the binding partner. A significant reduction 
of 14-3-3ε protein expression was observed in gastric cancer samples compared to their matched 
non-neoplastic tissue (257, Leal). Neuron navigator 2 (NAV2) is required to induce neurite 
outgrowth in human neuroblastoma cells. Knockdown of 14-3-3ε leads to a decrease in neurite 
outgrowth, similar to the elongation defects observed when NAV2 is depleted or mutated. The 
discovery of an interaction between NAV2 and 14-3-3ε provided insight into the mechanism by 
which NAV2 and 14-3-3 participate in promoting cell migration and neuronal elongation (258, 
Marzinke). 
 
In conclusion, the majority of proteins found as partners of PEBP1 are multifunctional 
proteins. They are implicated in numerous cellular processes and are related to membrane and 
cytoskeletal organization. The presence among them of glycolytic enzymes and protein 
biosynthesis factors supports the assumption that cytoskeleton changes are coordinated with 
energy and synthesis of newly translated proteins. There is a role for PEBP1 for modulating the 
interactions between them depending on the cellular status, signaling pathways and concentration 
of different substrates (particularly ATP) as well as natural or synthesized products coming from 
the cell external microenvironment. 
 
3.2- S-nitrosylated proteins in Alzheimer’s disease 
PEBP1 was identified among 45 S-nitrosylted proteins in Alzheimer’s disease (AD) (259, 
Zahid). Autopsied brain specimens were from well-characterized AD patients. Differential S-
nitrosylation of proteins was studied in human brain hippocampus, substantia nigra and cortex. 
Apart PEBP1, eleven S-nitrosylated proteins are part of the 35 protein partners described above 
(Table I): these are tubulin beta chain, actin cytoplasmic 1, the six glycolytic enzymes (pyruvate 
kinases isozymes M1/M2, Glyceraldehyde-3-phosphate dehydrogenase, L-lactate dehydrogenase 
A and B chains, alpha-enolase and fructose-bisphosphate aldolase A), HScognate 71 kDa, 
VDAC1 and 14-3-3 epsilon (259, Zahid). S-nitrosylation is a result of the covalent binding of 
NO with cysteine residues of target proteins with the formation of nitrosothiols (SNOs); it is a 
reversible post-translational modification. SNOs extensively modify protein function and play a 
key role in the pathology of multiple neurodegenerative diseases (260, Nakamura). On the basis 
of all these findings, the authors postulated that NO-induced PTM may alter the normal 
structural/functional protein pattern as well as protein–protein interaction mechanisms that lead to 
AD-associated conditions (259, Zahid). 
 
 
3.3- Interaction between PEBP1 and small ligands 
 
Amazingly, PEBP1 was described to bind various natural or synthesized small ligands. The 
most part of these ligands binds the small cavity present near the surface of PEBP1. Thus, this 
small cavity is considered the binding site of PEBP1, it plays a role in binding small ligands but 
also in interacting with other proteins, particularly with protein kinases. Figure 2 indicates the 
PEBP1 binding site and the edges of a furrow interacting with kinases of signaling pathways 
modulated by PEBP1 (23, Serre; 24, Banfield; 261, Martin; 262, Park; 263, Shemon). 
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3.3.1- ligands of natural origin: organic anions, nucleotides, phosphotyrosine, phospholipids 
and model membranes 
As soon as the bovine brain PEBP1 was discovered, its association with membrane lipids 
was observed, and it was needed to delipidate the brain extract to purify PEBP1 (1, Bernier). 
Then, the purified PEBP1 was shown to bind organic anions and phosphatidylethanolamine (5, 
Bernier). The crystal structure of PEBP1 from bovine brain revealed a novel structural family of 
proteins. The PEBP1 tridimensional structure contains no internal hydrophobic pocket, but a 
small cavity close to the protein surface that displayed a high affinity for anions, such as 
phosphate and acetate, and also phosphorylethanolamine (the polar head group of 
phosphatidylethanolamine) (23, Serre). The ligand binding site for anions was confirmed by the 
crystal structure of human PEBP1 which was identical to the bovine PEBP1 structure and 
revealed a molecule of cacodylate set up in the cavity of PEBP1 (24, Banfield).  
The affinity of PEBP1 toward model membranes such as large unilamellar vesicles (LUV), 
small unilamellar vesicles (SUV) and phospholipid monolayers was measured. It was shown that 
the whole PEBP1 was able to bind membranes (264, Vallée). The crystal structure of PEBP1 
indicated that the N-terminal and C-terminal parts of PEBP1 were exposed at the protein surface 
and could be involved in the interaction with membranes. Therefore, two peptides were 
synthetized, one of them was a 12-amino-acid peptide corresponding to the N-terminal extremity 
(residues 1-12) of PEBP1, whereas the other one was a 19-amino-acid corresponding to the C-
terminal helix (residues 168-186) of PEBP1. Both peptides bound model membranes and 
displayed the same behavior as whole PEBP1, indicating that they could participate in the 
binding of the whole protein to membranes. Overall, the results suggested that PEBP1 
may directly interact with negatively charged membrane microdomains in living cells (264, 
Vallée). 
Otherwise, the sequence determination of bovine PEBP1 (2, Schoentgen) allowed to build a 
molecular model through hydrophobic cluster analysis and molecular modelling. At this time on, 
the analysis of the model and comparison with other proteins present in the Protein Data Bank 
(PDB) revealed a putative ATP binding site (265, Schoentgen). Thus, the affinity of nucleotides 
(anionic components) toward PEBP1 was experimentally tested. The more effective nucleotides 
to bind PEBP1, presented in decreasing order, were: FMN > GTP > GDP > GMP > FAD > ATP 
> NADP > CTP > UTP > ADP (6, Bucquoy). Later on, the binding of FMN and GTP was 
confirmed by nuclear magnetic resonance (NMR) and mass spectrometry under conditions 
similar to what is found in cells regarding pH, salt concentration and temperature (266, Tavel). 
Another study described the binding of phosphotyrosine to the ligand site of PEBP1. The 
structure of PEBP1 bound to pTyr showed that the PEBP1 ligand binding pocket molded 
complementary to the shape of the pTyr side chain (267, Simister). As studies have previously 
indicated that phosphorylation of the S338SYY341 region of Raf-1 enhances binding to PEBP1 
leading to suppression of MEK activation (262, Park), a mechanism was proposed for 
PEBP1/Raf-1 interaction in which PEBP1 regulates Raf-1 activity via direct steric inhibition of 
the Tyr341 region (267, Simister). NMR titration studies further confirmed that the pocket region 
is the binding site for the tri-phosphorylated peptide 331RPRGQRDpSpSYpYWEIEASEV349, 
corresponding to the minimal region 331-349 of Raf-1 required for rat PEBP1 binding. In 
addition, the results indicated that residues in the vicinity of the pocket rather than those within 
the pocket were required for interaction with Raf-1 (266, Tavel). These results raised the 
question whether PEBP1 could be classified as a bona fide pTyr binder but it was concluded that 
direct, physiological or structural, evidence for complex formation is required before PEBP1 can 
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be classified as a bona fide pTyr binder (268, Kaneko). Finally, by Affinity Elution in Tandem 
Hydrophobic Interaction Chromatography, it was demonstrated that PEBP1 is an ATP-binding 
protein and that ATP attenuates the interaction between PEBP1 and Raf-1. In parallel, short-term 
ATP depletion in cultured HEK293 cells augments interaction between PEBP1 and Raf-1, 
resulting in decreased activation of the downstream ERK signaling. Therefore, the ATP-binding 
function renders the inhibition of Raf-1 by PEBP1 modulated by cellular ATP concentrations. 
These data shed light on how energy levels affect the propagation of cellular signaling (269, 
Huang 2016). 
 
3.3.2- Binding of PEBP1 to synthetic inhibitors, drugs and prodrugs  
Besides the binding of intracellular small ligands as nucleotides and phospholipids, PEBP1 
was also found to bind small synthetic molecules.  By identifying protein "interactors" of PF-
3717842, a high-affinity phosphodiesterase-5 (PDE5) inhibitor, from rat testis tissue lysate, 
PDE5 and a few other PDEs were strongly and specifically enriched. However, in addition to 
these expected affinity-enriched proteins, PEBP2 (the PEBP isoform specific of testis) was found 
as a putative binder to the PDE5 inhibitor. By using recombinant forms of the related murine 
mPEBP2, mPEBP1 and human hPEBP1 it was confirmed that they all can bind strongly to 
immobilized as well as soluble PF-3717842. These results suggested that the synthetic PDE5 
inhibitor PF-3717842 might form a platform to synthesize enhanced binders/inhibitors of the 
family of PEBP proteins (8, Dadvar).  
Locostatin, another interesting product was fortunately discovered as interacting with 
PEBP1. Locostatin, a cell migration inhibitor, was demonstrated to bind four proteins in MDCK 
cell lysates: PEBP1, glutathione S-transferase omega 1-1, aldehyde dehydrogenase 1A1 and 
prolyl oligopeptidase (270, Zhu). The possibility for PEBP1 to be the main target of locostatin 
appeared very strong: PEBP1 is one of only four proteins specifically bound by locostatin and the 
only one of the four whose binding profile for locostatin analogs correlates with the effects of the 
analogs on cell locomotion (271, Bement). The protective effect of PEBP1 against drug inhibitor 
of migration suggested a new role for RKIP in potentially sequestering toxic compounds that may 
have deleterious effects on cells (263, Shemon). It was shown that locostatin disrupted 
interactions of PEBP1 with Raf-1 and also with GRK2. In contrast, locostatin did not disrupt 
binding of PEBP1 with IKKα and TAK1. These results implied that different proteins interact 
with different regions of PEBP1. After binding PEBP1, part of locostatin is slowly hydrolyzed, 
leaving a smaller PEBP1-butyrate adduct. The residue alkylated by locostatin was identified as 
His86, a conserved residue of the PEBP1 ligand-binding pocket (272, Beshir). The use of 
locostatin as an inhibitor of PEBP1 revealed the important roles of PEBP1 in the regulation of 
cell adhesion, as it positively controls cell-substratum adhesion while negatively controls cell-cell 
adhesion (54, Mc Henry). In the same way, locostatin revealed that PEBP1 induces extracellular 
matrix (ECM) in uterine leiomyoma and myometrial cells. Uterine Leiomyoma is a tumor with 
fibrotic characteristics and accumulates excessive amounts of ECM mainly composed of 
collagens, fibronectin, and versican. Locostatin treatment resulted in the activation of the MAPK 
signal pathway (ERK phosphorylation), reduced GSK3 expression and reduced ECM 
components. Moreover, the inhibition of PEBP1 by locostatin impaired cell proliferation and 
migration in both leiomyoma and myometrial cells (273, Janjusevic). 
As mentioned above, it was observed that after binding PEBP1, part of locostatin is slowly 
hydrolyzed, leaving a smaller PEBP1-butyrate adduct (272, Beshir). Another product, namely 
Prasugrel, was also described to be hydrolysed by PEBP1. Prasugrel is a thienopyridine 
antiplatelet prodrug that undergoes rapid hydrolysis in vivo to a thiolactone metabolite by human 
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carboxylesterase-2 (hCE2) during gastrointestinal absorption. The thiolactone metabolite is 
further converted to a pharmacologically active metabolite by cytochrome P450 isoforms. PEBP1 
was identified as another protein capable of hydrolyzing prasugrel to its thiolactone metabolite, 
and to play a significant role with hCE2 in prasugrel bioactivation in human intestine. The 
estimated contributions of these two hydrolyzing enzymes to the prasugrel hydrolysis were 
approximately 40% for PEBP1 and 60% for hCE2. Thus, PEBP1 was described for the first time 
as a hydrolase involved in drug metabolism (274, Kazui). 
 
4- Cellular processes 
PEBP1 is known to be implicated in several cellular processes, these are summarized in Table II. 
Apart from signaling pathways discussed in generalities paragraph, the other main processes 
modulated by PEBP1 are presented below. 
 
4.1- Roles of PEBP1 in membrane remodeling and association with vesicles 
Very soon, at the time of the identification of PEBP1, its localization along the plasma 
membrane of oligodendrocytes in brain (275, Roussel) and its implication in spermatogenesis 
(276, Seddiqi) led us to assume that PEBP1 may be implicated in membrane remodeling. Since 
then, PEBP1 was described to participate in several processes affecting directly cellular 
membrane features. Among them, we specifically discuss below sperm capacitation, receptors 
internalization, exosomes formation and neuronal synapse. 
4.1.1- Sperm capacitation 
The role of PEBP1 in the sperm capacitation was demonstrated by the study of a PEBP-1(-
/-) mice. Testicular germ cells express high levels of PEBP1 mRNA during spermatogenesis, 
essentially from late pachytene spermatocytes to elongate spermatids. Sperm from PEBP1-
deficient mice were precociously capacitated compared with their wild-type counterparts (49, 
Moffit). Data from mating experiments indicate decreased reproduction rates between crosses of 
PEBP1(-/-) male mice and either heterozygous or PEBP1(-/-) females. Furthermore, PEBP1 
immunolocalization of epididymal sperm supported transfer of the protein from germ cell 
cytoplasm to the sperm via the cytoplasmic droplet during epididymal transport (49, Moffit). 
Interestingly, the homozygous mice developed dramatic olfaction deficits in the first year of life 
(75, Theroux).  
4.1.2- Internalization of receptors and desensitization 
GRK2 is well-known to phosphorylate and desensitize G protein-coupled receptors 
(GPCRs) (277, Robinson). It was shown that PEBP1 switched from Raf-1 to GRK2 when 
phosphorylated by protein kinase C (PKC) on serine 153. Thus, after stimulation of G-protein-
coupled receptors (GPCRs), pS153PEBP1 which associated with GRK-2, blocked its activity (88, 
Lorenz).  
4.1.2.1- Opioid receptors 
Among GPCRs, opioid receptors were several times mentioned to be in close relationships 
with PEBP1, without PEBP1 being itself an opioid receptor. First, rat brain PEBP1 was eluted 
from a morphine-derived affinity column suggesting that although not an opioid receptor itself, 
PEBP1 may be associated with such a receptor (4, Grandy). Later on, it was shown that inside 
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the secretory granules of bovine primary chromaffin cells, PEBP1 directly interacted with 
endogenous morphine glucuronides (M3G and M6G) but not with morphine. Thus, it was 
suggested that, during stress, M6G-PEBP1 complexes may be released into circulation to target 
peripheral opioid receptors (278, Atmanene). Even later, the role of PEBP1 in µ-opioid 
receptor-mediated ERK activation was investigated in Chinese hamster ovary/µ cells and 
SH-SY5Y cells, as well as in human embryonic kidney HEK293 cells. It appeared that PEBP1 
did not have a significant role in µ-opioid receptor-mediated regulation of ERK. In the same 
study, only the activation of Gq-coupled adrenergic α1A receptors induced an upregulated 
phosphorylation of PEBP1, which was protein kinase C activity dependent (279, Bian).  
Contrary to µ-opioid receptor (MOR), PEBP1 was proved to impact -opioid receptor 
(DOR) activity. While most clinical opioids target MOR, those that target the DOR class also 
demonstrated analgesic efficacy. However, DOR are analgesically incompetent in the absence of 
inflammation. It was reported that GRK2 naively associated with plasma membrane DOR in 
peripheral sensory neurons to inhibit analgesic agonist efficacy. This interaction prevented 
optimal Gβ subunit association with the receptor, thereby reducing DOR activity. Under the 
effect of the inflammatory mediator bradykinin, GRK2 moved away from DOR and onto PEBP1. 
Then, PKC-dependent PEBP1 phosphorylation induced GRK2 sequestration, restoring DOR 
functionality in sensory neurons (90, Brackley). 
4.1.2.2- Beta-adrenergic receptors 
pS153PEBP1 inhibited agonist-induced internalization of 2-adrenergic receptors of HEK-
293 cells and of cardiomyocytes in rat osteosarcoma ROS 17/2.8 cells. It was concluded that 
inhibition of GRK-2 by pS153PEBP1 enhanced signaling and decreased receptor internalization 
(88, Lorentz). Recently, PEBP1 exhibited a combination of favorable effects for heart failure 
patients as the endogenous PEBP1 was found to activate adrenergic receptors (βAR) signaling of 
the heart. The first favorable effect was that, the gain/increase of cardiac contractile efficiency by 
the activation of Gs signaling/ 1AR led to functional recovery of the heart. Secondly, the 
protection of the heart under sympathetic stress from exaggerated 1AR downstream signaling 
included protection from apoptosis and proarrhythmic adverse effects via 2AR activation. In a 
more general way, it was observed that in the context of heart failure, PEBP1 comprises several 
favorable characteristic effects on calcium cycling, calcium sensitivity and G-protein recruitment 
to beta adrenergic receptors (280, Lorentz, 2017). In cardiomyocytes, the binding of GRK2 to 
the βγ subunits of activated G proteins (Gβγ), regulates the activation of beta-adrenergic receptor 
(βAR) signaling. PEBP1 binds GRK2 in the amino-terminal domain and the downregulation of 
PEBP1 inhibits beta-adrenergic signaling and contractile activity (281, Sorriento 2016). 
4.1.2.3- Vasoactive intestinal peptide receptors  
In the gastrointestinal tract, the neuropeptides vasoactive intestinal peptide (VIP) and 
pituitary adenylyl cyclase-activating peptide (PACAP) were colocalized in a subset of myenteric 
neurons that innervate the smooth muscle, and their release was functionally linked to smooth 
muscle relaxation (282, Ulrich). The biological actions of VIP and PACAP were mediated by a 
family of G protein-coupled receptors, which were designated as VPAC1, VPAC2, and PAC1 
receptors (282, Ulrich). In gastrointestinal smooth muscle cells, VPAC2 receptor desensitization 
is exclusively mediated by GRK2. Muscle cells, stimulated with acetylcholine in the presence of 
the M2 receptor antagonist methoctramine (i.e., activation of M3 receptors) displayed inhibition 
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of VPAC2 receptor phosphorylation, internalization, and desensitization (283, Huang 2007). The 
inhibition was mediated by PKC, derived from Muscarinic receptor M3 activation. In these 
conditions, acetylcholine induced phosphorylation of PEBP1, increased PEBP1-GRK2 
association, decreased PEBP1-Raf-1 association, and stimulated ERK1/2 activity (283, Huang, 
2007). 
4.1.2.4- Mitochondrial localization of GRK2 
It is now validated that GRK2 regulates several intracellular signaling pathways not only 
through the phosphorylation of specific substrates but also through protein–protein interactions 
independently from its catalytic activity (283, Sorriento 2016). Moreover, it should be noted, 
that apart from heart failure, GRK2 was found, in fibroblasts, to increase ATP cellular content by 
enhancing mitochondrial biogenesis; also, it antagonized ATP loss after hypoxia/reperfusion and 
was detected to localize in the mitochondrial outer membrane (284, Fusco). In macrophages, in 
response to lipopolysaccharide, GRK2 accumulated in mitochondria, increasing biogenesis. The 
overexpression of the carboxy-terminal domain of GRK2 (βARK-ct), known to displace GRK2 
from plasma membranes, induced earlier localization of GRK2 to mitochondria in response to 
lipopolysaccharide leading to increased mt-DNA transcription and reduced ROS production and 
cytokine expression (285, Sorriento  2013). Interestingly, the effect of PEBP1 on mitochondria 
via GRK2 is in accordance with its effect on Raf1. Indeed, during hepatitis B virus X-mediated 
hepatocarcinogenesis, the PEBP1 downregulation induced the translocation of Raf-1 into 
mitochondria by increase of the free Raf-1 level in the cytosol. Subsequently, the enhanced 
mitochondrial Raf-1 imparted the anti-apoptotic effect on cells (286, Kim SY 2011). 
 
4.1.3- PEBP1 is associated with several types of vesicles 
4.1.3.1- Exosomes 
Numerous studies have described the association of PEBP1 with various types of vesicles. 
Among them exosomes were often reported to contain PEBP1. Exosomes are defined as vesicles 
in the range of 30–100 nm, they are released by several types of cells and have been found in 
numerous body fluids (287, H Rashed). Exosomes can contain microRNAs, mRNAs, DNA 
fragments, and proteins, which are shuttled from a donor cell to recipient cells. Notably, tumor 
cells have been shown to produce and secrete exosomes in greater numbers than normal cells.  
Recently, as it appeared that the tumor microenvironment influences cancer progression and 
metastasis, the role of exosomes in cancer was extensively studied (288, Brinton; 289, Kahlert; 
290, Zha). PEBP1 was previously described as a released or a potentially secreted protein in 
several organs and cells. It was particularly found in testicular interstitial fluid (291, Turner), in 
epididyme (292, Dacheux), in chromaffin cell secretory granules (293, Goumon) and in non-
small cell lung cancer (294, Huang, 2006). In addition, proteome profiling of exosomes have 
revealed the presence of PEBP1 in ovarian cancer ascites (295, Shender), in prostate cancer 
(296, Kharaziha) and in lipid rafts of prostasomes that are membranous vesicles released by the 
prostate gland epithelial cells into seminal fluid (297, Dubois). PEBP1 was also identified in 
soluble secretome of primary cancer cell line SW480 and lymph node metastatic colorectal 
cancer cells SW620 (298, Ji). Finally, independently of cancer, PEBP1 was also detected in 
extracellular vesicles from tissues of the central nervous system (299, Gallart-Palau). 
4.1.3.2- Other cellular vesicles 
A quantitative proteomics analysis revealed that PEBP1 belongs to a subset of the 
endoplasmic reticulum that contributes to the phagosome. Phagosomes, by killing and degrading 
pathogens for antigen presentation, are organelles implicated in key aspects of innate and 
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adaptive immunity. It was well established that phagosomes consist of membranes from the 
plasma membrane, endosomes, lysosomes, and also from the endoplasmic reticulum (ER) 
membrane which contributes to about 20% of the early phagosome proteome. Only a subset of 
ER proteins (among which PEBP1) was recruited to the phagosome, suggesting that a specific 
subdomain of the ER might be involved in phagocytosis (300, Campbell-Valois). 
PEBP1 was also detected in neuromelanin granules isolated from human brain substantia 
nigra (301, Plum). The substantia nigra is a basal ganglia structure located in the midbrain that 
plays an important role in reward and movement. Neuromelanin granules could form during 
aging by the fusion of many neuromelanin-laden endosomes and lysosomes in multivesicular 
bodies (301, Plum). 
 
4.2- PEBP1 in neuronal synapse  
 
PEBP1 was shown to have several neurophysiological roles in mammalian brain, including 
neural development and differentiation, circadian clock and synaptic plasticity with implications 
in certain pathologies such as Alzheimer’s disease and brain cancer (62, Ling). Particularly, the 
implication of PEBP1 in neuronal plasticity was demonstrated by its role in cerebellar long-term 
synaptic depression (LTD) and in hippocampus long-term potentiation (LTP) in transgenic mice. 
LTD and LTP are two important mechanisms for learning and memory. Moreover, the level of 
PEBP1 expression was found to be regulated by neuronal activity and also by alcohol, nicotine 
and psychoactive drugs. 
 
4.2.1- Regulation of PEBP1 expression in rat hippocampus  
PEBP1 expression was found to be upregulated by excitation of hippocampal pyramidal 
neurons and to be dependent on muscarinic cholinergic and glutamatergic receptors. HCNP is 
derived from the N-terminal region of PEBP1 (11 N-terminal residues). It was originally isolated 
from the hippocampus of young rats and enhances acetylcholine synthesis in rat medial septal 
nucleus in vitro. The precursor of HCNP is PEBP1, thus the role and the expression of PEBP1 
was specifically studied in hippocampus. The highest expression of PEBP1 mRNA is in 
hippocampal pyramidal neurons that are a type of multipolar neurons found in areas of the brain 
including the cerebral cortex, the hippocampus, and the amygdala. Pyramidal neurons are the 
primary excitation units of the mammalian prefontal cortex and the corticospinal tract. In an in 
vitro rat hippocampal slice, PEBP1 mRNA expression was regulated by neuronal activity (304, 
Iwase). Selective inhibition with pharmacological agents revealed that stimulation of ionotropic 
glutamate receptors, as well as activation of either muscarinic receptors or metabotropic 
glutamate receptors, may act cooperatively to modulate PEBP1 mRNA expression. Finally, the 
main results suggested that in the rat hippocampus: (1) membrane depolarization increases 
PEBP1 mRNA expression; (2) glutamatergic and cholinergic neurotransmitter pathways 
contribute to a reciprocal regulation of PEBP1 expression; (3) L-type Ca2+ channels and NMDA 
receptors are both important for the regulation of PEBP1 expression; and (4) the activity-
dependent and constitutive expressions of  PEBP1 may be regulated by different routes, 
involving calcium influx via L-type Ca(2+) channels and NMDA receptors (304, Iwase). 
 
4.2.2- Alcohol, nicotine and psychoactive drugs modify the expression of PEBP1. 
4.2.2.1- Alcohol, innate differences 
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Two-dimensional gel electrophoresis (2-DE) was used to separate protein samples 
solubilized from the nucleus accumbens and hippocampus of alcohol-naïve, adult, male inbred 
alcohol-preferring (iP) and alcohol-nonpreferring (iNP) rats (303, Witzmann). Several protein 
spots were excised from the gel, destained, digested with trypsin, and analyzed by mass 
spectrometry. The results indicated that selective breeding for disparate alcohol drinking 
behaviors produced innate alterations in the expression of several proteins that could influence 
neuronal function within the nucleus accumbens and hippocampus. Particularly, PEBP1 was 
more abundant in hippocampus and nucleus accumbens of alcohol-non preferring rats than 
alcohol-prefering rats (1.2 fold in hippocampus and 1.4 fold in nucleus accumbens) (303, 
Witzmann).  
4.2.2.2- Alcohol, long-term exposure 
It was shown that long-term ethanol exposure impairs neuronal differentiation of human 
neuroblastoma cells. Chronic ethanol interfered with the development of a neuronal network 
consisting of cell clusters and neuritic bundles. Furthermore, neuronal and synaptic markers were 
reduced, indicating impaired neuronal differentiation. Brain-derived neutrophic factor (BDNF)-
mediated activation of the ERK cascade was found to be continuously impaired by ethanol. 
However, BDNF also activated PKC signaling and PEBP1 phosphorylation, which finally led to 
ERK activation (304, Hellmann). In this study, PEBP1, acting as a signaling switch at the merge 
of the PKC cascade and the Raf/MEK/ERK cascade, was associated with neuronal differentiation 
and was found to be significantly reduced in ethanol treatment. Moreover, PKC expression itself 
was even more strongly reduced. Reduced PEBP1 and PKC levels and subsequently reduced 
positive feedback on ERK activation provided an explanation for the striking effects of long-term 
ethanol exposure on BDNF signal transduction and neuronal differentiation (304, Hellmann).  
4.2.2.3- Nicotine exposure 
Proteomic analysis of the hippocampus and cortex of mice treated for 6 months with 
nicotine was performed (305, Matsuura). The expression level of PEBP1 was not changed in the 
hippocampus but was increased by 1.2 fold in the cortex (305, Matsuura). 
4.2.2.4- Psychoactive drugs 
A study focused on determining changes in the proteome that occurred after long-term 
exposure of rats to two clinically effective antidepressant drugs, fluoxetine (a selective serotonin 
reuptake inhibitor) and venlafaxine (a dual serotonin/norepinephrine reuptake inhibitor). The 
hippocampus was chosen for analysis, taking into consideration the involvement of this important 
anatomic region in clinical depression (306, Nestler). Either venlafaxine or fluoxetine was 
administered systemically to adult rats for 2 weeks, and protein patterns from rat hippocampal 
cytosolic extracts were compared. Thirty-three proteins were modulated by both drug treatments 
compared to controls. Among them, the upregulation of PEBP1 was observed: 2.0 fold with 
venlafaxine and 1.9 with fluoxetine treatment. It was concluded that PEBP1 would contribute to 
the long-term maturation, extension of neurites, and integration of developing granular cells 
within the existing hippocampal circuitry (306, Nestler). Parallel studies to investigate further the 
effects of venlafaxine and fluoxetine on adult hippocampal neurogenesis in vivo revealed a 
significant drug-induced increase in the proliferation rate and long-term survivability of 
progenitor stem cells located in the subgranular zone. The upregulation of PEBP1 was 2.0 with 
venlafaxine and 1.0 with fluoxetine. These data suggested that the two drugs share wide-ranging 
proteome changes within the hippocampal formation, beyond serotonin/norepinephrine 
neurotransmission and that this may reflect long-term functional adaptations required for 
antidepressant activity (131, Khawaja).  
4.2.2.5- Neurotoxics  
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Methylmercury (MeHg) is a neurotoxic and ubiquitous environmental contaminant for 
which the brain is considered to be the main target organ (National Research Council, 2000). In 
order to investigate molecular mechanisms underlying MeHg neurotoxicity as well as to identify 
protein biomarker candidates for environmental monitoring, changes in the brain proteome of 
Atlantic cod (Gadus morhua) following MeHg exposure were studied. The doses were given in 
two injections, half of the dose on the first day and the second half after 1 week, and the total 
exposure period lasted 2 weeks. The level of 71 proteins to be 20% or more significantly altered 
following MeHg exposure was observed, and 40 of these proteins were successfully identified. 
PEBP1 expression was 1.6 fold increased in brain of cods submitted to MeHg exposure. Several 
of the proteomic alterations seem to reflect well-established molecular targets and mechanisms of 
MeHg-induced neurotoxicity in mammals, such as mitochondrial dysfunction, oxidative stress, 
altered calcium homeostasis, tubulin/disruption of microtubules and calpain-cleavage. In 
addition, indications of glycolysis as a target for MeHg were strengthened by the demonstration 
of up-regulation of four glycolytic enzymes (fructose 1,6-diphosphate aldolase, glyceraldehyde-
3-phosphate dehydrogenase, phosphoglycerate kinase, phosphoglycerate kinase). These results 
were considered indicative of the molecular mechanisms underlying MeHg neurotoxicity and 
defense responses (307, Berg).  
Asiaticoside was found to counteract the neurotoxic effects of the natural pesticide 
rotenone. Asiaticoside (AS), a triterpenoid saponin isolated from the Indian medicinal herb 
Centella asiatica is known to exert a neuroprotective effect by attenuating the neurobehavioral, 
neurochemical and pathological changes in animal models. Rotenone (ROT), a commonly used 
natural pesticide extracted from the roots of tropical plants, such as Derris elliptica, is able to 
freely cross the blood brain barrier, plasma membrane and mitochondrial membranes thus 
inducing Parkinson disease-like symptoms (308, Gopi) . Expression of PEBP1 after ROT-
infusion in rat model was significantly increased when compared to control group. However, 
increased PEBP1 expression was not observed on AS administration in ROT received rats. This 
implies that AS treatment may normalize hypercholinergic stimulation, and also maintain normal 
synaptic function by preserving PEBP1. It was concluded that ROT-infused generation of ROS 
and hence oxidation of cytosolic dopamine might be altered by AS not only by its antioxidant 
potential but also by its effect on proteins that need phosphoinositides for their function and 
localization, thus ensuring an improved cytoprotection, phosphoinositides assisted vesicular 
trafficking and synaptic integrity (308, Gopi). 
 
4.2.3- Localisation of PEBP1 with CRMP2 at presynaptic terminals 
It was demonstrated that the amount of collapsin response mediator protein-2 (CRMP-2) is 
increased in hippocampus of PEBP1 transgenic mice. PEBP1 co-localizes with CRMP-2 at 
presynaptic terminals and PEBP1 overexpression increases synaptophysin levels. These findings 
suggested that PEBP1, in association with CRMP-2, plays an important role in presynaptic 
function in the hippocampus (56, Kato). It was demonstrated that PEBP1 predominantly 
colocalized and associated with unphosphorylated and/or pSer-522-CRMP-2 at presynaptic 
terminals in the hippocampus. Interestingly, PEBP1 did not associate with pThr-509/514-CRMP-
2, which is primarily localized at postsynaptic terminals. These results suggested that PEBP1, in 
association with unphosphorylated and/or pSer522-CRMP-2, plays an important role in 
presynaptic function in the mature hippocampus (57, Mizuno). 
 
4.2.4- PEBP1 is implicated in LTD and LTP 
4.2.4.1- Long-term depression (LTD) 
 34 
 
LTD is an activity-dependent reduction in the efficacy of neuronal synapses lasting hours 
or longer following a long patterned stimulus. LTD is thought to result mainly from a decrease in 
postsynaptic receptor density, although a decrease in presynaptic neurotransmitter release may 
also play a role. Cerebellar LTD has been hypothesized to be important for motor learning.  
It was demonstrated that a positive feedback loop, including protein kinase C (PKC) and 
mitogen-activated protein kinase (MAPK), is required for the gradual expression of cerebellar 
long-term depression (LTD). PKC and MAPK are mutually activated in this loop. To test the 
hypothesis that PEBP1, a substrate of PKC, was implicated in this loop, Yamamoto et al. (64, 
Yamamoto) used a mutant form of PEBP1 that was not phosphorylated by PKC and thus 
constitutively inhibited Raf-1 and MEK. When this PEBP1 mutant was introduced into Purkinje 
cells of mouse cerebellar slices through patch-clamp electrodes, LTD was blocked, while wild-
type PEBP1 had no effect on LTD. Physiological experiments demonstrated that PEBP1 worked 
downstream of PKC and upstream of MAPK during LTD induction. Furthermore, biochemical 
analyses demonstrated that endogenous PEBP1 dissociated from Raf-1 and MEK during LTD 
induction in a PKC-dependent manner, suggesting that PEBP1 inhibition of Raf-1 and MEK is 
removed upon LTD induction. It was concluded that PKC-dependent regulation of PEBP1 led to 
MAPK activation that is required for LTD (64, Yamamoto). 
4.2.4.2- Long-term potentiation (LTP) 
Long-term potentiation (LTP) is the opposing process to LTD; it is the long-lasting increase 
of synaptic strength. In conjunction, LTD and LTP are factors affecting neuronal synaptic 
plasticity. Glutamate is the primary excitatory neurotransmitter at almost all synapses in the 
central nervous system. Acetylcholine is an excitatory neurotransmitter involved in synaptic 
transmission at neuromuscular junctions, visceral motor systems and various sites within the 
central nervous system (309, Picciotto). Although all acetylcholine receptors respond to 
acetylcholine, they respond to other molecules as well. Nicotinic and muscarinic are two main 
kinds of "cholinergic" receptors. To examine the physiological function of PEBP1 on 
hippocampal neural activity, Ohi et al. (310, Ohi) investigated whether overexpression of PEBP1 
strengthened the efficiency of neural activity in the hippocampus. The results suggested that 
muscarinic (M1) modulation of glutamatergic postsynaptic function may be involved in 
strengthening LTP transgenic mice overexpressing PEBP1. As it was reported that 
overexpression of PEBP1 in the transgenic mice increased the amount of cholineacetyltransferase 
in the septal nucleus, a possible explanation was that the remaining axon terminals from the 
septum may play some role in synthesizing large amounts of acetylcholine and reinforcing 
exocytosis in PEBP1 transgenic mice (310, Ohi). 
 
4.2.5- Localization of PEBP1 in rat intestine nerve cells 
Independently of neural cells in brain, HCNP and/or PEBP1 was also detected by 
immunoreactivity in nerve processes and nerve cell bodies in the rat small intestine (311, 
Katada). Labeled nerve processes were numerous in the circular muscle layer and around the 
submucosal blood vessels. The data provided evidence that HCNP and/or PEBP1 nerve cell 
bodies and nerve fibers are present in the submucosal and myenteric plexuses of the rat small 
intestine. By immunohistochemical staining, HCNP and/or PEBP1 was observed on the 
membranes of various subcellular organelles, including the rough endoplasmic reticulum, Golgi 
saccules, ovoid electron-lucent synaptic vesicles in axon terminals associated with submucosal 
and myenteric plexuses, and the outer membranes of a few mitochondria. The synaptic vesicles 
of HCNP and/or PEBP1 terminals were 60-85 nm in diameter. An immunohistochemical light 
microscopic study revealed that in both the submucosal and myenteric ganglia, almost all choline 
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acetyltransferase (ChAT)-immunoreactive neurons were also immunoreactive for HCNP and/or 
PEBP1. These observations suggested that HCNP proper and/or PEBP1 is a membrane-
associated protein with a widespread subcellular distribution, that PEBP1 may be biosynthesized 
within neurons localized in the rat enteric nervous system, and that HCNP proper and/or PEBP1 
are probably stored in axon terminals (311, Katada). 
 
4.3- PEBP1 prevents primary cilium formation 
Using the Cep290 mutant mouse retinal degeneration (rd16), it was shown that Cep290-
mediated photoreceptor degeneration is associated with aberrant accumulation of PEBP1, and 
that Cep290 physically interacts with PEBP1. For the first time, these data suggested that PEBP1 
prevents cilia formation and is associated with Cep290-mediated photoreceptor degeneration (75, 
Murga-Zamalloa). PEBP1 co-localized with Cep290 at the transition zone of the photoreceptors, 
which is the region between the basal body and the axoneme. PEBP1 revealed to be present in the 
apical inner segment, transition zone, and to a lesser extent, at the basal body and centriole of the 
photoreceptors. The concentrated signal of PEBP1 at these sites and its ability to interact with 
Rab8A suggested its involvement in the regulation of docking and transport of membrane 
protein-containing vesicles in photoreceptors (75, Murga-Zamalloa). The ectopic accumulation 
of PEBP1 led to defective cilia formation in zebrafish and cultured cells, this effect being 
mediated by the interaction of PEBP1 with the ciliary GTPase Rab8A.  PEBP1 preferentially 
associated with Rab8A in the presence of GDP substrate, suggesting that the PEBP1-Rab8A 
(GDP) complex may need to dissociate for the release of Rab8A-GDP and subsequent conversion 
to Rab8A-GTP for appropriate ciliary transport. These results suggested that PEBP1 modulates 
the localization of a distinct set of proteins required for cilia assembly and maintenance (see 
Figure 3 for a schematic representation of primary cilium). Moreover, PEBP1 levels appeared to 
be critical for cilia formation, injection of mRNA encoding PEBP1 into wild-type zebrafish 
embryos resulting in defective ciliogenesis. Finally, the accumulation of PEBP1 seemed to be due 
to increased stability of the protein. The phosphorylation of PEBP1 at Ser153 did not affect its 
ability to reduce cilia formation (75, Murga-Zamalloa). To complete these results, the study of 
double knockout mice Cep290 rd16: PEBP1 ko/ko showed that retinal degeneration in the Cep290 
rd16 mice could be delayed by downregulating the expression of PEBP1 (76, Subramanian). The 
data also suggested a role of CEP290 in modulating PEBP1 levels for normal photoreceptor 
development and survival. Moreover, as it was previously shown that PEBP1 could be degraded 
via the ubiquitin-proteasome system (UPS) (118, Qu 2013) and given the involvement of cilia 
and basal body proteins in regulating the UPS (312, Liu 2014), it seemed conceivable that 
CEP290 targets PEBP1 to the UPS (76, Subramanian). 
All these results are in accordance with other studies suggesting PEBP1 implication in 
primary cilium functioning. Particularly, cilia movement regulates expression of PEBP1 (129, 
Sas). It was shown that PEBP1 levels were significantly reduced in mice lacking cilia and that 
PEBP1 levels with cilia bending were diminished by a PKC inhibitor (129, Sas). Malfunction of 
primary cilium was associated with various pathological disorders, many of them leading to 
cystic disorders in kidney, liver and pancreas. In kidney, primary cilia were shown to be present 
on nearly all epithelial cells and extend from the apical surface into the tubular lumen, where they 
respond to luminal fluid flow. Cilia bending, with changes in apical flow, led to various 
intracellular signaling events including increases in intracellular calcium concentrations, thereby 
acting as mechanosensors (313, Rydholm) and also served an important role in the maintenance 
of cell differentiation (314, Bacallao). 
 36 
 
 
4.4- PEBP1 regulates the mitotic spindle checkpoint 
PEBP1 was described to associate with centrosomes and kinetochores and to regulate the 
spindle checkpoint in mammalian cells (155, Eves). The centrosome is an organelle that serves as 
the main microtubule organizing center (MTOC) of animal cells. It acts as a multifunctional 
platform for numerous signaling processes and is functionally implicated in processes such as cell 
cycle progression, cell polarity, migration, mitosis, and ciliogenesis (315, Tollenaere). In mitosis 
the nuclear membrane breaks down and the centrosome nucleated microtubules can interact with 
the chromosomes to build the mitotic spindle. During the process of cell division, the spindle 
checkpoint prevents separation of the duplicated chromosomes until each chromosome is 
properly attached to the spindle apparatus (316, London; 317, Musacchio). The kinetochores are 
large protein complexes assembled on the centromeric region of the chromosomes, they mediate 
spindle–microtubule attachment and control the movement of chromosomes during mitosis and 
meiosis (318, Yamagishi). PEBP1 depletion decreased the mitotic index, decreased timing from 
nuclear envelope breakdown to anaphase, and caused an override of mitotic checkpoints induced 
by spindle poisons such as Taxol (155, Eves). PEBP1 depletion reduced kinetochore localization 
and kinase activity of Aurora B which is a regulator of the spindle checkpoint (155, Eves). In 
complex with other “chromosomal passenger” proteins, Aurora B accumulates at inner 
centromeres during prometaphase and controls the interactions of microtubules with 
kinetochores. Loss of PEBP1 led to a defective spindle checkpoint through a mechanism 
involving enhanced Raf-1 activation and Aurora B kinase inhibition. Thus, it appeared that 
PEBP1 regulates normal timing of mitosis from nuclear envelope breakdown to anaphase, and 
accumulation of cells in metaphase. In addition, PEBP1 depletion increased chromosomal 
damage upon exposure of HeLa cells to Taxol, due probably to relaxation of the spindle 
checkpoint (155, Eves). Figure 4 shows a schematic representation of mitotic spindle according 
to Prosser and Pelletier (319, Prosser). 
Phosphorylated PEBP1 (pS153PEBP1) was also localized at kinetochores and PEBP1 
phosphorylation was specifically increased during mitosis, leading probably to the activation of 
the MAP kinase cascade (155, Eves). In contrast to elevated MAP kinase signaling during the 
G1, S or G2 phases of the cell cycle that activated checkpoints and induced arrest or senescence, 
loss of PEBP1 during M phase led to bypass of the spindle assembly checkpoint and the 
generation of chromosomal abnormalities. Thus, PEBP1 and the MAP kinase cascade seemed to 
play a role in ensuring the fidelity of chromosome segregation prior to cell division. The need for 
precise titration of the MAP kinase signal to ensure the integrity of the spindle assembly process 
was highlighted and it was proposed that PEBP1 status in tumors could influence the efficacy of 
treatments such as poisons that stimulate the Aurora B-dependent spindle assembly checkpoint 
(156, Rosner). Using HEK-293 PEBP1 depleted (termed HEK-499) it was observed that PEBP1 
silencing accelerated DNA synthesis and G1/S transition entry. It was proposed that PEBP1 
silencing deregulates the expression of key genes involved in DNA replication, G1/S phase 
transition, G2/M checkpoint and chromosomal stability, which in summation may accelerate S-
phase transition and mitosis, leading to the observed higher proliferation rate in HEK-499 cells. 
PEBP1 depletion down-regulated G2/M checkpoint molecules like Aurora B, cyclin G1 and 
sertuin that slow the G2/M transition time. These changes in the kinetics of the cell cycle resulted 
in the higher proliferation rate of HEK-499 compared to control cells (38, Al-Mulla 2011).  
 
4.5- Role of PEBP1 in apoptosis  
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4.5.1- Pro-apoptotic role of PEBP1 
Since 2003, the decrease of PEBP1 in cancer cells was associated with metastasis occurring 
and, consequently, PEBP1 expression was considered as a possible marker of cancer clinical 
course (61, Fu 2003). Unfortunately, during cancer treatment, the acquisition of resistance to 
therapies such as radiation, chemo- and immunotherapeutic drugs appeared to be a major obstacle 
to eliminate tumor cells. Nevertheless, in tumorigenic human prostate and breast cancer cells, it 
was shown that low expression levels of PEBP1 were rapidly induced upon chemotherapeutic 
drug treatment with 9-nitrocamptothecin (9NC), sensitizing the cells to apoptosis (120, 
Chatterjee). Expression levels were low in prostate cancer cells and increase after DNA damage. 
The direct correlation of PEBP1 expression with the extent of apoptosis suggested that 
upregulation of PEBP1 sensitized cancer cells to apoptotic signals in response to DNA damage. 
Indeed, both DU145 and PC3 cells have a low level of PEBP1 expression, which could be 
significantly induced to high levels after DNA damage (120, Chatterjee). PEBP1 has been 
shown to abrogate the survival and anti-apoptotic properties of the Raf1/MEK/ERK and NF-
kappa B signaling pathways via physical interaction with Raf-1 and MEK1/2 in the former and 
NIK or TAK in the latter. PEBP1 was then considered to play a pivotal role in cancer, regulating 
apoptosis induced by drugs or immune-mediated stimuli. However it appeared that 
chemosensitization or direct trigger of apoptosis by PEBP1 induction might be cell type specific 
or depending on the differentiation stage and the activation status of the signaling molecules in 
the cells (130, Odabaei). 
In fact, a lot of studies on various cells and cancer types, have led to the description of 
several signaling pathways regulated by PEBP1 to trigger apoptosis. In most cases, the ERK and 
NFB pathways were considered the targets of PEBP1 to regulate apoptosis, migration and 
invasion of cancer cells. In cultured SW1990 and AsPC-1 pancreatic tumor cell lines, 
overexpression of PEBP1 suppressed cell proliferation, promoted apoptosis and inhibited cell 
migration and invasion through downregulating Raf-1-MEK1/2-ERK1/2 signaling pathway. In 
vivo, PEBP1 could also suppress tumorigenesis by diminishing the volume of the tumors (37, 
Dai).  
Artemisinin and its derivatives, such as dihydroartemisinin (DHA), were used for treatment 
of recurrent and metastatic cervical cancer. DHA have been shown to inhibit tumor growth with 
low toxicity to normal cells. The expression of PEBP1 was significantly upregulated and the 
expression of bcl-2 was significantly downregulated in DHA-treated HeLa and Caski cells 
compared with control cells. DHA treatment caused a significant inhibition of tumor growth and 
a significant increase in the apoptotic index in nude mice bearing Hela or Caski tumors. Thus, it 
was concluded that DHA inhibited cervical cancer growth via upregulation of PEBP1 and 
downregulation of bcl-2 (136, Hu).  
Besides, the major genetic causes for the incidence and therapeutic refractoriness of 
neuroblastomas include amplification of the oncogene N-Myc and loss of tumor suppressor p53. 
The flavonoid didymin inhibited proliferation and induced apoptosis irrespective of p53 status in 
neuroblastomas. Mainly didymin inhibited N-Myc as confirmed at protein, mRNA, and 
transcriptional level. But, also, didymin upregulated PEBP1 levels and downregulated PI3K, 
pAkt, Akt and vimentin. Lastly, didymin induced G(2)/M arrest along with decreasing the levels 
of cyclin D1, CDK4, and cyclin B1 (320, Singhal). Similar results were obtained on human 
HepG2 liver carcinoma cells wherein didymin strongly inhibited the viability, clonogenicity and 
migration of HepG2 cells. Didymin attenuated the mitochondrial membrane potential, 
accompanied by the release of cytochrome c and inhibited the ERK/MAPK and PI3K/Akt 
pathways by increasing the level of PEBP1. Thus, the results indicated that didymin induced 
 38 
 
apoptosis of HepG2 cells through mitochondrial dysfunction and inactivation of the ERK/MAPK 
and PI3K/Akt pathways by up-regulating PEBP1 (43, Wei). 
A particular role of NO on the pro-survival/anti-apoptotic loop 
NFκB/Snail/YY1/PEBP1/PTEN was identified in cancer (321, Bonavida 2013). It was shown 
that in tumor cells, the modification by NO of this dysregulated loop was responsible, in large, 
for the reversal of chemo and immune resistance and sensitization to apoptotic mechanisms by 
cytotoxic agents. Moreover, tumor cells treated with exogenous NO donors resulted in the 
inhibition of NFκΒ activity, inhibition of Snail, inhibition of transcription repression of YY1 and 
subsequent inhibition of epithelial-mesenchymal transition (EMT), but induction of PEBP1 and 
induction of PTEN. Each gene product modified by NO in the loop was involved in chemo-
immunosensitization. Overall, NO-donors interference in the regulatory circuitry resulted in 
chemo-immunosensitization and inhibition of EMT (322, Bonavida 2015). 
In human gastric cell lines, PEBP1 suppressed cell proliferation and invasion and enhanced 
apoptosis. In that case, the down-regulation of PEBP1 expression was attributed to miR-224 
which negatively regulated the expression PEBP1 (31, Liu). In another study, PEBP1 was 
described to be implicated in sensitization to TRAIL apoptosis. LFB-R603 (a chimeric anti-CD20 
monoclonal antibody) resensitized resistant Ramos cells to TRAIL-apoptosis through 
modification of the dysregulated NF-κB/Snail/PEBP1/PTEN circuitry. In this loop, both NFκB 
and Snail regulated resistance whereas both PEBP1 and PTEN regulated sensitivity, each of these 
gene products being involved in the regulation of tumor cells sensitivity to TRAIL. Cells 
overexpressing PEBP1 were resensitized to TRAIL apoptosis, thus, indicating the direct role of 
PEBP1 in the reversal of tumor resistance to TRAIL (323, Baritaki). 
4.5.2- Anti-apoptotic role of PEBP1 
Contrary to the above studies indicating a pro-apoptotic role of PEBP1, it was brought out 
that PEBP1 attenuates apoptosis in neural cells and in particular conditions as oxygen deprivation 
or under the effect of microwaves. PEBP1 was overexpressed or knocked down using lentivirus 
in PC12 cells (embryonic origin from the neural crest), which were then challenged by oxygen-
glucose deprivation (OGD). PEBP1 overexpression significantly increased the viability of OGD 
cells, and attenuated apoptosis, cell cycle arrest, and reactive oxygen species generation. PEBP1 
overexpression significantly inhibited NFκB pathway by inhibiting IKK, IκBα, and P65 
phosphorylation and also inhibited the ERK pathway by inhibiting MEK, ERK, and CREB 
phosphorylation. These results on PC12 cells, were confirmed on animal models of focal cerebral 
ischemia (92, Su). In another study, it was observed that OGD downregulated PEBP1 in 
microglia cells. Overexpression of PEBP1 reduced focal cerebral ischemia injury and 
significantly attenuated microglia cells apoptosis. In addition, PEBP1 overexpression inhibited 
the upregulation of phosphorylation of NFκB induced by OGD and cerebral ischemia and 
decreased cell transwell migration. Overall, these results showed that PEBP1 protected against 
ischemic stroke through inhibition of microglial cells excessive activation, inhibited their 
motility, and promoted neuronal survival partly though IKKβ-IκBα-NFκB signaling axis (324, Su 
2017).  
The effects of electromagnetic fields on human health have been widely studied. 
Differentiated PC12 cells were exposed to continuous microwave radiation at 2.856 GHz for 
5 min. The results showed that PEBP1 was downregulated after microwave. PEBP1 
downregulation led up to excessive activation of the MEK/ERK/CREB pathway, decrease in the 
Bcl-2/Bax ratio, and activation of caspase-3, finally triggering the execution of apoptosis (41, 
Zuo). 
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4.6- Role of PEBP1 in autophagy 
PEBP1 was identified to interact with the microtubule-associated protein 1 light chain 3 β 
(LC3) to regulate the initiation of autophagy (44, Noh). When deprived of nutrients or growth 
factors, cells trigger the self-eating process called autophagy in order to supply the nutrients 
necessary for cell survival. Upon signaling, double-membraned cup-shaped structures called 
phagophores engulf portions of cytoplasm. After fusion of the membranes closing the cup-shaped 
phagophore, the autophagosome is formed. These vesicles traffic along microtubules towards the 
microtubule-organizing center, where lysosomes are concentrated. This brings autophagosomes 
close to lysosomes, enabling fusion and degradation of the contents of the resulting 
autolysosomes by lysosomal hydrolases (325, Rubinsztein). LC3 is a cytosolic protein, it can 
associate with intracellular membranes through Phosphatidylethanolamine-dependent 
conjugation upon induction of autophagy and regulates initiation of autophagy through 
interaction with many autophagy-related proteins possessing an LC3-interacting region (LIR) 
motif. The LIR motif is composed of tryptophane and Leucine amino acids separated by 2 non-
conserved amino acids (WXXL). The PE-conjugated LC3 proteins in the membranes (called 
LC3-II) play a critical role in regulating the formation of autophagosomes and sequestering 
cellular components into the phagophore lumen (326, Kabeya). Specifically, PEBP1 interacted 
with only LC3-I, the cytosolic unconjugated LC3 form, but not PE-conjugated LC3-II. A LIR 
motif was identified in the PEBP1 sequence (W55DGL57) which is situated in a loop of the 
PEBP1 tridimensional structure. Mutation of the conserved LIR motif (WXXL to AXXA) 
abolished the ability of PEBP1 to bind LC3. These data indicated that PEBP1 could associate 
with LC3 to regulate autophagy before inclusion of LC3-II proteins within autophagosomes (44, 
Noh 2016). Overexpression of PEBP1 stimulated the Akt/mTORC1 pathway, indicating that 
PEBP1 could suppress autophagy through activation of Akt/mTORC1 under conditions of 
nutrient deprivation. PEBP1 phosphorylation at Ser153 caused dissociation of LC3 from the 
PEBP1-LC3 complex for autophagy induction. PEBP1 was involved in holding LC3 in the 
PEBP1-LC3 complex that makes LC3 not accessible for PE-lipidation. Upon the activation of 
autophagy, kinases may phosphorylate PEBP1 to liberate LC3, leading to PE conjugation which 
is a critical step necessary for autophagosome biogenesis. Thus, overexpression of PEBP1 
significantly prevented starvation-induced autophagy, while, knockdown of PEBP1 expression 
induced high levels of autophagy via stimulation of LC3-lipidation and Akt/mTORC1 activation 
(44, Noh 2016).  
Another role of PEBP1 associated with LC3 was observed in preadipocytes. It was shown 
that LC3 overexpression in 3T3-L1 preadipocytes stimulated adipocyte differentiation via direct 
modulation of PEBP1-dependent ERK1 activity (327, Hahm). 
In Parkinson disease, CDK5 was activated and was responsible for associated neuronal loss 
(328, Cheung). Surprisingly, this mechanism occurred via the degradation of PEBP1 by 
chaperone-mediated autophagy. Indeed, excessive CDK5 activation resulted in the 
phosphorylation of PEBP1 on T42, promoting the exposure of the motif 179KLYEQ183 situated in 
the C-terminal helix of PEBP1. Then, Hsc 70 recognized the KLYEQ motif and transported 
PEBP1 to lysosomes for destruction. In turn, the ERK cascade was activated, triggering neuron 
cells to S-phase reentry and causing neuronal death (45, Wen). 
 
4.7- PEBP1 in cell motility 
Numerous studies have been undertaken to decipher the mechanisms underlying migration 
and invasion in various types of cancer. The results revealed that PEBP1 regulates cell motility 
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under various actions. In particular, PEBP1 was described to modulate several signaling 
pathways, to interact directly with key proteins involved in cellular migration, to regulate the 
expression of matrix metalloproteinases and also to regulate the expression of several miRNAs. 
 
4.7.1- Signaling pathways 
It was shown that PEBP1 modulates some of the main signaling pathways implicated in 
cellular motility, notably in cancer cells. Indeed, previous studies have shown that PEBP1 can 
interfere with the Raf-1-MEK1/2-ERK1/2 signaling pathway (13, Yeung; 7, Kim), inhibit the 
transcription factor nuclear factor kappa B (NFB) (329, Beshir) and G protein-coupled receptor 
kinase signal transduction pathways (330, Zeng), all of which being closely related to 
tumorigenesis and cancer metastasis. In several cancer types, MEK/ERK and PI3K/Akt activities 
were indispensable for the cellular effects of a natural phosphoantigen upon γδ T-cell activation 
and proliferation, Th1 cytokine secretion and anti-tumor cytotoxicity (331, Correia). Other 
evidence exhibited that tamoxifen, an anti-estrogen reagent, inhibited tumor cell invasion and 
metastasis in mouse melanoma through suppression of both PKC/MEK/ERK and PKC/PI3K/Akt 
pathways (332, Matsuoka). In the AsPC-1 human pancreatic adenocarcinoma cell line, (-)-
epigallocatechin 3-gallate, strongly regulated PEBP1/ERK/NF-κB and/or PEBP1/NF-κB/Snail to 
inhibit invasive metastasis (7, Kim). In colorectal cancer, the functional impact of proteins from 
different signaling pathways varies between tumor center and tumor front. Indeed, 
overexpression of pAkt, Bcl2, VEGF, APAF-1, pERK, EphB2, PEBP1, CDX2, E-cadherin, 
MST1 and pSMAD2 was more frequently observed in the tumor center, whereas matrix 
metalloproteinase 7 and Laminin5γ2 overexpression was associated with the invasive front. In 
other words, in colorectal cancer progression, VEGF overexpression seemed to play a role in the 
tumor center, whereas Laminin5γ2-overexpression combined with PEBP1 loss was associated 
with tumor invasion at the front (333, Karamitopoulou).  
Functional studies on hepatocellular carcinoma cells HCCLM3 and HepG2 revealed the 
inhibitory role of PEBP1 in migration and invasion in vitro and tumor growth in vivo. However, 
the engagement of PEBP1 in regulating Raf/ MEK1/2-ERK1/2 and NF-κB signaling pathways 
appeared to be cell type-specific. TNF-α-induced NFκB signaling transduction was negatively 
regulated by PEBP1 in HCCLM3 cells, but not in HepG2 cells. In addition, PEBP1 functioned 
through EGF-activated Raf/MEK1/2-ERK1/2 signaling pathway to control HCCLM3 cell 
invasiveness, but not in HepG2 cells. These contradictive findings suggested that the mechanisms 
of signaling regulation are complicated in different HCC cells, and PEBP1-mediated modulation 
may be cell type-specific and context-dependent (334, Wu).  
GRK2 was also described to be involved in cell migration since data have revealed a 
complex GRK2 interactome that includes a variety of proteins related to cell motility (335, 
Ribas). Altered GRK2 expression or activity may differentially affect the functionality of its 
interaction partners, thus affecting cell motility in distinct ways, depending on the cell type 
and/or stimuli involved (336, Penela). 
 
4.7.2- Direct interaction of PEBP1 with protein partners 
It was described that PEBP1 influences cell motility by interacting with several molecular 
partners. In cancer, PEBP1 was primarily shown to inhibit cell motility and metastasis formation, 
but PEBP1 was also found to enhance cell motility in cells depending on GSK3 for motility (36, 
Al-Mulla 2012b; 96, Al-Mulla 2011).  
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4.7.2.1- PEBP1 inhibits cell invasion and metastasis  
STAT3 
The signal transducer and activator of transcription 3 (STAT3) is a latent cytoplasmic 
transcription factor; it is known to be activated by cytokines, growth factors, and oncogenic 
proteins. Once phosphorylated and activated, STAT3 enters the nucleus and regulates gene 
transcription (337, Germain).  STAT3 is constitutively activated in a number of malignancies 
and promotes cell survival, EMT, invasion and metastasis (338, Devarajan). It has been reported 
that PEBP1 overexpression resulted in constitutive physical interaction with STAT3 and blocked 
c-Src-phosphorylating and activating STAT3 (98, Yousuf). To explore the role of PEBP1 in 
nasopharyngeal carcinoma (NPC) metastasis in vivo, NPC cell lines with stable PEBP1 
expression changes were established. The effect of PEBP1 was tested in a xenograft metastasis 
model in which PEBP1 knockdown 6-10B cells, PEBP1 overexpression 5-8F cells, and their 
corresponding control cells were used to generate pulmonary metastases in nude mice. Then the 
effects of PEBP1 were tested on the phosphorylated level of ERK- 1/2, STAT3, NFκB (IKK-α/ β 
and IκB-α) and GSK3β. The results indicated that PEBP1 inhibited ERK, NFκB, and STAT3, 
and activated GSK3β in NPC cells. The general conclusion was that in NPC cells, PEBP1 acted 
essentially by inhibiting STAT3 activation. PEBP1 interacted with and then blocked STAT3 
phosphorylation, inhibiting its activation. Consequently, PEBP1 downregulation promoted NPC 
invasion, metastasis and EMT-like molecular alterations by activating STAT3 signaling (100, 
He). 
Syntenin/MDA-9 
In contrast to PEBP1, melanoma differentiation associated gene-9 (MDA-9), also known as 
syntenin, is a positive regulator of melanoma progression and metastasis. It was documented that, 
upon extracellular matrix engagement, MDA-9 interacts with c-Src leading to c-Src 
phosphorylation and FAK auto-phosphorylation (339, Bouckerche). These biochemical changes 
result in formation of an active focal adhesion complex with resultant activation of the NFκB 
pathway and secretion of MMP-2, thereby causing augmented tumor cell motility and metastatic 
competence. It was found that MDA-9 transcriptionally downregulated PEBP1. Furthermore, 
MDA-9 and PEBP1 physically interacted. The interaction of PEBP1 created a steric interference 
for c-Src interaction with MDA-9 in a manner that correlated with a suppression of FAK and c-
Src phosphorylation. Avoiding these crucial steps, necessary for MDA-9 to promote FAK/c-Src 
complex formation, prevented the initiation of signaling cascades leading to invasion and 
metastasis. Ectopic PEBP1 expression in melanoma cells counteracted MDA-9-mediated 
signaling, inhibiting cell invasion, anchorage-independent growth, and in vivo dissemination of 
tumor cells (55, Das). 
Notch1 
In H1299 cells (lung cancer cell line) and in HeLa (cervical cancer cell line), activation of 
Notch1 promotes tumor invasion/ migration and upregulation of epithelial-mesenchymal 
transition-related proteins. Upon activation of Notch signaling, Notch1 is cleaved in a stepwise 
manner mediated by the proteolytic actions of the γ-secretase complex, leading to the subsequent 
release of Notch intracellular domain (NICD), the activated form of Notch1. Therefore, inhibition 
of γ-secretase would prevent Notch1 activation, resulting in suppression of the Notch signaling 
pathway. Interestingly, PEBP1 can directly interact with full-length Notch1 but not with the only 
NICD. These data suggested that PEBP1 prevents activation of Notch1 by directly binding to the 
whole Notch1 (intracellular/transmembrane domain), consequently inhibiting the proteolytic 
activity of γ-secretase (18, Noh 2016). 
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4.7.2.2- Via GSK3, PEBP1 promotes cell invasion and metastasis 
PEBP1 influences cell motility by interacting directly with several partners. A particular 
case is the glycogen synthase kinase 3 (GSK3) because PEBP1 has been shown to inhibit 
Raf/MEK/ERK, NFB and GRK2 but to activate the GSK3 signaling pathway (53, Al-Mulla, 
2012a). It is well-known that in most cell types, PEBP1 overexpression inhibits migration of cells 
and conversely its silencing enhances it. On the contrary, in MDCK cells the effect of PEBP1 on 
cellular motility is reversed as PEBP1 expression induces cellular motility and vice versa. Now, 
these cells depend on GSK3 for their motility (36, Al-Mulla 2012b). GSK3 suppresses tumor 
progression by downregulating multiple oncogenic pathways including Wnt signaling and cyclin 
D1 activation. PEBP1 binds GSK3 proteins and maintains GSK3 protein levels and its active 
form. In colorectal cancer cells HEK-499 (silencing PEBP1) it was found that the phosphorylated 
and active form of p38 was significantly increased. PEBP1 silencing induced a rapid p38 
activation and phosphorylation of GSK3 at Thr-390 that culminated in its degradation (96, Al-
Mulla 2011). Therefore, loss of PEBP1 induces the inactivation and ubiquitination of GSK3 
and loss of cellular motility in these cells that depend on GSK3 for cellular motion (36, Al-
Mulla 2012b). In another study, conditioned medium from ionizing radiation-induced senescent 
MCF7 cells significantly increased cell proliferation, invasion, migration, and wound healing 
activity in MCF7 cells and HUVECs. Downregulation of PEBP1 suppressed MCF7 migration 
and prevented the potential effects of the secretome from ionizing radiation-induced senescent 
tumor cells on neighboring cell migration. It is to note that in this study, PEBP1 was found as a 
secretory proteins produced by senescent tumor cells treated by ionizing radiation (35, Han). 
Interestingly, GSK3 signaling was described as a key pathway in MCF7 cells, which notably 
regulates autophagy activation (340, Gavilan).  
 
4.7.3- Regulation of matrix metalloproteinases expression 
Independently of direct interaction with protein partners, PEBP1 acts also on cellular 
motility through the regulation of the expression levels of other proteins. As an example, it was 
shown that PEBP1 depletion in HEK-499 cells led to the overexpression or stabilization of beta-
catenin, vimentin, tyrosine-protein kinase MET and serine/threonine protein kinase PAK1, 
SNAIL and SLUG (38, Al-Mulla 2011b). 
Otherwise, migration and invasion of cells are tanglesome courses including cytoskeletal-
reorganizations and degradations of extracellular matrix (ECM) (341, Cheng 2010). Normally, 
degradations of ECM are primary steps of cancer cell invasions and matrix metalloproteinases 
(MMPs) may be the mediations of these courses (33, Lei). PEBP1 is especially known to inhibit 
cell invasion and metastasis through downregulation of several matrix metalloproteinases 
(MMPs) expression. In glioma cells U87, overexpression of PEBP1 diminished the MMP2, 
MMP9 expression and also the HMGA2 expression (33, Lei). In Cholangiocarcinoma cells that 
originate in the biliary epithelium, PEBP1 inhibited the invasive and metastatic ability of the 
cholangiocarcinoma cell line RBE, by downregulating MMP-9 and upregulating the tissue 
inhibitor of metalloproteinases (TIMP-4) mRNA expression (342, Ma). In human pancreatic 
adenocarcinoma cells AsPC-1, (-)-epigallocatechin 3-gallate (EGCG) induced PEBP1 
upregulation via the inhibition of histone deacetylase (HDAC) activity which increased histone 
H3 expression and inhibited Snail expression, NFκB nuclear translocation, MMP-2 and -9 
activity and Matrigel invasion (7, Kim). PEBP1 inhibited the invasive and metastatic abilities of 
esophageal cancer cell line TE-1 by downregulating mRNA expression of LIN28 and MMP-14 
(104, Zhao 2013). The NFκB pathway, but not the Raf pathway, appeared to positively control 
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the invasion of breast cancer cells and a regulatory loop involving an opposing relationship 
between PEBP1 and the NFκB pathway was suggested to control the level of MMP expression 
and cell invasion (329, Beshir 2010). In a panel of breast cancer, colon cancer and melanoma cell 
lines, PEBP1 negatively regulated the invasion of the different cancer cells through extracellular 
matrix barriers by controlling the expression of various MMPs, particularly MMP-1 and MMP-2 
(329, Beshir). In another study on breast cancer cells, it was considered that AP-2alpha, 
interleukin-4 (IL-4), E-cadherin, fibulin 1D, p16(INK4alpha), PTEN and PEBP1, are suppressors 
of cancer cell invasiveness, which are located upstream of MMPs in cell signaling pathways. In 
MDA-MB-231 breast cancer cells, MMP-1, MMP-2, MMP-9, MMP-11, MMP-13, MMP-14, 
MMP-16, and MMP-19 were enhancers of cancer cell invasiveness. The results indicated that 
each upstream cancer-progression determinant reaches these MMP expressions through different 
sets of signaling pathways. Particularly, PEBP1 could be involved in the control of the expression 
of MMP1, 3, 7, 11, 13 and 14 by modulating the Raf/MEK/ERK pathway that, in turn, regulates 
NF-B, p53, cJun/cFos, PEA3 and CREB pathways (343, Delassus 2008; 344, Delassus 2010).  
In human prostate PC-3M cells, data indicated that PEBP1 does not affect cell proliferation in 
PC-3M cells, but inhibits both cell migration and cell invasion. In association with this inhibitory 
effect on motility, PEBP1 down-regulated MMP-2 and MMP-9, cathepsin B and urinary 
plasminogen activator (uPA) (34, Xinzhou). Finally, by using an unbiased PCR based screening 
and by analyzing DNA microarray expression datasets it was observed that the expression of 
multiple metalloproteases (MMPs) including MMP1, MMP3, MMP10 and MMP13 are 
negatively correlated with PEBP1 expression in breast cancer cell lines (MDA-MB231, 4T1 and 
168 FARN) and clinical samples. It was shown that the expression signature of PEBP1 and 
MMPs is better at predicting high metastatic risk than the individual gene (345, Datar). Using a 
combination of loss- and gain-of-function approaches, the results showed that MMP13 is a cause 
of PEBP1-mediated inhibition of local cancer invasion. Moreover, PEBP1 negatively regulated 
MMP13 through the ERK2 signaling pathway and the repression of MMP13 by PEBP1 was 
transcription factor AP-1 independent (345, Datar). In conclusion, following all the results 
described above, PEBP1 appears to be able to regulate the expression of MMP1, 2, 3, 7, 9, 10, 
11, 13, 14, 16 and 19. PEBP1 is probably involved in the control of the expression of all these 
MMPs by modulating different signaling pathways. 
 
4.7.4- Regulation of miRNAs expression 
Aside regulating the expression of proteins partners, PEBP1 controls also cell motility by 
regulating the expression of various miRNAs. Several studies have identified miRNAs operating 
to promote or suppress tumor invasion or metastasis via regulating metastasis-related genes. 
Using microRNA expression arrays to analyze small non-coding microRNAs that are regulated 
by PEBP1, 50 differentially expressed microRNAs were identified in breast cancer 1833 cells 
expressing S153E-PEBP1. These analyses showed that miR-200b was the most significant 
microRNA that positively correlated with PEBP1 expression in a cohort of breast cancer patient 
samples. It was found that PEBP1 induced expression of miR-200b that directly inhibited 
expression of lysyl oxidase (LOX), leading to decreased invasion. This was a novel signaling 
pathway targeted by PEBP1 that regulates remodeling of the extracellular matrix and tumor 
survival (346, Sun). 
Using an orthotopic murine model, PEBP1 was shown to inhibit invasion by metastatic 
breast cancer cells and to repress cell intravasation and bone metastasis. The mechanism involved 
inhibition of MAPK, leading to decreased transcription of LIN28 via Myc. Suppression of LIN28 
enhanced let-7 processing in breast cancer cells. Elevated let-7 expression inhibited HMGA2, a 
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chromatin remodeling protein that activates pro-invasive and pro-metastatic genes, including 
Snail (101, Dangi-Garimella). 
Another study of glioma tissues and cell lines U251, U57 and SHG44, showed that the 
expression of PEBP1 and miR-98 were significantly lower and HMGA2 was higher than that in 
normal brain tissues. MiR-98 belongs to the mature let-7 family of miRNAs and was initially 
found to be downregulated in leukemia cell lines (347, Yu). Overexpression of PEBP1 
upregulated miR-98 expression and inhibited glioma cell invasion but had no effect on glioma 
cell proliferation. These results indicated that PEBP1 functions as a potent tumor invasion 
repression gene through regulating miR-98 expression. The PEBP1/miR-98 to HMGA2 axis 
provided a potential mechanism for glioma cell invasion but not proliferation (348, Chen). 
In breast cancer tissues, the expression of PEBP1 and miR-185 was significantly lower than 
that in normal breast tissues. In breast cancer cell lines MCF7 and MDA-MB-231, over-
expression of PEBP1 up-regulated miR-185 expression, inhibited breast cancer cell growth and 
invasion, and inhibited miR-185 target gene HMGA2. These findings described PEBP1/miR-185 
to HMGA2 axis and provided one more potential mechanism for breast cancer cell growth and 
invasion (30, Zou). 
 
4.8- Cell adhesion to substratum, cell-cell adhesion 
Following initial solid tumor formation and neovascularization, metastasis is a complex 
process involving not only cell motility but also changes in cell adhesion, secretion of a range of 
proteases and the development of distant metastases (349, Bogenrieder; 350, Kopfstein). 
Exploring the role of PEBP1 in cell adhesion, it was found that overexpression of PEBP1 in 
Madin-Darby canine kidney (MDCK) epithelial cells increased adhesion on multiple substrata, 
while decreasing adhesion of the cells to one another. PEBP1 also increased the ability of cells to 
generate productive traction force. Knockdown of PEBP1 in both MDCK and MCF7 cells 
(human breast adenocarcinoma cells) resulted in reduced cell–substratum adhesion (54, Mc 
Henry). In contrast, PEBP1 appeared to play a negative role in the control of cell–cell adhesion, 
regulating the expression of the adherens junction protein E-cadherin and the localization of the 
tight junction protein ZO-1 in MDCK cells. Knockdown of PEBP1 in MCF7 cells led to a slight 
decrease in the rate of wound closure, an effect consistent with that of PEBP1 knockdown in 
MDCK cells. Thus, PEBP1 displayed important roles in the regulation of cell adhesion, 
positively controlling cell-substratum adhesion while negatively controlling cell-cell adhesion 
(54, Mc Henry). 
Cadherins are a class of transmembrane proteins. They play main roles in cell adhesion, 
forming adherens junctions to bind cells within tissues together. They are dependent on Ca2+ 
ions to function. Cell-cell adhesion is mediated by extracellular cadherin domains, whereas the 
intracellular cytoplasmic tail associates with a large number of adaptor and signaling proteins. A 
study investigated the expression of PEBP1 and epithelial cadherin (E-cadherin) in lung 
squamous cell carcinoma tissue and its correlation with the clinical pathology of lung squamous 
cell carcinoma (351, Zhu). The rates of positive PEBP1 and E-cadherin mRNA expression were 
significantly lower in lung squamous cell carcinoma than in the surrounding normal tissues. The 
positive expression rates were significantly lower in those with lymph node metastasis than in 
those without. The rates of positive PEBP1 and E-cadherin mRNA expression were significantly 
lower in patients at advanced (III, IV) stages than in patients at early (I, II) stages. It was 
concluded that low expression levels of PEBP1 and E-cadherin may be associated with initiation, 
invasion and/or metastasis, as well as with the inhibition of lung squamous cell carcinoma 
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differentiation (351, Zhu). Similar studies were performed in esophageal squamous cell 
carcinoma (ESCC) to detect the expressions of PEBP1, E-cadherin and NF-B p65. The 
expressions of PEBP1 and E-cadherin in ESCC tissues were obviously lower than those in the 
paracancerous tissues, the expressions in ESCC tissues from cases with lymph node metastasis 
were lower than those from cases without lymph node metastasis. Downregulation or depletion of 
PEBP1 was related to the onset and progression of ESCC, and facilitated the invasion and 
metastasis of ESCC by downregulating E-cadherin and upregulating NF-B p65 (352, Ping). 
Focal adhesion kinase (FAK) can influence the cytoskeleton, structures of cell adhesion 
sites and membrane protrusions to regulate cell movement. FAK signaling has been associated 
with the disassembly of integrin-based adhesion sites (353, Webb). In melanoma cells it was 
documented that upon adhesion to fibronectin, MDA-9 activated c-Src through phosphorylation 
at Tyr418 leading to FAK phosphorylation and initiated a signaling cascade that resulted in 
enhanced cell invasion. In metastatic melanoma cells, restored PEBP1 physically interacts with 
MDA-9 and potentially interferes with c-Src phosphorylation and subsequent FAK 
phosphorylation (55, Das). 
 
In conclusion, PEBP1 is mainly implicated in processes affecting the plasma membrane 
features such as receptors internalization, neuronal synapse, adhesion, motility, primary cilium 
formation, and neuronal synapse. PEBP1 appears to be particularly involved in membrane 
sensing, participating in signal transduction. PEBP1 expression is directly bound to what happens 
at the plasma membrane. Autophagy is a process that involves also partly plasma membrane as 
well as other cellular membranes and that needs vesicles formation and trafficking. Apoptosis is a 
programmed cell death that is strongly depending of signaling pathways and that leads to 
important biochemical events, changes in cell morphology and finally to cell death. Interestingly, 
the role of PEBP1 in mitotic spindle checkpoint reveals its implication in the control of 
attachment between microtubules and kinetochores. Finally, all the processes modifying 
membrane changes and cellular shape are underlain by cytoskeleton organization. 
 
5- Relationships between the cellular processes modulated by PEBP1 
PEBP1 appears to be concerned by numerous cellular phenomena that implicate connection 
between membrane and cytoskeleton, this is the case for signal transduction, endocytosis, 
exocytosis, division, differentiation, adhesion and motility. It is interesting to note that several of 
the processes modulated by PEBP1 need to be coordinated and some of them are most of the time 
mutually exclusive. Indeed, throughout their life cycle, the cells have to decide between division 
and differentiation, survival and death or even adhesion and motility. PEBP1 appears to follow 
and modulate the signaling pathways that govern the various options leading to cellular fate. But, 
in addition, PEBP1 appears to play a role in the coordination of cellular processes by binding to 
the main proteins and complexes that govern each of them. In order to point out the strong level 
of interplay and coordination existing between numerous cellular processes, we present here 
several examples of well-known relationships between several cellular mechanisms that are 
modulated by PEBP1. 
 
5.1- Endosomes, multipurposes and crosstalks 
5.1.1- Endosomes are platforms for signaling complex assemblies, interactions between 
different signaling pathways and spatiotemporal regulation of transcription factor activation 
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Endosomes efficiently recycle the large array of cargo that is taken up during endocytosis 
back to the cell surface or deliver it to other endocytic compartments. Therefore, endosomes 
control many important physiological processes, including nutrient absorption, signal 
transduction from membrane receptors, immune surveillance and antigen presentation (354, 
Gould). Endosomes function to terminate signaling processes (for example, through the 
internalization of receptors) and function in signal propagation by facilitating the recruitment and 
integration of signaling cascades on the surface of endocytic vesicles (355, Emery). 
An interesting study suggested that canonical GPCR signaling occurs from endosomes as well as 
the plasma membrane (356, Irannejad). The authors describe the application of conformation-
specific single-domain antibodies (nanobodies) to directly probe activation of the β2-
adrenoceptor, a prototypical GPCR, and its cognate G protein Gs in living mammalian cells. The 
results showed that the adrenergic agonist isoprenaline promotes receptor and G protein 
activation in the plasma membrane as expected, but also in the early endosome membrane, and 
that internalized receptors contribute to the overall cellular cyclic AMP response within several 
minutes after agonist application (356, Irannejad).  
Endosomes can regulate the localization of signaling complexes either by spatially 
restricting signaling activity to particular loci in the cell or by acting as vesicular carriers to 
transport signaling proteins to cellular locations that are unreachable by diffusion (357, Howe). 
Endosomes can also isolate signaling components and prevent unwanted signaling interactions. 
This strategy is likely to occur in the regulation of glycogen synthase 3 beta (GSK3-), a kinase 
that has numerous phosphorylation targets in distinct pathways, including Wnt, Hedgehog, 
epidermal growth factor (EGF)/mitogen-activated protein kinase (MAPK), and transforming 
growth factor beta (TGF-) signaling. Thus, the endosome membrane facing the cytoplasm forms 
a physical platform for signaling complex assemblies where endosomal scaffolds can facilitate 
signaling reactions between the recruited components (358, Palfy). 
Scaffold proteins can not only facilitate signal transduction within a pathway, but are also 
known to regulate interactions between different signaling pathways at the plasma membrane or 
in the cytoplasm. On Wnt-induced signaling, GSK3-, dishevelled (DVL), and AXIN have been 
shown to localize to the cell membrane as well as to endosomes following internalization of the 
-catenin destruction complex (359, Cliffe). AXIN also can integrate TGF- and Wnt signals. 
The endosomal scaffold protein APPL can facilitate crosstalk between Akt and GSK3- kinases, 
which are key components of insulin and Wnt pathways, respectively (360, Schenck) and the 
endosomal scaffold EEA1 can mediate crosstalk between EGF/MAPK and insulin pathways by 
connecting p38 and Akt (361, Nazarewicz). Four scaffold proteins were found (GRB1, CCNE1, 
SARA, AXIN1) that were potentially capable of connecting proteins from five different pathways 
(JAK/STAT, Notch, Wnt, TGF-, and the RTK pathway, which contains insulin and EGF/MAPK 
cascades) (358, Palfy). Endosomes traverse the cell as they move inwards from the cell 
membrane toward the nucleus and their outer membrane is a unique surface to initiate artificial 
connections between signaling components. Therefore, because of the numerous deactivating 
mechanisms (e.g., phosphatase activity on protein kinases) and the long distances that signals 
travel within the cell, especially in highly polarized cells such as neurons with long axons, 
endosomes that are actively moved across the cytoplasm could play an essential role in ensuring 
that weak crosstalk signals exert their effect (362, Ascano). Thus, an important function of 
endosomes may be the spatiotemporal regulation of transcription factor activation (358, Palfy). It 
is conceivable that PEBP1 may participate in this spatiotemporal regulation of transcription 
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factor activation by blocking the kinases of the signaling pathways that are transported by 
endosomes from plasma membrane to their final place of action. 
5.1.2- Endosomes during cytokinesis 
During cytokinesis, after replication of the genetic material, a furrow forms between the 
two cells and constricts using an actomyosin-based contractile ring, leaving the daughter cells 
attached by a thin bridge. The resolution of this bridge, by a process called abscission, separates 
the two cells (363, Barr). Recent studies have implicated both secretory and endosomal 
trafficking processes in these events. In late telophase, both secretory and endocytic vesicles 
move rapidly into the midbody and accumulate in the intercellular bridge immediately adjacent to 
the midbody ring. The fusion of these vesicles, both with each other and with the surrounding 
plasma membrane (a process known as compound fusion), precedes abscission (364, Gromley). 
Endocytosis also has a central role in abscission itself, as Rab11-positive endosomes have 
been shown to traffic from centrosomes into the furrow from both daughter cells (365, Fielding). 
Phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) accumulates at the cleavage furrow (366, 
Emoto) whereas phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) is enriched at the 
poles of the dividing cells. The two enzymes that control the distribution of PtdIns(3,4,5)P3  (e.g. 
PTEN and class I PI3K) are enriched in the furrow and the poles of the dividing cells, 
respectively, and cells that lack these enzymes fail to complete cytokinesis (367, Janetopoulos). 
Such data might imply that endosomal vesicles could provide a unique platform for the assembly 
of the abscission machinery. 
5.1.3- Endosomes in cell polarity and cell migration 
Moreover endosomes are implicated in cell polarity. Membrane trafficking is essential for 
the generation and maintenance of polarity and it was shown that clathrin, a key protein involved 
in endocytosis also regulates basolateral polarity in mammalian cells (368, Deborde). Many cells 
polarize in response to a specific signal, and this is characterized by the reorganization of the 
cytoskeleton and the redistribution of certain organelles. This is clearly of importance in 
epithelial cells, where apical and basolateral surfaces need to be established, as well as during 
directed cell migration, where front-rear polarization enables the asymmetric morphology of cells 
migrating toward an extracellular signal. Endocytosis is an important regulator of cell 
polarization and cell migration since it regulates the trafficking of adhesion and polarity proteins 
(369, Lobert). E-cadherin is a type I transmembrane protein and an important component of 
Adherens junctions. Its recycling is thought to contribute to maintaining cell-cell junction 
integrity and is dependent on Rab8 and Rab13 (370, Yamamura). 
Recent work has suggested that endosomes might fulfil additional functional roles in cell 
migration. New studies have identified a so-called Wnt-mediated receptor–actin–myosin polarity 
(WRAMP) structure, which accumulates asymmetrically at the cell periphery in response to 
WNT5A. W-RAMP formation involves the recruitment of actin, myosin IIB and the Wnt ligand 
receptor frizzled 3, is dependent on Rab4 and Rab8, requires endosome trafficking, and is 
associated with multivesicular bodies (371, Witze). The formation of lamellipodia, waves or 
circular dorsal ruffles is important in cell migration. It is controlled by small GTPases such as 
Rac and Rabs, and is known to involve endocytic proteins. Indeed, Dynamin, a critical endocytic 
protein, is required for the formation of circular ruffles, and the early endosomal protein Rab5, a 
master regulator of endocytosis, is needed for actin dynamics leading to circular ruffling. In some 
settings, Rab5 can also induce the formation of lamellipodia. Rac-containing vesicles are 
transported from endosomes to cell surface ruffles in an ARF6-dependent step (372, 
Palamidessi). Altogether, the studies discussed above reinforce the hypothesis that, by using 
endosomal membranes as a platform, cells could assemble specific molecular machines in space 
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and time (354, Gould). By accompanying GPCR internalization, signaling pathways and 
interacting with specific proteins such as Rab8, PEBP1 may likely use the platforms formed by 
endosomal membranes to help in assembly/disassembly of specific molecular machines in precise 
localization and time during cellular processes. 
 
5.2- Relationships between primary cilium and centrosome  
It was shown that Cep290-mediated photoreceptor degeneration was associated with 
aberrant accumulation of its interacting partner PEBP1. Ectopic accumulation of PEBP1 led to 
defective cilia formation in zebrafish and cultured cells, an effect mediated by its interaction with 
the ciliary GTPase Rab8a (75, Murga-Zamalloa). CEP290 tethers flagellar transition zone 
microtubules to the membrane and regulates flagellar protein contents (373, Craige). CEP290 
binds Rab8 under ciliated and non-ciliated conditions, and its regulation of ciliogenesis is 
dependent on its interaction with Rab8. Dysfunction or absence of CEP290 perturbs the ciliary 
influx and localization of specific photo-transducers and odorant signaling molecules such as 
Golf and Gy in the cilia of olfactory receptor neurons (374, Chang). CEP290 is also a centriolar 
protein, it localizes to the distal ends of centrioles and to the cloud of pericentriolar material that 
surrounds the centrosome (374, Chang). When a living cell initiates its program of ciliogenesis, 
the centrosome migrates to the apical surface of the cell and, at only the distal end of the mother 
centriole, CEP290 is activated, resulting in the growth of the ciliary axoneme and the formation 
of the primary cilium (375, Tsang).  
Otherwise, PEBP1 was also described to regulate the mitotic spindle checkpoint by 
inhibiting Aurora B (155, Eves). To investigate a possible similar or common role of PEBP1 both 
in primary cilium and centrosome, we discuss below the separate role of primary cilium and 
centrosome as well as the known relationships between them. 
5.2.1- Role of primary cilium 
The primary cilium is a single antenna-like projection of the apical membrane, it is found in 
nearly every human cell type. This organelle plays important roles in numerous physiological 
phenomena, including tissue morphogenesis, signal transduction, determination of left-right 
asymmetry during development, and adult neurogenesis (376, Huang). Primary cilium has 
important sensory roles affecting multiple cellular processes, with a large proportion of G-protein 
coupled receptors, ion channels, and downstream effector molecules sequestered and confined to 
its membrane and lumen. To perform specialized sensory tasks, cilia are enriched with various 
receptors, for example, odorant receptors and rhodopsin to establish olfaction and vision (377, 
Singla). Furthermore, the primary cilium plays an active role in multiple signaling pathways 
including Wnt, PDGF and Hh, in which receptors traffic into/out of the ciliary axoneme during 
signal transduction (378, Conduit). It is to note here, that as the primary cilia, the motile cilia not 
only cause fluid flow but also sense signals from the flow to determine their orientation (379, 
Marshall). It has been shown that defects in primary cilium formation and function are 
responsible for a variety of human diseases and developmental disorders, termed ciliopathies 
(380, Drivas). The major organs affected by ciliopathy syndromes are the brain, kidney and eye. 
The cilium is formed as a membrane-bound microtubule extension, known as the ciliary 
axoneme, protruding from the distal end of the mother centriole at the apical surface of the cell 
(381, Qin). The barrier between the cilium and the cytosol is maintained at the transition zone of 
the cilium, the region of the organelle just proximal to the axoneme, in plane with the cortex of 
the cell.  
5.2.2- The centrosome 
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The centrosome is an important cellular organelle which nucleates microtubules (MTs) to 
form the cytoskeleton during interphase and the mitotic spindle during mitosis. Cep290 was 
found specifically localized in the mitotic centrosome and involved in spindle position. Depletion 
of Cep290 caused a reduction of the astral spindle, leading to misorientation of the mitotic 
spindle. CEP290 interacts with the centriolar satellites that are small, spherical granules with a 
diameter of approximately 70–100 nm that cluster in the vicinity of the centrosome. They served 
as vehicles for protein trafficking towards the centrosome and the physical coupling between the 
satellites and microtubule-associated motor proteins can be mediated by several proteins such as 
BBS4, Par6a, and CEP290 (382, Kim 2008).  
5.2.3- The primary cilium membrane is associated to centrosome 
The primary cilium is nucleated at its base by the basal body, consisting of the eldest 
centriole in the cell (named the mother centriole) with associated appendage proteins that dock it 
to the plasma membrane (383, Seeley; 384, Kim 2013; 385, Broekhuis). In a series of 
experiments the ciliary membrane was followed in dividing embryonic neocortical stem cells and 
cultured cells (386, Paridaen). Interestingly, in these cells, ciliary membrane attached to the 
mother centriole was endocytosed at mitosis onset, persisted through mitosis at one spindle pole, 
and was asymmetrically inherited by one daughter cell, which retained stem cell character. This 
daughter re-established a primary cilium harboring an activated signal transducer earlier than the 
non-inheriting daughter. These results are important as they highlight two major facts. First, upon 
entry into mitosis, the ciliary membrane was internalized together with one of the centrosomes, 
indicating that, contrary to previous concepts, primary cilia are not completely disassembled prior 
to mitosis. Secondly, the data implied that centrosome-associated ciliary membrane acts as a 
determinant for the temporal-spatial control of ciliogenesis. Moreover, it was found that, at the 
G2-M phase transition, the shortening cilium was internalized with the basal body. Because the 
basal body/mother centriole maintains its attachment to the remaining ciliary membrane, it serves 
a dual function as a basal body as well as a part of one mitotic spindle pole (386, Paridaen).  
The primary ciliary pocket is defined as the membrane domain starting from the transition 
fiber to the region where ciliary sheath emerges into extracellular environment. In 
photoreceptors, the ciliary pocket is part of the connecting cilium/transition zone (CC/TZ) where 
CEP290 and PEBP1 were colocalized (75, Murga-Zamalloa). The ciliary pocket was detected in 
various types of cells, particularly in retinal epithelial cell line (RPE1), epithelial kidney cells 
(IMCD3), murine embryonic fibroblasts (MEF) and murine oocytes. Interestingly, in these cells, 
ciliary pocket was shown to play a key role in membrane trafficking and endocytosis (387, 
Molla-Herman). In addition, the ciliary pocket connected to the actin cytoskeleton and probably 
served as an interface between the primary cilium and the actin cytoskeleton (388, Ke).  
The abnormal expression of Aurora Kinase family is closely associated with the 
development of tumor, because of the crucial role of Aurora Kinase family plays in the mitosis 
and cell cycle. Aurora A and B are tightly regulated during the cell cycle and are overexpressed 
in many carcinomas, such as hepatocellular, ovarian, esophageal, bladder, breast, prostate, 
pancreas and lung cancers (389, Wakahara). It was observed that the cancer cells with elevated 
activated Aurora A rarely possess a primary cilium (390, Yuan). As a consequence, the loss of 
primary cilia may render multiple regulatory signals incapable of tumor growth suppression (388, 
Ke).  
The localization of PEBP1 both at the primary cilium and at the mitotic spindle is in 
accordance with the fact that upon entry in mitosis, the ciliary membrane is internalized together 
with one of the centrosomes. Moreover, GRK2 was localized to centrosomes and described to 
play a central role in mitogen-promoted centrosome separation (391, So). PEBP1 appears to be 
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associated with a set of key proteins, such as CEP290, Rab8, and GRK2 which govern in a 
coordinated manner main cellular events such as receptors internalization, primary cilium and 
mitotic spindle. This assumption is reinforced by the role of ciliary pocket in membrane 
trafficking and endocytosis and its connection to the actin cytoskeleton. 
 
5.3- Primary cilium is involved in endocytosis, exocytosis, cell migration and 
immune synapse 
 
5.3.1- Primary cilium regulates environmental factors and controls extracellular matrix 
Primary cilia are known to regulate different ciliary signaling systems, such as those 
operated by G protein-coupled receptors (392, Schou) and receptor tyrosine kinases (395, 
Christensen) but also by transcient receptor potential (TRP) ion channels (394, Phua) or 
receptors for extracellular matrix proteins (395, Seeger-Nukpezah). Indeed, the transcient 
receptor potential (TRP) channels are known to accumulate inside the primary cilium and 
conduct calcium ions (Ca2+). Each subfamily member, namely TRPP2 TRPP3, TRPC1 and 
TRPV4, is gated by multiple environmental factors, including chemical (receptor ligands, 
intracellular second messengers such as Ca2+), mechanical (fluid shear stress, hypo-osmotic 
swelling), or physical (temperature, voltage) stimuli (394, Phua). Other interesting findings have 
revealed extensive signaling dialog between cilia and extracellular matrix (ECM), with defects in 
cilia associated with fibrosis in multiple contexts. It was demonstrated that primary cilia are 
essential for chondrocyte mechano-transduction and the control of ECM secretion in response to 
physiological compressive strain. In particular, the chondrocyte primary cilium is required for 
ATP-induced Ca2+ signaling. In these cells, under normal growth, cilia-localized polycystin 1 
mediates elevated extracellular ATP induced indirectly by cellular interactions with collagen 
during matrix compression. Thus, in chondrocytes, primary cilia are essential for 
mechanotransduction and the control of ECM secretion in response to physiological compressive 
strain (396, Wann). Finally, it appeared that primary cilium plays an important role in cellular 
homeostasis, based on its ability to integrate chemical cues and flow and compression forces. 
Disruptions in cilia deregulate cell growth and polarity, and produce an extracellular environment 
leading frequently to fibrosis. In turn, disruptions in the extracellular environment alter the 
signals received by cilia, again influencing cell growth properties (395, Seeger-Nukpezak).  
5.3.2- Endocytosis and exocytosis at the ciliary pocket 
As we have seen in a previous paragraph, the region between the plasma membrane and the 
ciliary membrane is structurally organized to produce a ciliary pocket in many cell types. This 
invagination comprises an interphase for the actin cytoskeleton and may function as a site for 
exocytosis and endocytosis of ciliary proteins, which regulates the spatiotemporal trafficking of 
receptors into and out of the cilium to control its sensory function (397, Ghossoub). Indeed, the 
periciliary membrane, comprises a site for clathrin-dependent endocytosis, which regulates 
signaling events associated with receptor internalization and subsequent recycling or degradation 
in the late endosomes/lysosomes compartment (398, Pedersen).  
During primary cilium formation, the Rab GTPase membrane trafficking regulators Rab8a, 
-17, and -23, and their cognate GTPase-activating are involved in primary cilia formation. 
Additionally, Rab8a specifically interacts with cenexin/ODF2, a basal body and microtubule 
binding protein required for cilium biogenesis and is the sole Rab enriched at primary cilia. (399, 
Yoshimura). At the ciliary base, active Rab11 promotes a cascade of signaling events, including 
the activation of Rab8 and its localization along the ciliary axoneme, where it controls cilium 
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elongation (400, Westlake). These findings provide a basis for understanding how specific 
membrane trafficking pathways cooperate with the microtubule cytoskeleton to give rise to the 
primary cilia. 
5.3.3- Primary cilium and cell migration 
Several works showed that primary cilia coordinate a series of signaling pathways critical 
to fibroblast cell migration during development and in wound healing. In particular, platelet-
derived growth factor receptor alpha (PDGFRα) is compartmentalized to the primary cilium to 
activate signaling pathways that regulate reorganization of the cytoskeleton required for 
lamellipodium formation and directional migration in the presence of a specific ligand gradient 
(401, Christensen). It was noted that the primary cilium points in the direction of cell migration 
(402, Albrecht-Buehler). Especially, PDGFRa is transported to and imported into the growing 
cilium where it dimerizes, becomes phosphorylated, and signals via the Akt and MEK1/2–
ERK1/2 pathways to control directional cell migration by influencing the transport and 
positioning of an Na+/H+ exchange protein to the lamellipodium (403, Clement; 404, 
Schneider).  
5.3.4- Primary cilium and immune synapse 
The intraflagellar transport (IFT) system was identified responsible for the assembly of the 
primary cilium, in the non-ciliated T-cell, where it controls immune synapse assembly by 
promoting polarized T-cell receptor recycling. It was shown that immune synapse and the 
primary cilium, which are both characterized by a specialized membrane domain highly enriched 
in receptors and signaling mediators, share architectural similarities and are homologous 
structures (405, Finetti 2013). Despite their obvious morphological differences, the immune 
synapse and the primary cilium both represent specialized membrane domains dedicated to sense 
the microenvironment and orchestrate the cellular response to extracellular cues. Moreover, 
similar to primary cilia, the immune synapse is enriched in lipid rafts, which are an important 
determinant in assisting the segregation of specific proteins to this location (406, Finetti 2011). 
Vesicular trafficking ensures the transport to the immune synapse of both receptors and 
membrane-associated signaling mediators from intracellular pools that are associated with 
recycling endosomes. In parallel, the finding that IFT/BBS proteins interact with Rab11, which is 
associated with the pericentrosomal recycling compartment, and Rab8 (407, Nachury) which is 
implicated in protein recycling to the apical membrane in polarized cells, strongly suggests that 
ciliary proteins may be targeted to the periciliary membrane by recycling endosomes. Moreover, 
IFT20 is centrally implicated in the assembly of the immune synapse, which strongly supports the 
notion that the immune synapse and the primary cilium are homologous structures sharing an 
ancestral trafficking machinery for receptor targeting to the respective membrane domains. 
Finally, among the regulators of signaling recruited to both the immune synapse and the primary 
cilium are specific ubiquitin-conjugating enzymes that are centrally implicated both in the 
regulation of signaling and in the breakdown of these structures (405, Finetti 2013). 
The implication of PEBP1 in primary cilium is coherent with its own role in modulating 
signaling pathways from various receptors, including chemical cues, flow and compression 
forces. Particularly, the ciliary pocket which is part of the connecting cilium/transition zone 
(CC/TZ) where CEP290 and PEBP1 were colocalized, is a site for exocytosis and endocytosis, 
which regulates the spatiotemporal trafficking of receptors into and out of the cilium to control its 
sensory function. It is to note that the ciliary pocket is also an interphase for the actin 
cytoskeleton. Finally, the relationships between primary cilium, centrosome, extracellular matrix, 
cell migration and immune synapse are in complete accordance with the multiple functions of 
PEBP1. 
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5.4- Crosstalk between apoptosis and autophagy 
PEBP1 was described to control cell death signaling by regulating the pathways 
Raf/MEK/ERK (13, Yeung 1999), TAK/NIK/IKK/NF-B (91, Yeung 2001), PI3K/Akt/mTOR 
(16, Lin) and MEK/ERK/CREB (41, Zuo). Moreover, PEBP1 is a member of the regulation loop 
NF-B/Snail/YY1/PEBP1/PTEN implicated in the NO-mediated sensitization of resistant tumor 
cells (408, Bonavida). In cancer, cells overexpressing PEBP1 were resensitized to TRAIL 
apoptosis (323, Baritaki). The expression levels of PEBP1 were observed to be associated with 
variation in expression of Bcl-2 (136, Hu). In cellular senescence, PEBP1 induction is fully 
dependent on p53 and in turn, PEBP1 is responsible for p53-mediated ERK suppression and 
senescence (409, Lee). Interestingly, it turns out that Bcl-2 and p53 are two important proteins in 
both apoptosis and autophagy. Finally, PEBP1 was found to bind LC3, a major protein regulating 
autophagy (44, Noh). Altogether, these data indicated that PEBP1 is involved in pro-apoptotic or 
anti-apoptotic processes and that it may participate in bifurcation between intrinsic and extrinsic 
apoptosis and in autophagy. De facto, it is well-known that apoptosis and autophagy are two 
complicated processes which furthermore are intricately linked. To clarify this complex issue, we 
describe below the broad outlines for each apoptosis and autophagy and we discuss the known 
crosstalk between them. 
5.4.1- Apoptosis, intrinsic and extrinsic pathways 
Apoptosis is a form of programmed cell death, or “cellular suicide”. Apoptosis plays 
critical roles in development, immune response, and tissue homeostasis; its deregulation leads to 
accumulation of “unwanted” cells and contributes to cancer development (410, Su; 411, El 
Khattouti). The pathways, which are involved in the regulation of apoptosis, are extremely 
complicated and appear to be both agent-dependent and tissues-specific (412, Ng). Apoptosis can 
be initiated through two major pathways, namely the intrinsic and the extrinsic pathways. In 
the intrinsic pathway the cell kills itself in response to cellular stress. The intrinsic pathway is 
triggered by a wide range of cellular stress signals, including DNA damage, endoplasmic 
reticulum stress, oxidative stress and growth factor withdrawal (413, Tait). A key step in the 
initiation of intrinsic apoptosis is mitochondrial outer membrane permeabilization (MOMP), 
which enables the release of pro-apoptotic factors, from the mitochondrial intermembrane space 
to the cytosol. The translocation of these intermembrane pro-apoptotic proteins, including 
cytochrome c and Smac/Diablo, is modulated by the members of Bcl-2 family (413, Tait). In 
the extrinsic pathway the cell kills itself because of signals from other cells. This pathway is 
initiated by transmembrane receptors such as Fas receptor, TNF-α receptor and death receptors 
DR3, DR4 and DR5. TNF-related apoptosis-inducing ligand (TRAIL) is a cytokine that is 
secreted by most normal tissue cell, it binds to the death receptors DR4 and DR5. TRAIL also 
binds the receptors DcR1 and DcR2, activating NF-B and leading to transcription of genes 
known to antagonize the death signaling pathway and/or to promote inflammation (414, 
Chicheportiche; 415, Luo). Furthermore, it should be noted that Bcl-2 family proteins are 
critical in regulating both the intrinsic and extrinsic apoptotic pathways (416, Zhao).  
 
5.4.2- Autophagy is a cytoplasmic quality-control mechanism 
Autophagy is the natural, regulated, destructive mechanism of the cell that disassembles 
unnecessary or dysfunctional components leading to their orderly degradation and recycling. 
Autophagy is an ancient and highly conserved intracellular degradation process that is induced 
under various forms of cellular stress. Autophagy is involved in vesicular formation, transport, 
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tethering, and fusion. In most cases, autophagy is a process of programmed cell survival and 
blocks the induction of apoptosis (416, Zhao). As a cytoplasmic quality-control mechanism, 
autophagy is vital for cellular homeostasis, and the dysfunction of autophagy may lead to many 
diseases such as neurodegenerative diseases, cardiomyopathy, tumorigenesis, and pathogenic 
infection (151, Ao). Autophagy starts with the formation of an isolation membrane called 
phagophore, usually at the contact sites between mitochondria and the endoplasmic reticulum. 
Upon autophagy induction, a portion of cytoplasm, including organelles, is enclosed by the 
phagophore to form the autophagosome. The outer membrane of the autophagosome 
subsequently fuses with the lysosome, and the internal material is degraded in the autolysosome, 
after which the degradation products are recycled by the cell (410, Su).  
Here, we must remember that LC3, a cytosolic protein, can associate with intracellular 
membranes through PE-dependent conjugation to regulate initiation of autophagy. The PE-
conjugated LC3 protein plays a critical role in regulating the formation of autophagosomes and 
sequestering cellular components into the phagophore lumen. PEBP1 interacted with the 
cytosolic unconjugated LC3 form, but not PE-conjugated LC3, indicating that PEBP1 could 
regulate autophagy before inclusion of PE-conjugated LC3 within autophagosomes (44, Noh).  
Besides its role in death and cell survival, autophagy is also involved in regulating cell 
cycle arrest. The mechanism responsible for modulating autophagy-induced cell cycle arrest is 
thought to be regulated by inhibition of the mTOR pathway. What is more, autophagy may also 
help to maintain optimal, high ATP levels that may facilitate the apoptotic process (417, Maiuri). 
 
5.4.3- Bcl-2, p53 and caspases are molecular crosstalks between apoptosis and autophagy 
5.4.3.1- Bcl-2 role in apoptosis and autophagy 
Apoptosis and autophagy share some common upstream signaling components including 
Beclin 1, Bcl-2, p53, and mTOR, all known to interfere with PEBP1 activity. They may act 
independently in parallel pathways or may influence each other via interconnected signaling 
proteins (416, Zhao). Bcl-2 is the founding member of a family of regulator proteins that regulate 
cell death, by either inducing or inhibiting apoptosis. In most cancer types Bcl-2 is overexpressed 
while PEBP1 is downregulated. An exception was found in multiple myeloma, in which the 
overexpression of Bcl-2 was observed along with overexpression of PEBP1 but in this case, 
PEBP1 was in its phosphorylated form (418, Shvartsur). Bcl-2 family members are divided into 
three subgroups: 1- Bax and Bak, which permeabilize the mitochondrial outer membrane by 
forming proteinaceous pores; 2- the anti-apoptotic family members Bcl-2, Bcl-xL, Mcl-1, Bcl-W, 
and Bcl-2a1 which oppose mitochondrial outer membrane permeabilization (MOMP); 3- Bim, 
Bid, Puma, Noxa, Bad, Bik, Bmf, and Hrk, which induce apoptosis by facilitating Bax and/or 
Bak activation (419, Dai). 
Anti-apoptotic Bcl-2 family proteins are important regulators of intrinsic apoptosis by 
controlling the mitochondrial outer membrane permeabilization (MOMP) (420, Youle) and 
inhibiting cytochrome c release from the mitochondria (421, Kilbride). Bcl-2 family proteins 
serve mainly to inhibit pro-apoptotic proteins, such as Bax and Bak. Beclin-1 is a component of 
the class III PI3K/Vps34 complex and is necessary for forming the autophagy vesicle. Beclin 1, 
acting as a critical autophagy initiator, interacts with Bcl-2, thereby regulating both apoptosis and 
autophagy. Thus, the interplay between Bcl-2 and Beclin-1 is essential to regulate the crosstalk 
between autophagy and apoptosis (422, Rubinstein). 
The balance between apoptosis and autophagy is complicated and depends of the cellular 
status. For instance, under the condition of sufficient nutrition, Beclin-1 and Bax/Bak bind to Bcl-
2 to inhibit autophagy or to Bcl-xL to inhibit apoptosis. Under conditions of starvation, C-Jun N-
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terminal protein kinase 1 (JNK1) is activated and phosphorylates Bcl-2 leading to Bcl-2-Beclin 1 
complex destruction, which induces autophagy (423, Wei). However, in the situation of extreme 
starvation, JNK1 promotes hyper-phosphorylation of Bcl-2 leading to Bcl-2 separating from Bax. 
Then, it induces apoptosis via caspase-3-dependent pathways (424, Li).  
It is important to note that compartmentalization of Bcl-2 to different cellular organelles 
allows independent control of autophagy and apoptosis. At the endoplasmic reticulum, Bcl-2 
inhibits autophagy by binding to Beclin 1. The binding of Bcl-2 to Beclin 1 is regulated by 
several mechanisms, including competitive binding of Bik to Bcl-2, phosphorylation of Bcl-2 by 
JNK1, and phosphorylation of Beclin 1 by DAPK. At the mitochondrion, Bcl-2 inhibits apoptosis 
by interacting with Bax and Bak. Bad, Noxa, Bid and others activate apoptosis by inhibiting Bcl-
2. The specific proteins Bid, Bim and Puma are also able to induce apoptosis by directly 
activating Bax and Bak (422, Rubinstein). Thus, the role of Beclin-1 in regulating autophagy is 
mediated by the localization of Bcl-2 at the endoplasmic reticulum. In turn, the regulation of 
apoptosis can be mediated through the localization of Bcl-2 to mitochondria. Accordingly, the 
cellular outcome between autophagy and apoptosis appears to depend on the entity of the 
mitochondria rather than the molecular mechanism induced (411, El-Khattouti). 
 
5.4.3.2- p53 role in apoptosis and autophagy 
Besides the Bcl2 protein family, p53 is also implicated in both apoptosis and autophagy. 
Upon stress, a cytoplasmic pool of p53 rapidly translocates to the mitochondrial surface, where it 
physically interacts with both anti- and pro-apoptotic Bcl-2 family members to inhibit or activate 
their respective functions, leading to MOMP and apoptosis (425, Nikoletopoulou). p53 is a 
master regulator of apoptosis in both the extrinsic and the intrinsic pathways. In the extrinsic 
pathway, nuclear p53 increases the expression of death receptors such as the Fas receptor and the 
TRAIL receptor DR4/5 (426, Kuribayashi), while cytoplasmic p53 activates caspase 8 and 
caspase 3. In the intrinsic apoptotic pathway, nuclear p53 activates the expression of the 
proapoptotic proteins such as Pidd, Puma, Noxa, Bax, and Bid; leading to cytochrome c release, 
and activation of caspase-9 and caspase-8. Meanwhile, cytoplasmic p53 translocates to the 
mitochondria and forms a complex with Bcl-2/Bcl-xL to liberate the proapoptotic proteins Bax 
and Bak (427, Moll). In contrast to apoptosis upregulation by p53, cytoplasmic and nuclear p53 
have contradictory roles in regulating autophagy. Cytoplasmic p53 inhibits autophagy through 
the activation of mTOR signaling via the inactivation of AMP kinase, while nuclear p53 activates 
autophagy by transcriptional activation of DRAM (damage-regulated autophagy modulator) 
which promotes the formation of autophagolysosomes (410, Su). 
Moreover, the class I PI3K/Akt/mTOR signaling is a well-known pathway involved in the 
regulation of both apoptosis and autophagy and may contribute to simultaneous or sequential 
induction of both processes (416, Zhao; 428, Levine). 
 
5.4.3.3- Role of Caspases in apoptosis and autophagy 
Caspases play also an important role in the interconnection between apoptosis and 
autophagy. For example, when Beclin 1 is bound to, and inhibited by Bcl-2 or Bcl-xL, this 
interaction can be disrupted by phosphorylation of Bcl-2 and Beclin 1, or ubiquitination of Beclin 
1. But more interestingly, caspase-mediated cleavage of Beclin 1 promotes crosstalk between 
apoptosis and autophagy (429, Kang). While autophagy mediates the degradation of caspases, 
caspases can also target the cleavage of autophagy-related proteins (411, El-Khattouti).  
 
5.4.4- Apoptosis and autophagy in cancer 
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In sum, autophagy and apoptosis are both cellular degradation pathways essential for 
organismal homeostasis. Therefore, both autophagy and apoptosis have been implicated in 
protecting organisms against a variety of diseases, especially cancer (430, Liu). Initially, 
autophagy was identified as a tumor suppressor pathway, as in normal cells it facilitates the 
degradation of oncogenic molecules. However, unlike apoptosis, the role of autophagy in cancer 
appears to be very diverse, dictated primarily by cellular contexts (410, Su). Apoptosis and 
autophagy often occur in the same cell, mostly in a sequence in which autophagy precedes 
apoptosis. For example, some anticancer agents induce autophagy preceding apoptosis through 
mitochondrial damage and/or endoplasmic reticulum stress (431, Park). The concept that 
inhibition of apoptosis results in autophagic/necrotic cell death is now extended, and it is clear 
that apoptosis and autophagy can act as partners to induce cell death in a synergistic or 
cooperative fashion (432, Kumar). 
In conclusion, apoptosis and autophagy are two intertwined processes regulated by 
common proteins and pathway. In this context, it is not surprising that PEBP1 participates in the 
two events by interacting with several shared main regulators as Beclin 1, Bcl-2, p53 and 
PI3K/Akt/mTOR pathway. 
 
5.5- Autophagy, focal adhesion and cell migration 
 
PEBP1 was found to interact with LC3 to inhibit its binding to PE, preventing starvation-
induced autophagy. These data indicated that PEBP1 could associate with LC3 to regulate 
autophagy before inclusion of LC3-II proteins within autophagosomes (44, Noh 2016). Upon the 
activation of autophagy, kinases may phosphorylate PEBP1 to liberate LC3, leading to PE 
conjugation which is a critical step necessary for autophagosome biogenesis. Thus, 
overexpression of PEBP1 significantly prevented starvation-induced autophagy, while, 
knockdown of PEBP1 expression induced high levels of autophagy via stimulation of LC3-
lipidation and Akt/mTORC1 activation (44, Noh 2016).  
A large number of proteins regulate various stages of autophagy, in particular, actin 
nucleation play an important role in the regulation of autophagosome formation and maturation. 
(433, Coutts). It was also shown that autophagy inhibition reduces tumor cell migration and 
invasion in vitro and attenuates metastasis in vivo (434, Sharifi). In contrast to starvation-induced 
autophagy, which involves nonspecific bulk uptake of cellular constituents, basal autophagy is 
highly selective in order to prevent the unwanted removal of cellular material. Selective 
autophagy should be modulated in time and space for proper coordination of focal adhesion 
assembly and disassembly (435, Kenific).  
 
5.5.1- Autophagy and focal adhesion 
Cell-matrix focal adhesions (FAs) are transmembrane protein complexes that traverse 
cytoskeletal infrastructures all the way to the extracellular matrix, producing traction at the 
leading edge of the cell, thus allowing for motility. Using live-cell imaging, it was seen that 
autophagy promotes optimal migratory rate and facilitates the dynamic assembly and disassembly 
of cell-matrix FAs which is essential for efficient motility. Additionally, autophagosomes 
associate with FAs primarily during disassembly, suggesting autophagy locally facilitates the 
destabilization of cell-matrix contact sites (435, Kenific). Furthermore, the selective autophagy 
cargo receptor neighbor of BRCA1 (NBR1) was identified as a key mediator of autophagy-
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dependent FA remodeling. It appeared that NBR1 enhances FA disassembly and reduces FA 
lifetime during migration (435, Kenific). 
Otherwise, numerous abnormally large FAs accumulate in autophagy-deficient tumor cells, 
reflecting a role for autophagy in FA disassembly through targeted degradation of paxillin. It was 
demonstrated that paxillin interacts with processed LC3 through a conserved LIR motif in the 
amino-terminal end of paxillin and that this interaction is regulated by oncogenic Src activity 
(434, Sharifi). It appeared that interaction between the LC3-interacting region of NBR1 and LC3 
proteins promotes the targeting of autophagosomes to focal adhesions which leads to 
sequestration of focal adhesion proteins (436, Kenific). The resulting focal adhesion disassembly 
drives turnover of cell–matrix adhesions and promotes cell migration (437, Xu). Clearly, 
autophagy contributes to the destabilization and turnover of cell–matrix contacts by locally 
capturing focal adhesion proteins. Tension induces autophagy, as shown by an increase in 
autophagosome-incorporated LC3 proteins coinciding with increased tension, suggesting that 
localized tension at focal adhesions could be one mechanism through which autophagy is 
spatially and temporally regulated (438, Ulbricht). 
 
5.5.2- Focal adhesions direct cell migration 
It was proposed that, at the front-most part of the cell, chemotactic GPCRs activated by a 
gradient of ligand could inhibit autophagy to favor the efficient formation of adhesions, while 
autophagy would remain active at distance from the site of GPCR activation/signaling in order to 
enable focal adhesion disassembly. Specifically, degradation of focal adhesion components, 
through selective autophagy, was shown to participate in the turnover of adhesions during cancer 
cell migration (439, Coly). Autophagic degradation of key proteins participating in actin 
remodeling may also constitute an efficient way of clearing these proteins from the cell rear and 
concentrating them at the cell front, in order to initiate the expansion of a single lamellipodium in 
the direction of the chemotactic stimulus (439, Coly). 
Moreover, focal adhesions are highly dynamic at the leading edge of migrating cells, 
undergoing continuous cycles of assembly and disassembly. GSK3β could have a role in spatially 
restricting selective autophagy to leading-edge focal adhesions. GSK3β is locally inactivated at 
leading-edge lamella where focal adhesions turnover (440, Barth) and phosphorylation of NBR1 
by GSK3β inhibits its ability to turnover ubiquitylated proteins (441, Nicot). This regulation 
suggests that NBR1 is preferentially activated at leading-edge focal adhesions where GSK3β is 
not active. 
Focal adhesions direct migration by mechanically transmitting forces generated by the actin 
cytoskeleton for movement such that the formation of focal adhesion sites at the front of the cell 
establishes traction for forward propulsion (442, Gardel). Filamin A is an actin cross-linker that 
stabilizes the actin cytoskeleton. It also functions to link integrins to actin and is recruited to focal 
adhesions in a tension dependent manner to reinforce tensional stresses on focal adhesions (443, 
Wolfenson). It was also demonstrated that targeting of microtubules to focal adhesions promotes 
their disassembly and it was proposed that microtubules might have an important role in 
promoting recruitment of autophagy proteins, including LC3 and NBR1, to focal adhesions.  
In conclusion, it appears that interaction between the LC3-interacting region of NBR1 and 
LC3 proteins promotes the targeting of autophagosomes to focal adhesions which leads to 
sequestration of focal adhesion proteins. The fact that PEBP1 interacts with LC3 and on the other 
hand may physically interact with MDA-9 in a manner that correlates with a suppression of FAK 
and c-Src phosphorylation is strongly indicative that PEBP1 may take part in the regulation of 
focal adhesion disassembly, a main event to allow cell motility. 
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5.6- Connections between endosomes, exosomes and autophagy 
 
5.6.1- Autophagy and endosomes 
5.6.1.1- The origin of autophagosomes membranes 
The formation and maturation of autophagosomes is a complex process, entailing vesicular 
trafficking and fusion events, and substantial reorganization of existing compartments, or 
subdomains of compartments, in particular, the endoplasmic reticulum but including the plasma 
membrane, Golgi, and mitochondria. In canonical autophagy, which originates in the 
endoplasmic reticulum, remodeling of the endoplasmic reticulum-derived autophagosome must 
occur to allow for their fusion with the endosome and lysosome (444, Tooze). Endocytosed 
material first enters endocytic vesicles, which then consolidate into early endosomes. After 
sorting, the material destined to be degraded is delivered to late endosomes, with which 
lysosomes fuse in a transient manner to pick up the material for final digestion and absorption. 
Lysosomes also drive autophagy and eventually fuse with the autophagic vacuole (445, 
Kiselyov). Late endosomes are also known as multivesicular bodies, because late endosomes 
have a multivesicular morphology. Taken together, the early endosomes, late endosomes, 
endolysosomes, and lysosomes provide a dynamic and adaptable continuum. The pathway is 
elusive because the vesicles are scattered, and undergoing continuous maturation, transformation, 
fusion, and fission (446, Huotari).  
5.6.1.2- Early endosomes and autophagy 
In HeLa and HEK293A cells it was shown that fusion of autophagic vacuoles with 
functional early endosomes is required for autophagy. Inhibition of early endosome function by 
loss of the coatomer COPI subunits (’, , or ) resulted in accumulation of autophagosomes.  
The data demonstrated that LC3–positive autophagic vacuoles accumulated in COPI-depleted 
cells due to an inhibition of early endosome function, resulting in the formation of autophagic 
vacuoles that cannot mature. These results provided direct evidence that early endosome fusion 
with autophagic vacuoles is a prerequisite for autophagic vacuole maturation, and occurs before 
fusion with late endosomes and multi-vesicular bodies (447, Razi).  
5.6.1.3- Late endosomes and autophagy 
Proteins and complexes of the endocytic pathway involve Rab proteins, clathrin coats and 
ESCRTs (endosomal sorting complex required for transport) (448, Papandreou).The role of 
ESCRTs was demonstrated to interplay between late endosomes and autophagosomes formation. 
The ESCRT complexes enable a unique mode of membrane remodeling that results in 
membranes bending/budding away from the cytoplasm. Moreover, the ESCRT machinery plays a 
vital role in a number of cellular processes including multivesicular body (MVB) biogenesis, 
cellular abscission, and viral budding (449, Schmidt; 450, Babst). Defects in the endosomal-
lysosomal pathway have been implicated in a number of neurodegenerative disorders. A key step 
in the endocytic regulation of transmembrane proteins occurs in a subset of late-endosomal 
compartments known as multivesicular bodies (MVBs), whose formation is controlled by 
ESCRT. Particularly, ESCRT-III dysfunction was associated with the autophagy pathway, that 
frontotemporal dementia linked to chromosome 3 (FTD3) (451, Lee). More recently, an 
interaction between the ATG12-ATG3 conjugate and the ESCRT-associated protein 
PDCD6IP/Alix was identified to promote basal autophagy and endolysosomal trafficking. In 
addition, the results highlighted the importance of late endosomes for basal autophagic flux and 
revealed distinct roles for the core autophagy proteins ATG12 and ATG3 in controlling late 
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endosome function. Moreover, ATG12-ATG3 was required for diverse functions including late 
endosome distribution, exosome secretion, and viral budding (452, Murrow).  
5.6.1.4- Recycling endosomes and autophagy 
A recent result was that the two autophagic proteins ATG9 and ATG16L1 both traffic from 
the plasma membrane to autophagic precursor structures following two different routes. ATG9 
localizes on the plasma membrane in clathrin-coated structures and was internalized following a 
classical endocytic pathway through early and then recycling endosomes. By contrast, ATG16L1 
was also internalized by clathrin- mediated endocytosis but via different clathrin-coated pits, and 
appeared to follow a different route to the recycling endosomes, bypassing the early endosomal 
compartment. Then, The R-SNARE VAMP3 mediates the coalescence of the 2 different pools of 
vesicles (containing ATG16L1 or ATG9) in recycling endosomes (453, Puri).  
The small GTPase Rab11 regulates endosomal traffic and function at the level of recycling 
endosomes. In D. melanogaster, loss of Rab11 led to accumulation of autophagosomes and late 
endosomes. Under fed conditions, Rab11 localized to recycling endosomes, and Hook anchored 
late endosomes to microtubules, thereby suppressing endosome maturation and fusion events. 
Autophagy induction by starvation resulted in the translocation of Rab11 from recycling 
endosomes to autophagosomes. Meanwhile, Rab11 removed Hook from late endosomes, 
allowing subsequent fusion of late endosomes with autophagosomes (454, Szatmari). 
 
In conclusion, collectively, all the results described above demonstrate a role for both early 
endosomes, recycling endosomes and late endosomes in autophagy. 
 
5.6.2- Autophagy and exosomes 
5.6.2.1- Secretory autophagy 
During autophagy, all cellular macromolecules including lipids, polysaccharides, and 
proteins are degraded in lysosomes by virtue of their hydrolase. Autophagy summarizes several 
pathways, by which macromolecules can access the lysosomal lumen from the cytosol. Macro-, 
micro- and chaperone-mediated autophagy are the main pathways (455, Münz). While micro- 
and chaperone-mediated autophagy perform this import directly across lysosomal or late 
endosomal membranes, macroautophagy generates new vesicles around its substrate. These 
double-membrane surrounded autophagosomes then fuse with lysosomes for degradation of the 
inner autophagosomal membrane and its cargo. However, these autophagosomes do not 
automatically fuse with lysosomes and they can also be diverted to fuse with the cell membrane 
for non-canonical exocytosis (455, Münz). Thus, the autophagic machinery is also involved in a 
process termed secretory autophagy, a route for unconventional secretion of cytoplasmic 
substrates (456, Hessvik). In conventional secretion, proteins possessing a signal peptide enter 
the lumen of the endoplasmic reticulum followed by the Golgi apparatus for secretion at the 
plasma membrane. In unconventional secretion, cytoplasmic proteins that lack a signal sequence 
are not delivered to the lumen of the endoplasmic reticulum but are transported into the 
extracellular milieu via diverse unconventional secretory pathways, including secretory 
autophagy (457, Ponpuak). It was demonstrated that inhibition of the phosphoinositide kinase 
PIKfyve increased exosome secretion and induced secretory autophagy. This might be caused by 
impaired fusion of lysosomes with both MVBs and autophagosomes, and increased fusion of 
MVBs with autophagosomes. The generated enlarged MVB-like structures are called 
amphisomes (456, Hessvik).  
5.6.2.2- Proteins and lipids in secretory autophagy 
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Secretory autophagy is associated specifically with the autophagy pathway defined by ATG 
factors that govern the biogenesis of autophagic membranes. The ATG factors directing 
canonical autophagy include ULKs (unc-51-like kinases), Beclins and LC3s (457, Ponpuak). 
Although the molecular machinery of autophagy, namely Atg proteins, was originally identified 
by its ability to allow cells to survive starvation via lysosomal degradation to recycle cellular 
components, it has recently become apparent that it is used by cells to secrete cytoplasmic 
constituents. Furthermore, viruses have learned to use this Atg supported exocytosis to exit cells, 
acquire envelopes in the cytosol and select lipids into their surrounding membranes that might 
allow for increased robustness of their virions and altered infection behavior (455, Münz). 
Rab GTPases regulate many steps of membrane trafficking, including vesicle budding, 
transport of vesicles along actin and tubulin, as well as membrane fusion. Knockdown of Rab2b, 
Rab5a, Rab9a, Rab27a and Rab27b decreased exosome secretion (458, Hessvik 2017). In 
mammalian cells, secretory autophagy of IL-1b depends upon the autophagy factor Atg5, and the 
small GTPase Rab8a, which regulates vectorial sorting to plasma membrane (459, Dupont). 
Rab8a has also been reported to regulate autophagic secretion of other cargo, including -
synuclein (460, Ejlerskov), a major constituent of Lewy bodies, which are the hallmark protein 
aggregates associated with Parkinson’s disease. Whereas Rab8a, a regulator of polarized sorting 
to the plasma membrane, was shown to be needed for secretory autophagy (459, Dupont), its 
closely related isoform Rab8b may be more important for maturation of the degradative 
autophagosome (461, Pilli). Furthermore, astrocytes normally secrete an insulin-degrading 
enzyme (IDE) extracellularly in the brain, one of the major proteases of the amyloid-β peptide 
which prevents its accumulation, a major marker of Alzheimer’s disease. IDE is secreted into the 
cerebrospinal fluid by Rab8a and GORASP (Golgi reassembly stacking protein) (448, 
Papandreou).  
Secretory autophagy of -synuclein (a cytosolic cargo) was enhanced by inhibiting fusion 
of autophagosomes with lysosome using bafilomycin A1 (460, Ejlerskov). In addition to -
synuclein aggregate expulsion, secretory autophagy has also been implicated in extrusion of 
amyloid beta peptide aggregates associated with Alzheimer’s disease (462, Nilsson). Additional 
leaderless cytosolic proteins have been reported in the autophagy-dependent secretome, including 
galectins (galectin-3), cytoskeletal proteins (tubulin), and others such as annexin-I (463, 
Öhman).  
Finally, lipids may also be important for sorting of specific proteins into exosomes because 
exosomal membranes may contain lipid rafts, membrane subdomains enriched in cholesterol and 
glycosphingolipids that play important roles in signaling and sorting (458, Hessvik 2017).  
 
5.6.2.3- Omegasomes, autophagosomes, amphisomes, exosomes; overlaps between exosome 
pathway and autophagy 
At the endoplasmic reticulum exit sites, in mammalian cells, omegasomes facilitate the 
formation of degradative autophagosomes, of which the elongation and closure require LC3. 
Upon closure, degradative autophagosomes display motility toward the minus end of the 
microtubules where they fuse with lysosomes resulting in the degradation of the engulfed 
contents by lysosomal hydrolases (457, Ponpuak). Conversely in secretory autophagy, 
omegasomes located near endoplasmic reticulum exit sites aid the formation of secretory 
autophagosomes. Secretory autophagosomes show vectorial motility toward the plus end of the 
microtubules and eventually fuse with the plasma membrane releasing their contents into the 
extracellular environment. 
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Autophagosome maturation includes autophagosome elongation, trafficking and 
autophagosome/lysosome fusion (448, Papandreou). Autophagosomes fuse with lysosomes, but 
might also give rise to exosome secretion. Cytoplasmic substrates are recruited to forming 
autophagic membranes, the isolation membrane, via proteins that contain LC3-interacting regions 
(LIRs). After completion of autophagosome formation, LC3 is recycled from the outer 
autophagosomal membrane prior to fusion with lysosomes (455, Münz). Lysosomal hydrolysis 
degrades autophagosome cargo and the inner autophagosomal membrane. However, the inner 
autophagosome membrane and its content can also be secreted and might give rise to exosomes 
(455, Münz). 
Exosomes are nanovesicles (30–150 nm in diameter) released from cells by fusion of 
multivesicular bodies (MVBs) with the plasma membrane. Exosomes were suggested to play a 
role in cell-to-cell communication (464, Mathivanan; 465, Record) and have been implicated in 
numerous physiological and pathological functions. Exosomes contain proteins, lipids and other 
metabolites, mRNAs, small RNAs such as miRNAs and probably DNA fragments, which can be 
delivered to recipient cells (456, Hessvik 2016).  
Thus, several overlaps between the MVB-exosome pathway and autophagy exist (466, 
Baixauli). Particularly, in mammalian cells, MVBs are affected by autophagic machinery since 
autophagosomes and MVBs interact to form hybrid structures referred to as amphisomes (467, 
Gordon; 468, Klionsky). Finally, the notion that autophagy, endosomes and secretion are three 
distinct pathways which share components should be reconsidered as they are intertwined in a 
highly intricate manner and there are no clear-cut borders between these processes (448, 
Papandreou). 
5.6.2.4- Roles of exosome secretion 
The secreted exosomes might be targeted to and degraded by phagocytes, but they might 
also have other destinations. Since secretory autophagy is induced in cells with lysosomal 
dysfunction this might be, an alternative way of eliminating waste products (458, Hessvik 2017). 
However, exosomes secreted as waste are likely to affect neighboring cells and possibly induce 
pathological conditions. Another possibility is that cells might communicate to neighboring cells 
about intracellular stress by increasing exosome release (458, Hessvik 2017). Finally, exosome 
secretion may function in close relation with autophagy pathway to preserve protein and RNA 
homeostasis, and to mediate the spreading of signals to surrounding cells in order to coordinate 
organismal systemic responses (466, Baixauli).  
Exosome secretion was described to play a role in several pathologies. It is established that 
loss of basal autophagy causes neurodegeneration and that exosomes are involved in the spread 
of toxic proteins in neurodegenerative diseases such as Alzheimer, Huntington, Parkinson, and 
prion diseases (466, Baixauli). In heart, reperfusion after an ischaemic insult might cause infarct 
extension. Mesenchymal stem cell (MSC)-derived exosomes could attenuate myocardial 
remodeling in animal models of myocardial ischemia reperfusion injury (MIRI) (469, Liu). In 
vitro, in H9C2 cells exposed to H2O2 for 12 h, treatment with exosomes enhanced autophagy via 
the AMPK/mTOR and Akt/mTOR pathways. Likewise, in vivo exosome injections in rats that 
underwent ischemia/reperfusion injury indicated that MSC-derived exosomes could reduce MIRI 
by inducing cardiomyocyte autophagy via AMPK/ mTOR and Akt/mTOR pathways (469, Liu). 
The concept that autophagy, endosomes and secretion are intertwined in a highly intricate 
manner and that there are no clear-cut borders between them is important. It suggests that PEBP1 
may play a global role in modulating and regulating molecular interactions in this set of events.  
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5.7- Primary cilium and autophagy 
 
By analyzing multiple ATG, IFT and centriolar satellite components, it was found that 
autophagy initiates ciliogenesis on serum starvation but limits ciliary growth under nutrient-rich 
conditions. Autophagy and ciliogenesis are regulating each other and nutrition deprivation is a 
shared signal (470, Pampliega; 471, Tang). Autophagy plays both a positive and a negative role 
in the formation and length of the primary cilium (470, Pampliega; 471, Tang), whereas cilium 
can serve as a staging ground for autophagic machinery components (471, Tang). Autophagy 
helps initiate cilium formation under starvation conditions by reducing levels of OFD1, a protein 
that accumulates at the centriolar satellites where it inhibits ciliogenesis (471, Tang). Basal 
autophagy limits uncontrolled cilium growth under nutrient-rich conditions by diminishing 
intraflagellar transport protein IFT20 levels.  
Thus, autophagy provides alternative trafficking routes for integral membrane proteins to 
reach the plasma membrane, but it also controls biogenesis of complex domains and organelles at 
the plasma membrane (470, Pampliega). 
 
5.8- Connection between cytoskeleton and autophagy 
 
Actin filament assembly and disassembly provide the mechanical forces for a wide range of 
cellular activities that involve membrane deformation, such as cell motility, phagocytosis, 
endocytosis and cytokinesis (472, Anitei). In fact, the membrane deformations implicated in 
numerous cellular processes are underspinned by cytoskeleton elements: in particular actin 
filaments of cell cortex and microtubules. Actin cytoskeleton dynamics play vital roles in most 
forms of intracellular trafficking by promoting the biogenesis and transport of vesicular cargoes. 
Thereby, branched actin polymerization is necessary for the biogenesis of autophagosomes from 
the endoplasmic reticulum membrane (473, Kast).  
In higher eukaryotes, following their detachment, mature autophagosomes are transported 
using both actin- and microtubule based mechanisms (474, Mauvezin). In selective autophagy, 
the fusion of autophagosomes with lysosomes depends on the recruitment of cortactin to fusion 
sites by the ubiquitin- binding deacetylase HDAC6 (475, Lee). Cortactin is a monomeric protein 
located in the cytoplasm of cells that can be activated by external stimuli to promote 
polymerization and rearrangement of the actin cytoskeleton, it is important in promoting 
lamellipodia formation, invadopodia formation, cell migration and endocytosis (476, Kirkbride). 
A tight spatiotemporal coordination of actin cytoskeleton and membrane dynamics is a 
distinctive feature of many cellular processes, including cell migration, morphogenesis and 
endocytosis. In these processes, Bin/Amphiphysin/Rvs (BAR) domain proteins have emerged as 
essential regulators, linking signaling pathways to the actin cytoskeleton and membrane 
remodeling. BAR domain proteins feature a curved membrane binding surface as well as other 
domains involved in protein–protein interactions, protein–membrane interactions and signaling 
that contribute to the membrane-binding activity and the recruitment of signaling and cytoskeletal 
proteins (473, Kast). 
The annexin family of Ca2+-regulated phospholipid-binding proteins constitutes another 
group of adaptors implicated in membrane budding and fusion and in the recruitment of binding 
partners to specific membranes (477, Gerke). Of the 12 annexins expressed in humans, several 
interact directly with actin, including annexins A1, A2, A5 and A6, and may therefore physically 
connect membranes to actin filaments (478, Hayes). Of these, annexins A2 and A5 have been 
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implicated in autophagy. Annexin A5 accumulates on lysosomal membranes during starvation, 
and overexpression and silencing experiments indicate that it induces autophagosome–lysosome 
fusion, thus increasing lysosomal protein degradation (479, Ghislat). Both BAR and annexin 
families that play a role in autophagy share the ability to recruit binding partners, including 
signaling proteins and actin (473, Kast). 
 
Strikingly, each cellular process implicating PEBP1 is governed by molecular mechanisms 
that are shared with other processes. Of particular interest is that autophagy, endosomes and 
secretion are intertwined in a highly intricate manner suggesting a global role for PEBP1 in 
modulating this set of events. In a same way, apoptosis and autophagy are strongly networked, 
being regulated by several shared proteins (especially Beclin1, Bcl-2, p53) and PI3K/Akt/mTOR 
pathway. Primary cilium formation and mitosis are also interdependent processes as upon entry 
in mitosis the ciliary membrane is internalized together with one of the centrosomes. Moreover, 
CEP290 and Rab8a which were found to localize with PEBP1 in the transition zone of primary 
cilium, are also components of centrosomes. Indeed, CEP290 is a centrosomal protein and Rab8-
dependent ciliary assembly is initiated by the relocalization of Rabin8 to Rab11-positive vesicles 
that are transported to the centrosome. All these data suggest that PEBP1 is associated with 
molecular machines to regulate and coordinate the assembly/disassembly of these organelles. In 
addition, endosomes, primary cilium and centrosomes may constitute platforms where PEBP1 
can interact with partners and accompany or deliver the signaling pathways where needed. 
Ultimately, the main cellular processes that underlie the primary PEBP1 features are 
probably primary cilium, autophagy and mitotic spindle checkpoint. Effectively, primary cilium 
is a sensory organelle capable of sensing chemical, physical and mechanical signals such as 
tension, pressure, flow, movement and temperature. In addition, the ciliary pocket which is part 
of the connecting cilium/transition zone where PEBP1 was localized, is a site for exocytosis and 
endocytosis, which regulates the spatiotemporal trafficking of receptors into and out of the cilium 
to control its sensory function. Autophagy also reflects a main feature of PEBP1 because it is a 
very important process to allow cell motility by governing focal adhesions. Yet PEBP1 plays an 
important role in controlling cell motility with dramatic effects in cancer when PEBP1 is 
downregulated. At last, mitotic spindle checkpoint is significant of PEBP1 implication in cell 
division. During mitosis PEBP1 controls Aurora B activity in order to trigger microtubules 
elongation when kinetochores are properly attached to the spindle apparatus.  
Interestingly, many of the processes modulated by PEBP1 concerned membrane changes 
(invagination, protrusion, engulfment, vesicle formation or fusion) and all of them need fine-
tuned cytoskeleton organization. 
 
6- Some other PEBP isoforms: human PEBP4, TFL1 and TF1 in plants 
 
PEBP isoforms have been characterized from numerous organisms such as mimivirus, 
bacteria, parasites, yeast, plants and mammals. In each studied species several PEBP isoforms 
were described. In human, apart from PEBP1, PEBP2 isoform was only colocalized in late 
spermatocytes and spermatids and on the midpiece of epididymal sperm. In addition to PEBP1, 
PEBP2 was demonstrated to participate in the MAP kinase signaling pathway, with a role in 
spermatogenesis and posttesticular sperm maturation (11, Hickox). Thus, the role of PEBP2 in 
membrane maturation and capacitation of sperm was clearly established (49, Moffit). PEBP4 
appeared also to play a role in plasma membrane changes, but surprisingly, some of its final 
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effects are opposite to those of PEBP1. This is particularly true in cancer where PEBP4 favors 
tumor and metastasis development. We discuss below some features of PEBP4. 
hPEBP4 
The molecular cloning and characterization of PEBP4 was derived from human bone 
marrow stromal cells (BMSCs). The cDNA potentially encoded a 227-residue protein. RT-PCR 
analysis revealed that hPEBP4 mRNA is expressed in most human tissues and in a variety of 
tumor cells and freshly isolated cells. The expression of PEBP4 in tumor cells was enhanced 
upon TNF-alpha treatment. Whereas hPEBP4 normally co-localized with lysosomes, TNF-alpha 
stimulation triggered its transfer to the cell membrane, where it bound to Raf-1 and MEK1 (12, 
Wang). L929 cells overexpressing hPEBP4 were resistant to both TNF-alpha-induced ERK1/2, 
MEK1, and JNK activation and TNF-alpha-mediated apoptosis. The effects of TNF-alpha on 
hPEBP4 mRNA expression in A549 and LoVo cells, which do not normally express hPEBP4 
provided evidence that hPEBP4 might be induced to translocate from lysosomes to the plasma 
membrane following cellular exposure to TNF alpha and that this translocation requires the 
binding site of PEBP4. Given that MCF-7 breast cancer cells expressed hPEBP4 at a high level, 
small interfering RNA was used to silence the expression of hPEBP4. It was demonstrated that 
down-regulation of hPEBP4 expression sensitizes MCF-7 breast cancer cells to TNF alpha-
induced apoptosis. Finally, hPEBP4 was described to promote cellular resistance to TNF-induced 
apoptosis by inhibiting activation of the Raf-1/MEK/ERK pathway, JNK, and 
phosphatidylethanolamine (PE) externalization. hPEBP4 was thought to be targeted to the cell 
membrane and binds to PE situated on the inner leaflet of the plasma membrane, preventing PE 
externalization, and maintaining membrane phospholipid asymmetry (12, Wang).  
The study of primary human skeletal muscle myoblasts (HSMM, non-cancerous cells) 
suggested that PEBP4 can form ternary complexes with Raf-1 and MEK, and might function as a 
scaffold protein for Raf-1/MEK interactions. This sharply distinguishes it from PEBP1, which 
disrupts the interaction between Raf-1 and MEK (13, Yeung et al, 1999), acting as a competitive 
inhibitor of MEK binding (78, Yeung et al, 2000). Importantly, a ternary endogenous Raf-
1/MEK/PEBP4 complex also exists in primary human skeletal muscle cells (SkMC) and MCF7 
cells. In contrast to PEBP1, which disrupts the Raf-1/MEK interaction, PEBP4 forms ternary 
complexes with Raf-1 and MEK, and can scaffold this interaction. PEBP4 expression was 
induced during the differentiation of primary human myoblasts. Consistent with the properties of 
a scaffold, PEBP4 enhanced the Raf-1/MEK interaction and the activation of MEK at low 
expression levels, whereas it inhibited these parameters at higher expression levels. 
Downregulation of PEBP4 by short hairpin RNA in human myoblasts increased MEK signaling 
and inhibited differentiation; by contrast, PEBP4 overexpression enhances differentiation (480, 
Garcia).  
A sequence alignment of several isoforms of mouse and human PEBPs predicted that 
PEBP4 contains a signal peptide. To test if PEBP4 was secreted, constructs were made with Myc 
epitope at the amino (N) terminus or carboxyl (C) terminus to mask the signal sequence or keep it 
free, respectively. The data revealed that both mouse and human PEBP4 were secreted when the 
epitope was tagged at their C-terminus. Surprisingly, secretion was dependent upon the C-
terminal conserved domain in addition to the N-terminal signal sequence. When the epitope was 
placed to the N-terminus, the recombinant protein failed to secrete and instead, was retained in 
the cytoplasm. Transfection of PEBP4 shRNA into HEK293T cells did not appear to affect ERK 
activation, suggesting that PEBP4 does not participate in the regulation of this pathway. In 
contrast, PEBP4 siRNA suppressed phosphorylation of Akt at S473 into HEK293T (481, He). 
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A homolog of human PEBP4 was purified from swine seminal plasma, it was named 
sPEBP4. The sequenced sPEBP4 displayed 201 aminoacids in length while the full-length cDNA 
encoded a protein of 222 residues, revealing a signal peptide of 21 residues in the N-terminal 
terminus of the protein. Immunohistochemical staining and western blotting analysis showed that 
sPEBP4 was secreted from epithelial cells in the epididymis to the seminal plasma. Sperms 
suspended in phosphate-buffered saline began to swim after the addition of purified sPEBP4, but 
not when swine serum albumin was added, indicating that sPEBP4 promotes sperm motility (482, 
An).  
 
PEBP4 in cancer 
PEBP4 was described to be upregulated in various cancers. In colorectal carcinoma, the 
positive expression rate in the cancer tissues from patients with positive lymph node and distant 
metastasis was significantly higher than that from the patients negative for lymph node and 
distant metastasis. The over-expression of PEBP4 protein was related to the tumorigenesis, 
development, metastasis, and invasion of colorectal cancer (483, Liu). The same effects were 
observed in non-small cell lung cancer (484, Wu 2012), in lung squamous cell carcinoma (485, 
Yu 2011) and in gliomas tissues (486, Huang). 
Numerous studies have linked the activation of Akt to the progression of cancer. This was 
the case in samples of pancreatic ductal adenocarcinoma (PDAC) in which the mRNA and 
protein levels of PEBP4 were elevated. It was found that overexpression of PEBP4 elevated the 
phosphorylation of Akt in the serine 473. The interaction between Akt and PEBP4 was 
demonstrated by immunoprecipitation in BXPC3 cells. Since PEBP4 interacted with Akt and 
promoted the phosphorylation of serine 473 in Akt, it was suggested that PEBP4 might promote 
the progression of PDAC through activating Akt signaling (487, Zhang). PEBP4 was found to 
cause tumor cell proliferation, migration and invasion by activating PI3K/Akt/mTOR signaling 
pathway in human breast cancer (488, Wang) and in gastric cancer (489, Wu). In another study, 
PEBP4 mRNA and protein expression were also markedly increased in the human prostate cancer 
tissues and cell lines. Knockdown of PEBP4 significantly inhibited hypoxia-induced 
migration/invasion and EMT program. Furthermore, knockdown of PEBP4 prevented the 
expression of p-Akt and p-mTOR induced by hypoxia in prostate cancer cells (490, Li). Finally, 
the overexpression of PEBP4 increases the phosphorylation levels of Akt and mTOR in lung 
cancer cells HCC827 suggesting that the PI3K/Akt/mTOR signaling axis may be a key molecular 
pathway via which PEBP4 promotes the proliferation and invasion of non-small cell lung cancer 
cells (491, Yu 2015). PEBP4 was highly expressed in various lung cancer cells (HCC827, A549, 
NCI-H661, NCI-H292, and 95-D), but its expression was low in a normal human bronchial 
epithelial (HBE) cell line. Cell viability, cell proliferation, and invasion of HCC827 cells in the 
PEBP4 knockdown group were significantly lower than that in the negative control and blank 
control groups. In HCC827 cells, the expression levels of cyclin D1, Bcl-2, MMP-2, and MMP-9 
in the PEBP4 knockdown group were significantly lower and the expression of p53 protein was 
significantly higher than that in the negative and blank control groups (492, Yu 2013).  
It was shown that the expression of PEBP4 could be on the control of miRNAs. Increased 
miR-15b expression was detected in tumor tissues sampled from lung adenocarcinoma patients 
treated with cisplatin-based chemotherapy and was proved to be correlated with low expression 
of PEBP4, decreased sensitivity to cisplatin and poor prognosis. These results suggested that 
upregulation of miR-15b could suppress PEBP4 expression and in turn contribute to 
chemoresistance of lung adenocarcinoma cells to cisplatin (493, Zhao). Another work 
demonstrated that overexpression of PEBP4 reduced the sensitivity of lung cancer cell line A549 
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to cisplatin-induced cytotoxicity and that PEBP4 expression was significantly decreased after 
transfection with miR-34a. These results suggested that PEBP4 is a target of miR-34a (494, Yu 
2014). 
The PEBP4 features are sharply different from that of PEBP1. Particularly, PEBP4 does not 
inhibit the Raf/MEK/ERK pathway but conversely activates the PI3K/Akt/mTOR pathway. 
Furthermore PEBP4 is normally localized with lysosomes and is transferred to cell membrane by 
TNF-alpha activation. These results suggested that the binding properties of PEBP4 toward 
molecular partners are significantly dissimilar than that of PEBP1. 
 
PEBP family members in plants 
It is to note that several PEBP isoforms were described in plants and numerous experiments 
were performed in various species due to the important role of PEBP isoforms in vegetative 
growth and flowering. Two main families of PEBP isoforms are known to regulate flowering and 
vegetative growth, they are called Flowering Locus T (FT) and Terminal Flower 1 (TFL). Just to 
give some examples concerning the FT family, in sugar beet (Beta vulgaris), FT1 and FT2 have 
antagonistic functions in the control of flowering (495, Pin), and in poplar, FT1 regulates 
reproductive onset in response to winter temperatures, whereas vegetative growth and the 
inhibition of bud set are promoted by FT2 in response to warm temperatures and long days in the 
growing season (496, Hsu). In Norway spruce, gene expression and population genetic studies 
have suggested a role for TFL2 in the control of growth cessation and bud set as well as in local 
adaptation resulting in variation for timing of bud set. The temporal and spatial expression of 
FTL1 and FTL2 largely complemented each other, which suggested that they act in concert to 
control perennial growth in Norway spruce (497, Karlgren). 
The floral inhibitor Terminal Flower1 (TFL1) is a homolog to FT. TFL1 acts as a repressor 
of flowering and extends the vegetative growth state while maintaining the indeterminate state of 
inflorescences (498, Shannon; 499, Bradley). TFL1 is expressed in the nucleus and cytoplasm 
but interacts with Flowering Locus D solely in the nucleus and represses genes activated by FT 
(500, Hanano). 
These some examples are indicative of the role of FT and TFL1 as sensors of plant cell 
membrane changes during temperature variations and length of daylight dependent on season. FT 
and TFL1 are implicated in signal transduction, allowing the plants to adapt to their environment. 
 
7- Discussion 
 
7.1- PEBP1 is a regulator and a switch in cell signaling 
PEBP1 was demonstrated to regulate several signaling pathways such as Raf/MEK/ERK 
(13, Yeung 1999), GRK2 (88, Lorentz), NF-B (91, Yeung 2001), PI3K/Akt/mTOR (16, Lin), 
GSK3 (96, Al-Mulla 2011), p38 MAPK (86, Vandamme),  Wnt (14, Shin),  STAT3 (98, 
Yousuf), LIN28/Let-7/HMGA2 and BACH1 (101, Dangi-Garimella; 102, Yun), Notch1 (18, 
Noh). In most cases PEBP1 was demonstrated to regulate the phosphorylation cascades by 
inhibiting the kinases implicated in the pathway. Inhibition is due to physical interaction of 
PEBP1 with the kinases, preventing them to interact with their cascade targets. Only one 
exception was noted with GSK3 which is activated by PEBP1 (96, Al-Mulla 2011). The 
regulation of signaling pathways is dependent of the cell. This fact could be explained by the 
ability of PEBP1 to regulate the pathways that are actually activated in a given cell at a given 
time (340, Gavilan).  
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In addition to its role in regulation of signaling pathways, PEBP1 reveals to be potentially a 
switch between different pathways. Indeed, phosphorylation of PEBP1 at Ser153 by PKC 
switches the inhibitory effect of PEBP1 to GRK2 while releasing the Raf/MEK/ERK pathway 
(89 Corbit). In this case, PEBP1 functions as a switch between the Raf/MEK/ERK and GRK2 
pathways. The same kind of mechanism is suggested for other processes. For instance, in 
autophagy, PEBP1 interacts with LC3 preventing the association of LC3 with 
phosphatidylethanolamine. The phosphorylation of PEBP1 at Ser153 induces the dissociation of 
PEBP1 from LC3, initiating autophagy (44, Noh). Another example is the phosphorylation of 
PEBP1 at Thr42 during mitosis that may trigger the mitotic spindle checkpoint by Aurora B 
activation (140, Dephoure). Loss of PEBP1 during mitosis phase led to bypass of the spindle 
assembly checkpoint and the generation of chromosomal abnormalities (156, Rosner).  
 
7.2- Properties of protein partners and small ligands. Role of PEBP1 in molecular 
interactions and stability 
Most of the proteins that bind PEBP1 are multifunctional, they are implicated in main 
cellular processes or machineries and bring into play several targets. Among them are CEP290 
(75, Murga-Zamalloa), Rab8 (75, Murga-Zamalloa), LC3 (44, Noh), GSK3 (96, Al-Mulla 
2011), syntenin (55, Das). In addition, the interactome of overexpressed PEBP1 in gastric cancer 
cell (157, Gu) revealed cytoskeletal proteins, biosynthesis proteins, glycolytic enzymes, 
molecular chaperones and mitochondrial proteins such as ATP synthase and VDAC1 (see Table 
1). Among the cytoskeletal proteins are tubulin beta that polymerizes with tubulin alpha 
into microtubules and actin that form microfilaments. Actin filament assembly and disassembly 
are crucial to create mechanical forces for motility, phagocytosis, endocytosis and cytokinesis 
(472, Anitei). In addition, several proteins that bind actin such as plectin, F-actin-capping protein 
and vinculin were identified by the interactome analysis. Finally, proteins implicated in 
intermediate filaments such as keratins and vimentin were also characterized. Thus, the main 
components of cytoskeleton, essential to constitute actin filaments, microtubules and intermediate 
filaments were found as first or second partners of PEBP1.  
Interestingly, the most part of the proteins partners of PEBP1 found by interactome analysis 
possess a binding site for nucleotides. In particular actin is known to be an ATPase and tubulin a 
GTPase, the 90-kDa heat shock protein (Hsp90) is a molecular chaperone that assists in an ATP-
dependent manner the folding of numerous targets such as nuclear hormone receptors and protein 
kinases. CEP290 is a protein with an ATP/GTP binding site motif A and a region with similarity 
to the chromosome segregation ATPases SMC (structural maintenance of chromosomes). All the 
proteins implicated in protein biosynthesis display ATP or GTP binding sites, glycolytic enzymes 
hydrolyze different nucleotides and VDAC1 displays a binding site for NAD.  Nucleotide 
concentrations may influence the binding of PEBP1 to these proteins. PEBP1 was demonstrated 
to be an ATP-binding protein and ATP attenuated the interaction between PEBP1 and Raf-1 
resulting in increased activation of the downstream ERK signaling (269, Huang). Therefore, 
the ATP-binding function of PEBP1 renders its inhibition on Raf-1 modulated by 
cellular ATP concentrations, revealing how energy levels may affect the propagation of cellular 
signaling.  
Apart from nucleotides and phospholipids, various small ligands were described to bind 
PEBP1 suggesting that in living cell, competition can be installed between small ligands that in 
turn could modulate interaction between PEBP1 and its protein targets. Surprisingly, PF-
3717842, a soluble inhibitor of PDE5 was found to bind PEBP1 (8, Dadvar). Locostatin, a cell 
migration inhibitor, was demonstrated to bind PEBP1 (501, Rudnitskaya). Locostatin disrupted 
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interactions of PEBP1 with Raf-1 and also with GRK2. In contrast, locostatin did not disrupt 
binding of PEBP1 with IKKα and TAK1. After binding PEBP1, part of locostatin was slowly 
hydrolyzed, leaving a smaller PEBP1-butyrate adduct (273, Beshir). More astonishingly, PEBP1 
was able to hydrolysate another ligand, namely the prodrug Prasugrel. This synthetic product is a 
thienopyridine antiplatelet prodrug that undergoes rapid hydrolysis in vivo to a thiolactone 
metabolite by human carboxylesterase-2 (hCE2) during gastrointestinal absorption. The 
estimated contributions to prasugrel hydrolysis were approximately 40% for PEBP1 and 60% for 
hCE2 (275, Kazui). Thus PEBP1 appears to destabilize locostatin and prasugrel. In contrary, 
PEBP1 was described to stabilize proteins such as Kelch-like ECH-associated protein1 (Keap1). 
PEBP1 enhanced KEAP1 stability in colorectal cancer tissues and HT29 CRC cell line. PEBP1 
silencing in immortalized HEK-293 cells correlated significantly with Keap 1 protein degradation 
and subsequent NRF2 addiction in these cells (53, Al-Mulla 2012 a). Keap1 associates with actin 
filaments in the cytoplasm. Disruption of the actin cytoskeleton promotes nuclear entry of Nrf2. 
The actin cytoskeleton therefore provides scaffolding that is essential for the function of Keap1, 
which is the sensor for oxidative and electrophilic stress (502, Kang). In lung adenocarcinoma 
cells, Keap1 expression regulates rearrangements of F-actin-containing microfilament bundles, 
suggesting that F-actin-containing microfilament bundle rearrangements may be involved in 
Keap1-mediated cell invasiveness (503, Chien). Moreover, PEBP1 was also found among the 
major proteins responsible for the maintenance of human tear film stability (504, Perumal). 
 
7.3- PEBP1 with membranes and vesicles 
One can notice that several of the main cellular functions of PEBP1 match with plasma 
membrane changes and reorganization. Indeed, when phosphorylated by PKC, PEBP1 is known 
to regulate receptor internalization by inhibiting GRK2 (88, Lorentz). PEBP1 is also involved in 
autophagy (44, Noh), in sperm capacitation (49, Moffit), cilium formation (75, Murga-
Zamalloa), adhesion (54, Mc Henry), motility (36, Al-Mulla 2012 b). PEBP1 was also found to 
be associated with different types of vesicles such as lipid rafts (505, Goumon) and exosomes 
(35, Han). 
In brain hippocampus, a role for PEBP1 was also described in synapse and more 
particularly in presynapse (56, Kato). Especially, it was suggested that PEBP1, in association 
with unphosphorylated and/or pSer522-CRMP-2, plays an important role in presynaptic function 
in the mature hippocampus (57, Mizuno). The role of PEBP1 in presynaptic function was also 
described in neuroblastoma where didymin inhibits MYCN through Raf-dependent and -
independent mechanisms by inhibiting clathrin-dependent endocytosis through PEBP1, GRK, 
PKC, and Let-7 micro-RNA (103, Singhal). Clathrin which is a partner of PEBP1 in the 
interactome analysis (Table 1) plays a role in synaptic vesicle endocytosis. Indeed, it is known 
that in neuromuscular junctions actin polymerization is required for fast endocytosis (506, 
Watanabe 2013). Thus, when actin polymerisation was blocked in cultured neurons, the failure 
of ultrafast endocytosis leads to clathrin-mediated endocytosis on the plasma membrane. In other 
words, in the absence of ultrafast endocytosis, synaptic vesicles are retrieved directly from the 
plasma membrane by clathrin-mediated endocytosis (507, Watanabe, 2014). 
The possibility that PEBP1 plays also a role at the mitochondrial membrane was suggested 
by the fact that mitochondrial ATP synthase was identified in the interactome of overexpressed 
PEBP1 in gastric cancer cell (Table1). Furthermore, GRK2 antagonized ATP loss after 
hypoxia/reperfusion and was detected to localize in the mitochondrial outer membrane. Raf-1 
was also encountered at the mitochondrial membrane (284, Fusco). During hepatitis B virus X-
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mediated hepatocarcinogenesis, the PEBP1 downregulation induced the translocation of Raf-1 
into mitochondria by increase of the free Raf-1 level in the cytosol (286, Kim). 
  
Vesicles are common features between endocytosis, autophagy and exocytosis. The early 
endosomes, late endosomes, autophagosomes and exosomes are in fact a continuum of vesicles 
and their membranes originate from different cell organelles such as plasma membrane but also 
from reticulum endoplasmic and mitochondria (446, Huotari). Endosomes play a role in signal 
propagation by facilitating the recruitment and integration of signaling cascades on the surface of 
endocytic vesicles (355, Emery) and it was demonstrated that canonical GPCR signaling occurs 
from plasma membrane and from endosomes (356, Irannejad). In fact, endosomes are platforms 
to transport signaling pathways, but they are also a physical platform for signaling complex 
assemblies where endosomal scaffolds can facilitate crosstalk between the recruited kinases (358, 
Palfy). Considering that PEBP1 controls signal transduction by inhibiting kinases, it is tempting 
to propose that PEBP1 uses endosomes to preserve signal intact during transport. It seems likely 
that the inhibition of kinases is needed to synchronize the fast kinases activities with the time 
necessary to transfer the signal across the whole cell during vesicle trafficking. It is also essential 
to synchronize the downstream physical membrane and cytoskeleton reorganization in response 
to proper signaling. We propose that PEBP1 may play a role in signal conservation during vesicle 
trafficking and synchronize the pathway signaling with cellular processes. In addition, endosomes 
could also be platforms where PEBP1 may coordinate various signaling pathways between them. 
 
7.4- Common features and molecular interactions in cellular processes. 
On the molecular point of view, PEBP1 appears to prevent several cellular mechanisms by 
dissociating interaction between partners. 
7.4.1- PEBP1 dissociates the pathway cascades.  
PEBP1 inhibits signaling pathways by physical interaction with the enzymes of the 
pathways. This was well demonstrated for Raf/MEK/ERK (78, Yeung 2000), TAK/NIK/NF-B 
(91, Yeung 2001; 93, Tang). Direct interaction was also found with GRK2 (88, Lorenz), GSK3 
(96, Al-Mulla, 2011), STAT3 (98, Yousuf) and Notch1 (18, Noh). 
7.4.2- PEBP1 prevents the primary cilium formation.  
It was shown that Cep290-mediated photoreceptor degeneration is associated with aberrant 
accumulation of PEBP1, and that Cep290 physically interacts with PEBP1. The concentrated 
signal of PEBP1 at the apical inner segment, transition zone, and to a lesser extent, at the basal 
body and centriole of the photoreceptors, together with its ability to interact with Rab8A 
suggested its involvement in the regulation of docking and transport of membrane protein-
containing vesicles in photoreceptors (75, Murga- Zamalloa). The ectopic accumulation of 
PEBP1 led to defective cilia formation in zebrafish and cultured cells, this effect being mediated 
by the interaction of PEBP1 with the ciliary GTPase Rab8a.  PEBP1 preferentially associated 
with Rab8a in the presence of GDP substrate, suggesting that the PEBP1-Rab8a (GDP) complex 
may need to dissociate for the release of Rab8a-GDP and subsequent conversion to Rab8a-GTP 
for appropriate ciliary transport (75, Murga-Zamalloa). Primary cilia are microtubule-based 
organelles that are generated from mother centrioles (also called basal body) by an evolutionarily 
conserved process called intraflagellar transport (IFT). IFT and other ciliary proteins facilitate 
cilia formation and maintenance by cooperating with small GTPases such as Rab8a (75, Murga-
Zamalloa). Activation of Rab8 is linked to the formation of filopodia, lamellipodia, protrusions, 
ruffles, and primary cilia, whereas inhibition of Rab8 affects negatively their appearance. All 
these structures are containing actin (508, Peranen). Rab8 was also associated with focal 
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adhesions, promoting their disassembly in a microtubule-dependent manner. This Rab8 effect 
involved calpain, MMP14 and Rho GTPases. Moreover, the role of Rab8 was also demonstrated 
in the cell migration process. The data revealed that Rab8 drives cell motility by mechanisms 
both dependent and independent of Rho GTPases, thereby regulating the establishment of cell 
polarity, turnover of focal adhesions and actin cytoskeleton rearrangements, thus determining the 
directionality of cell migration (152, Bravo-Cordero). A specific role of Rab8 in signaling and 
endocytosis (509, Esseltine) and in protrusion (510, Vidal-Quadras) was also described in 
details. 
7.4.3- PEBP1 delays mitosis.  
By allowing the control of mitotic spindle checkpoint PEBP1 delays mitosis. Loss of 
PEBP1 accelerates G1/S and leads to the bypass of mitotic checkpoint (155, Eves). At the 
kinetochore, Aurora B phosphorylates, and thereby inactivates, the microtubule-destabilizing 
proteins mitotic centromere-associated kinesin and stathmin, which promotes microtubule growth 
around kinetochores (319, Prosser). By inhibiting Aurora B, PEBP1 prevents microtubule 
growth around kinetochores that is consistent with the report that PEBP1 depletion causes an 
override of mitotic checkpoints induced by spindle poisons such as Taxol (155, Eves).  
7.4.4- PEBP1 blocks autophagy initiation.  
By sequestering LC3, PEBP1 prevents its association with phosphatidylethanolamine (44, 
Noh). LC3 was first identified as one of three light chains associated with purified 
microtubule‑associated protein (MAP)1A and MAP1B and is considered to be involved in 
microtubule assembly/disassembly (142, Tang). However, the function of LC3 is known to 
extend above and beyond its role in autophagosome formation. Especially, the cytoplasmic 
nonlipidated form, interacts with the Chlamydia trachomatis inclusion as a microtubule-
associated protein rather than an autophagosome-associated component. Inclusion-bound LC3 
was shown to be connected with the microtubular network and depolymerization of the 
microtubular architecture disrupted the association of LC3/MAP1s with the inclusion (511, Al-
Younes).  
Thus, in signaling pathways, primary cilium, mitosis and autophagy, PEBP1 delays the 
mechanisms to allow their initiation at the correct time and space. PEBP1 acts by targeting key 
proteins such as GRK2, Aurora B, LC3 and Rab8. In all these processes, PEBP1 appears to 
protect the inactive form of its targets preventing their activation. The association/dissociation of 
PEBP1 from its target is controlled by posttranslational modifications of PEBP1, especially 
phosphorylation. 
 
7.5- Direct partners of PEBP1 interact with cytoskeletal elements 
Interestingly, most of the described partners of PEBP1 are known to interact with 
cytoskeletal elements. Here are some examples. 
7.5.1- ERK. 
The signaling ERK pathway is known to be implicated in cytoskeleton organization and 
cell motility but it may act in association with PI3K pathway. In human breast tumor cells MDA-
MB-231 LM2, the Ras-ERK pathway was found responsible for the disruption of stress fibers 
and for the expression of genes associated with the lung metastasis signature. However, inhibition 
of the Ras-ERK pathway did not result in inhibition of cell motility but was accompanied by 
activation of the PI3K pathway. Inhibition of both ERK and PI3K pathways was required to 
inhibit motility of MDA-MLM2 cells (512, Choi). 
7.5.2- NF-κB inducing kinase (NIK). 
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A constitutive association between filamin A and the NF-κB inducing kinase (NIK), in both 
Jurkat and human primary T cells was identified. CD28 (Cluster of Differentiation 28) is one of 
the proteins expressed on T cells that provide co-stimulatory signals required for T cell activation 
and survival. Both proline and tyrosine residues within the C-terminal proline-rich motif of CD28 
are involved in the recruitment of filamin A/NIK complexes to the membrane as well as in the 
activation of NIK and IKKα (513, Muscolini). 
7.5.3- GRK2 
Since a long time GRK2 is considered to bind and phosphorylate tubulin (514, Haga). 
More recently, GRK2 appears to be a key integrative node in cell migration control. GRK2 was 
identified as a modulator of diverse molecular processes involved in motility, such as gradient 
sensing, cell polarity or cytoskeletal reorganization. GRK2 dynamically associates with and 
phosphorylates HDAC6 to stimulate its α-tubulin deacetylase activity at specific cellular 
localizations such as the leading edge of migrating cells, thus promoting local tubulin 
deacetylation and enhanced motility (515, Lafarga). Thus, GRK2 can play an effector role in the 
organization of actin and microtubule networks and in adhesion dynamics, by means of substrates 
and transient interacting partners, such as the GIT1 scaffold or the cytoplasmic HDAC6. The 
overall effect of altering GRK2 levels or activity on chemotaxis would depend on how such 
different roles are integrated in a given cell type and physiological context (516, Penela). 
7.5.4- GSK3 
Several studies described the relationships between GSK3 and cytoskeleton. As an 
example, mechanistically, GSK3β signaling promoted preferential hematopoietic stem and 
progenitor cell migration by regulating actin rearrangement and microtubule turnover, including 
CXCL12-induced actin polarization and polymerization (517, Lapid).  
7.5.5- STAT3 
Cytoplasmic STAT3 was demonstrated to interact with both tubulin and microtubules. The 
localization of STAT3 on microtubules and its activation are independent of HDAC6 activity. 
Moreover, cytoplasmic STAT3 is physically associated with microtubules, whereas its activation 
and nuclear translocation are independent of microtubule dynamics, implicating that the 
association of STAT3 with microtubules might be involved in the regulation of non-canonical 
functions of STAT3 in the cytoplasm (518, Yan).  
7.5.6- Notch 
The Notch pathway has been recognized as one of the main contributors in regulating 
neural development and has been proposed as a key mediator in neuroplasticity by modulating 
neuronal cytoskeleton (519, Bonini). Several pathways are implicated in the microtubule 
assembly/disassembly process, among them Notch acts as a microtubule dynamics regulator. It 
was demonstrated that activation of Notch signaling results in increased microtubule stability and 
changes in axonal morphology and branching. By contrast, Notch inhibition leads to an increase 
in cytoskeleton plasticity with intense neurite remodeling (520, Bonini). 
7.5.7- Drugs and prodrugs 
The drugs fortunately found to be captured by PEBP1 (i.e. PDE5 inhibitors, locostatin, 
prasugrel) may interact also with cytoskeletal elements. Chronic treatment with the PDE5 
inhibitor Tadalafil used in diabetic patients was demonstrated to modulate proteins involved in 
cytoskeletal rearrangement and redox signaling of the heart, which may explain the beneficial 
effects of PDE-5 inhibition in diabetes (521, Koka). The protective effect of PEBP1 against 
locostatin, a drug inhibition of migration, suggested a new role for PEBP1 in potentially 
sequestering toxic compounds that may have deleterious effects on cells (263, Shemon). The 
prodrug Prasugrel hydrolyzed by PEBP1 is a P2Y12 receptor antagonist. In cultured Vascular 
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Smooth Muscle Cells (VSMCs), the activation of P2Y12 receptor inhibited cAMP/protein kinase 
A signaling pathway, which induced cofilin dephosphorylation and filamentous actin 
disassembly, thereby enhancing VSMCs motility and migration (522, Niu).  
All these data suggest that PEBP1 may be implicated in protection and organization of 
cytoskeleton. 
 
7.6- Cytoskeleton in cancer 
Interestingly, metastatic disease, or the movement of cancer cells from one site to another, 
is a complex process requiring dramatic remodeling of the cell cytoskeleton. The various 
components of the cytoskeleton, actin (microfilaments), microtubules (MTs) and intermediate 
filaments, are highly integrated and their functions are well orchestrated in normal cells. In 
contrast, mutations and abnormal expression of cytoskeletal and cytoskeletal-associated proteins 
play an important role in the ability of cancer cells to resist chemotherapy and metastasize. 
Studies on the role of actin and its interacting partners have highlighted key signaling pathways, 
such as the Rho GTPases, and downstream effector proteins that, through the cytoskeleton, 
mediate tumour cell migration, invasion and metastasis. An emerging role for MTs in tumour cell 
metastasis is being unravelled and there is increasing interest in the crosstalk between key MT 
interacting proteins and the actin cytoskeleton (523, Fife). 
It was illustrated that the proportion of microtubules and actin microfilaments is different in 
grade I and grade IV colon cancer cells in a manner that microtubules attain an effectual role in 
progressive reorganization of cytoskeleton in transition from nonaggressive to malignant 
phenotypes in cancer cells. Furthermore, it was concluded that larger instantaneous Young's 
modulus value (which defines the relationship between stress and strain in a material) for high 
grade cells is related to the existence of extensively build-up actin networks at the cell cortex 
(524, Pachenari). The ability of a eukaryotic cell to resist deformation, to transport intracellular 
cargo and to change shape during movement depends on the cytoskeleton, an interconnected 
network of filamentous polymers and regulatory proteins. Recent work has demonstrated that 
both internal and external physical forces can act through the cytoskeleton to affect local 
mechanical properties and cellular behavior. An important insight emerging from this work is 
that long-lived cytoskeletal structures may act as epigenetic determinants of cell shape, function 
and fate (186, Fletcher).  
 
7.7- Actin filaments and microtubules are tension sensors 
While the actin filament (F-actin) has been viewed as dynamic in terms of polymerization 
and depolymerization, more recent results suggested that F-actin itself may function as a highly 
dynamic tension sensor (525, Galkin). Tensile forces generated by stress fibers drive signal 
transduction events at focal adhesions and it was reported that stress fibers act as a platform for 
tension-induced activation of biochemical signals. ERK is activated on stress fibers in a myosin 
II-dependent manner. By quantifying myosin II- or mechanical stretch-mediated tensile forces in 
individual stress fibers, ERK activation on stress fibers correlated positively with tensile forces 
acting on the fibers, indicating stress fibers as a tension sensor in ERK activation. Myosin II-
dependent ERK activation is also observed on actomyosin bundles connecting E-cadherin 
clusters, thus suggesting that actomyosin bundles work as a platform for tension-dependent ERK 
activation. (526, Hirata). A single actin filaments was placed under tension using optical 
tweezers. When a fiber was tensed, it was severed after the application of cofilin with a 
significantly larger delay in comparison with control filaments suspended in solution. The 
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binding rate of cofilin to an actin bundle decreased when the bundle was tensed, resulting in a 
decrease in its effective severing activity (527, Hayakawa).  
In yeast kinetochore, the Ndc80 complex (Ndc80, Nuf2, Spc24 and Spc25) is a highly 
conserved protein essential for end-on anchorage to spindle microtubule plus ends and for force 
generation coupled to plus-end polymerization and depolymerization. Spc24/Spc25 at one end of 
the Ndc80 complex binds the kinetochore, the N-terminal tail and calponin-homology domains of 
Ndc80 bind microtubules, and an internal domain binds microtubule-associated proteins such as 
the Dam1 complex. A mechanical model of force generation at metaphase was proposed where 
the position of the kinetochore relative to the microtubule plus end reflects the relative strengths 
of microtubule depolymerization, centromere stretch and microtubule-binding interactions with 
the Ndc80 and Dam1 complexes (528, Suzuki).  
 
7.8- Main properties and functions of PEBP1 
In summary of the main molecular specifications of PEBP1, we can say: 
- PEBP1 is essentially implicated in cell processes implying membrane changes and cytoskeleton 
reorganization (e.g. cell motility, autophagy, cytokinesis, primary cilium formation). 
- By direct interaction, PEBP1 inhibits several proteins containing nucleotide sites, particularly 
kinases of main signaling pathways, GRK2, Aurora B and the GTPase Rab8. 
- PEBP1 is a switch that inhibits or releases specific targets depending on its own 
posttranslational modifications. By blocking signaling pathways kinases, GRK2, Aurora B and 
LC3, PEBP1 exerts a spatiotemporal control of signaling pathways, receptors internalization, 
mitotic spindle checkpoint and phagocytosis initiation, respectively. 
- PEBP1 binds small ligands such as nucleotides, locostatin, polyphenols and drugs. It may act as 
a hydrolase. 
- Depending on the small ligands present in the cell, PEBP1 is a modulator of interactions 
between protein kinases of main signaling pathways.   
- PEBP1 may act as a cytoskeleton protector by stabilizing proteins (Keap1), or destabilizing 
toxic compounds that may have deleterious effects on cells (locostatin). 
- As an interaction controller, PEBP1 may synchronize the fast activity of enzymes (e.g. kinases 
and Rab8 GTPase) with the time necessary for the downstream physical organization of 
membrane and cytoskeleton that is needed to perform cellular processes.  
All the cellular processes in which PEBP1 is implicated are in very close relationships, they 
constitute a variety of cellular responses to external or internal signals. A large majority of these 
processes leads to membrane changes and all of them are underlain by cytoskeleton 
rearrangement. PEBP1 participates in sensing the plasma membrane status by acting on receptors 
internalization and by controlling the formation of primary cilium that is a sensory organelle. The 
continuity between the sensing of physical and chemical membrane status (captured notably by 
actin) and the cytoskeletal reorganization is assumed by several signaling pathways. It is likely 
that the circuits regulating the cellular response to signals may be multiple and more or less long, 
depending on cell status and signaling pathways in action. 
Most of the proteins interacting with PEBP1 are themselves involved in great cellular 
functions such as proliferation, differentiation, division, survival and motility by interacting with 
several targets, thus confirming the existence of consistent molecular complexes regulating cell 
processes. Furthermore, the fact that in cancer cells, overexpressed PEBP1 interacts with proteins 
governing cytoskeletal network, glycolysis and protein biosynthesis is in concordance with the 
need of energy and protein synthesis for cancer cells. It is likely that these interactions may also 
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exist in non-pathological conditions, suggesting a coordinated link of cytoskeletal organization 
with energy and protein biosynthesis needed to perform cytoskeleton changes.  
It is interesting to note that PEBP4 was described to act as a chaperone and did not display 
the regulator effect of PEBP1. Consequently, its global effect is the opposite of that of PEBP1, 
favoring motility and migration of cells (529, Zhang). On the contrary, TFL1 and FT1 in plants 
confirm a role of PEBP family to sensing cell membrane and controlling signaling pathways, 
consistent with their implication in adaptation of cells to their environment by regulating 
circadian rhythm and temperature depending thermo-sensitive flowering regulation (530, Kim). 
 
In conclusion 
In addition to regulate protein kinases, PEBP1 possibly regulates also guanine exchange 
factors as GPCRs and GTPases such as Rab8. PEBP1 is involved in integrative system(s) which 
lead and control various phenomena such as membrane sensing, cellular shape and vesicular 
traffic, all depending on cytoskeleton organization. PEBP1 is a modulator of molecular 
interactions which adjusts signaling pathways and works as a switch between them in order to 
block or initiate specific cellular mechanisms, allowing the cell to constantly adapt to its 
microenvironment. Mechanically, PEBP1 acts as a node between signaling pathways and 
cytoskeleton organization by targeting specific proteins. Then, it is convenient that PEBP1 may 
interact directly or indirectly with components of cytoskeleton as actin, tubulin and vimentin. 
PEBP1 is a modulator of molecular interactions, it may stabilize or destabilize some protein 
partners and ligands. It inhibits several signaling pathway kinases and key proteins having hand 
in cytoskeleton organization such as GRK2, Aurora B and LC3. Cytoskeletal organization is a 
complex and integrative mechanism, it underlies numerous cellular mechanisms and is implicated 
in main cellular diseases such as cancer, Alzheimer’s, ciliopathies and diabetic nephropathy. 
The levels of PEBP1 concentration seem to be essential for its action as well as the 
presence and concentration of other partners and different ligands in the cell, particularly ATP. 
The level of PEBP1 expression is controlled by complicated loops and is influenced by various 
small ligands such as ATP and polyphenols. Its rapid degradation is conducted by chaperone-
mediated autophagy. In cancer cells, methylation of the promotor region in the gene encoding 
PEBP1 was demonstrated explaining the downregulation of PEBP1 in these cells.  
Thus PEBP1 seems to adapt interactions between partners according to the cell status and 
to the presence of different ligands into the cell. This action may allow the correct response of the 
cell according to its external environment and also to its internal composition. In addition, the 
sharp regulation of molecular interactions likely permit to adapt reciprocal conversion of 
chemical forces represented by molecular interactions to physical forces generated by membrane 
deformation and cytoskeleton tension. 
As saying that the fine-tuned interactions between PEBP1 and its partners are far from to be 
determined. In the future, a particular effort should be made to decipher what leads to the 
complex and kinetic interactions between all these molecular actors. Probably, in addition to the 
basic affinity between them, it will be useful to consider the intracellular medium, the location of 
the molecular partners, their reciprocal concentration and input order of appearance as well as the 
dynamics of the events in which they are implicated. 
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Table I – Close partners of PEBP1  
 
Uniprot ID Protein name Protein function 
   
 I- Cytoskeleton-related proteins (28%) 
 
 Microtubules  
P07437 Tubulin beta chain (SNO) Major constituent of microtubules 
 
 Actin filaments and actin binding proteins 
P60709 Actin cytoplasmic 1 (SNO) Involved  in various types of cell motility 
  
Q15149 Plectin, isoform 1 Actin binding 
 
P52907 F-actin-capping protein subunit alpha 1 Actin binding 
 
P18206 Vinculin, isoform 1 Actin-filament binding protein 
 
 Intermediate filaments  
P05783 Keratin type I cytoskeletal 18 Cytoskeleton of intermediate filaments 
 
P05787* Keratin type II cytoskeletal 8* Cytoskeleton of intermediate filaments 
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P08670 Vimentin Cell motility, structural constituent of 
cytoskeleton 
 Organization of the cytoskeleton, multifunctional proteins 
P35579 Myosin-9 Cytokinesis, secretion, affects actin 
cytoskeleton 
 
P46940 Ras GTPase-activating-like protein 
IQGAP1 
Actin cytoskeleton, cell adhesion, cell cycle, 
ERK pathway modulation, transcription 
 
 II Protein biosynthesis (22.8 %) 
  
P68104 Elongation factor 1-alpha 1 GTPase, delivery of aminoacyl-tRNAs to the 
ribosome 
 
P41252 Isoleucyl-tRNA synthase cytoplasmic Isoleucine-tRNA ligase, ATP binding 
 
P26640 Valyl-tRNA synthase Valine-tRNA ligase, ATP binding 
 
P26641 Elongation factor 1-gamma Delivery of aminoacyl tRNAs to the 
ribosome 
 
P13639 Elongation factor 2 GTP-dependent translocation of the 
ribosome 
 
P60842 Eukaryotic initiation factor 4A-1 Binding of mRNA to 40S ribosomal subunits, 
ATP-dependent RNA helicase 
 
P63244 Guanine-nucleotide-binding protein 
subunit beta-2-like1 
 
Major component of translating ribosomes 
 
P23396 40S ribosomal protein S3 Ribosomal domain where translation is 
initiated 
 
 III Glycolytic enzymes (17%) 
 
P14618 Pyruvate kinase isozymes M1/M2 (SNO) Final step of glycolysis, production of 
pyruvate and ATP 
 
P04406 Glyceraldhehyde-3-phosphate 
dehydrogenase (SNO) 
 
G3P dehydrogenase, nitrosylase activity 
 
P07195 L- lactate dehydrogenase B chain (SNO) L-lactate dehydrogenase activity 
 
P00338 L- lactate dehydrogenase A chain (SNO) L-lactate dehydrogenase activity 
 
P06733 Alpha-enolase (SNO) Multifunctional enzyme 
 
P04075 Fructose-bisphosphate aldolase A (SNO) Production of DHAP and G3P, Actin 
binding 
 
 121 
 
 IV- Molecular chaperones (14.3%) 
 
P08238* Heat shock protein HSP-90 beta* Stress related 
 
P11142 Heat shock cognate 71 kDa (SNO) Stress related 
 
P07900 Heat shock protein HSP-90 alpha Stress related 
 
P38646 Stress-70 mitochondrial Related with cell proliferation and aging 
 
P10809 60kDa heat shock protein, mitochondrial Stress related 
 
 V- Mitochondrial proteins (5.7%) 
 
P06576 ATP synthase subunit alpha 
mitochondrial 
 
Mitochondrial membrane ATP synthase 
 
P21796 Voltage-dependent anion-selective 
channel protein 1 VDAC1 (SNO) 
 
Voltage-gated anion channel activity 
 
 VI- Transport of proteins and vesicles (5.7%) 
 
Q14974 Importin subunit beta 1 Protein domain specific binding (NLS), 
transport into the nucleus 
 
Q00610 Clathrin heavy chain 1 Polyhedral coat of coated pits and vesicles 
 
 VII- Others (5.7%) 
 
P04083 Annexin A1  Ca2+-dependent phospholipid-binding 
proteins, phospholipase A2 inhibitory 
activity 
 
P62258* 14-3-3 protein epsilon* (SNO) Binding of signaling proteins, recognition 
motif 
 
 
Table 1- The 35 proteins close partners of PEBP1 identified by MiMI analysis (159, Gu H 
2013). They are gathered in seven families. The percentage following the name of each family is 
representative of the number of proteins in the family against the total of 35 proteins. The 7 
proteins identified as close partners of PEBP1 with the three protein network diagrams are 
indicated in bold characters and underlined. The three proteins identified for the first time as 
partners of PEBP1 are indicated by a star. (SNO), S-nitrosylated proteins in Alzheimer’s disease 
(261, Zahid). 
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Table II - Main cellular processes implying PEBP1 
 
 
 
Cellular processes 
 
PEBP1 activity  
 
 
Modulation of signaling pathways 
Inhibition of Raf/MEK/ERK, GRK2, NFkB, PI3K/Akt, 
p38MAPK, Wnt, STAT3, LIN28/Let-7 miRNA 
Activation of GSK3 
 
Internalization of receptors and 
desensitization      
GPCRs: opioid receptors, beta-adrenergic receptors, 
VPACs 
 
 
Neural development 
 
Differentiation into neurons and oligodendrocytes 
 
 
Neuronal synapse 
 
Neuronal plasticity: long-term synaptic depression, 
long-term potentiation 
 
 
Hippocampal presynaptic terminals 
 
Co-localization with CRMP-2 
 
 
Rat intestine nerve cells 
 
Stored in axon terminals 
 
 
Vesicles formation and trafficking 
 
Exosomes, autophagosomes, endosomes  
  
 
Primary cilium 
 
Prevention of primary cilium formation 
 
 
Mitotic spindle checkpoint 
 
Inhibition of Aurora B 
 
 
 
Apoptosis 
- Pro-apoptotic via Raf1/MEK/ERK and NFkB 
pathways 
- Anti-apoptotic under oxygen-glucose deprivation, 
through IKK/IkB/NFkB pathway 
 
 
Autophagy 
 
Inhibition of autophagy initiation; interaction with 
LC3-I 
 
 
Cell motility 
Inhibition of cell invasion and metastasis, except via 
GSK3 
Regulation of MMPs and miRNAs expression 
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Cell adhesion 
Increased adhesion to substratum, decreased cell-cell 
adhesion 
 
 
Table II - Main cellular processes implying PEBP1. PEBP1 was described to participate in 
several cellular processes, most of them implicate plasma membrane and cell shape changes. The 
role of PEBP1 in each process is mentioned. 
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Figure 1 
 
 
 
 
Figure 1. Main signaling pathways modulated by PEBP1. Direct binding of PEBP1 with 
several pathway kinases were demonstrated. Moreover, the pathways are known to be 
interconnected and to crosstalk between them.  Stimulation,  inhibition. 
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Figure 2 
 
 
Figure 2. PEBP1 interactions with kinases and small ligands. Upper part, the surface model of 
PEBP1, lower part, the ribbon model. A pocket is indicated, it is the binding site of PEBP1 for 
small ligands (particularly nucleotides, cacodylate, phosphate, acetate, phospholipids and PDE5 
inhibitor). The protein kinases modulated by PEBP1 were described to interact with the binding 
site and also with two regions situated on the edges of a shallow furrow beneath the binding site, 
these two regions are colored in magenta. When phosphorylated, Ser153 shifts PEBP1 binding 
from Raf-1 to GRK2. The 3D structure was published by Serre et al. (23, Serre) and the 
predicted interaction sites based on this structure was published in (263, Martin). 
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Figure 3 
 
 
Figure 3. Schema of primary cilia structure. The ciliary skeleton is composed of axoneme and basal 
body. The transition zone is indicated by Y-shaped bridges extending from microtubule doublets to ciliary 
membrane and distal appendages, it corresponds to the transition between microtubule triplets (basal body 
and distal appendages) to microtubule doublets (axoneme). PEBP1, CEP290 and Rab8 were described to 
interact at the transition zone (77, Murga-Zamalloa). Primary ciliary pocket is defined to be membrane 
domain starting from distal appendages to the region where ciliary sheath emerges to extracellular 
environment. Primary cilia pocket plays a role in endocytosis. Incoming vesicles (from Golgi complex) 
dock at membrane junction at distal appendages and keep balances between ciliary membrane addition 
and removal (390, Ke YN). One pathway for protein targeting to the ciliary membrane is led by the 
BBSome and its interactor Arl6, which recruits Rab8 and its guanine nucleotide exchange factor Rabin8 at 
the base of the cilium. Rabin8 is transported to this location in Rab11+ vesicles. Some membrane receptors 
destined for the ciliary membrane are transported from the trans-Golgi network apparatus to Rab8+ 
vesicles with the assistance of the adapter AP-1 (407, Fenetti). In this figure, the general drawing of the 
primary cilium is based on Fig. 1 from (390, Ke YN ) and the transport of Rab proteins is inspired by fig.1 
from (407, Finetti). 
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Figure 4 
 
 
Figure 4. Schema of mitotic spindle. In this figure, the overview of the mitotic spindle is drawn 
according to Fig.1 in (321, Prosser).The chromosomes attach to the microtubules via kinetochores on the 
centromere of each sister chromatid. Three nucleation pathways drive the formation of microtubules to 
form the mitotic spindle: nucleation pathway from the centrosome, from the chromatin and from 
microtubules. The resulting spindle comprises three different types of microtubules: the kinetochore 
microtubules which attach the chromosomes to the spindle poles and move the sister chromatids apart, 
non-kinetochore microtubules which originate from the opposing poles, help to separate them and provide 
stability to the spindle, and astral microtubules which radiate out from the poles, contact the cell cortex, 
and play a part in spindle positioning. Once 20–30 Kinetochore microtubules have attached to the 
kinetochore, they become stabilized into bundles called kinetochore fibers.  
The centre of the figure shows the mechanism by which microtubules grow from kinetochore. At the inner 
centromere (the part of chromosome that links sister chromatids) Haspin phosphorylates histone H3, 
which leads to the recruitment of the chromosome passenger complex (CPC) and trans-
autophosphorylation activation of Aurora B. Then Aurora B phosphorylates, and thereby inactivates, the 
microtubule-destabilizing proteins mitotic centromere-associated kinesin (MCAK) and stathmin (STMN1) 
which promotes microtubule growth around kinetochores. PEBP1 is an inhibitor of Aurora B, it prevents 
microtubule growth around kinetochore (321, Prosser).  
 
